







CHARACTERIZING A STRUCTURAL AND FUNCTIONAL MODEL OF NITRIC OXIDE 



















Submitted in partial fulfillment of the requirements 
for the degree of Doctor of Philosophy in Biochemistry  
in the Graduate College of the 








 Doctoral Committee:  
 
  Professor Yi Lu, Chair 
  Professor Robert Gennis 
 Assistant Professor Erik Procko  




Nitric oxide reductase (NOR) is a membrane-bound metalloenzyme in the denitrification 
pathway of many bacteria. NORs are structurally homologous to subunit I of HCOs (heme-copper 
oxidases); however, the copper site (CuB) in HCOs is replaced with a non-heme iron site (FeB) in 
NOR, and each metal contains a different primary and secondary coordination sphere.1 NOR and 
HCO also have cross-reactivity, though they are more reactive toward their native substrate. NOR 
is capable of O2 reduction and some members of the HCO superfamily are capable of NO 
reduction.2–4 Therefore, an important question is whether the identity of the metal helps tune 
activity in homologous protein metal binding sites, namely the CuB site in HCO and the FeB site 
in NOR. 
A CuB site was engineered into the scaffold protein myoglobin (CuBMb).
5 However, FeII 
binding was not observed in CuBMb. To mimic the conserved glutamate(s) in NOR, and aim to 
also bind FeII, a glutamate was introduced near the heme of CuBMb, called FeBMb. 
Crystallographic and/or spectroscopic studies showed that FeBMb could bind Fe or Cu in its 
engineered FeB site, and was observed to be both a structural and functional model of native NORs 
through multiple generations of mutants6,7 Still remaining to be understood are detailed studies 
about the particular roles that specific designed features play in conferring and fine-tuning the 
different reactivities of FeBMb. 
This thesis describes work utilizing FeBMb to better describe the role of structural features, 
such as nonheme metal ion, in conferring biologically significant activities such as NO and O2 
reduction. A detailed understanding of the role that nonheme Fe plays in NOR reactivity in FeBMb 
was previously unexplored, but replacement of Fe-PPIX with Zn-PPIX allowed for detailed 
spectroscopic characterization of the nonheme Fe-nitrosyl species.8 Enrichment of each site with 
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57Fe allowed for advanced NRVS measurements of all vibrational modes of the 57Fe sites, as well 
as any 57Fe-nitrosyl species, important for understanding mechanistic intermediates in the NOR 
reaction.9 Unique studies of the reactivity of FeBMb performing both NO and O2 reduction while 
utilizing nonheme Fe, Mn, Co, and Cu were also carried out. Finally, work aimed at engineering 
more complex metal binding sites, such as those for the FeMo cofactor of nitrogenase, utilizing 
the Rosetta software suite are described in detail. 
Insights gained from the study of FeBMb and its relevance to NOR and HCO include 
evidence to support the so called trans mechanism of NO reduction, whereby 2 molecules of NO 
bind at the FeBMb active site, one to each Fe, before N2O formation. Additionally, NRVS 
measurements demonstrated site-specific 57Fe-labelling of both the heme and nonheme sites of 
FeBMb, and identified nitrosyl species for each. Replacement of nonheme Fe with other metals, 
such as Mn and Co, identified a nonheme metal redox-inactive mechanism of O2 reduction in 
FeBMb. These results demonstrate that the use of small, easy to characterize, experimentally 
tractable mimics of larger, more complex native metalloenzymes provides a wealth of knowledge 
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Chapter 1 Introduction 
1.1 Bacterial Nitric Oxide Reductases (NOR) 
1.1.1 The nitrogen cycle and the importance of rational protein design in understanding how 
metalloproteins function 
Nitrogen is the fifth most abundant element in the solar system, along with hydrogen, 
carbon, and oxygen, and is one of the key elements for life.10 For every 100 atoms of carbon 
incorporated into cells, between 2 to 20 atoms of nitrogen follow.11 Thus, it is clear that to better 
understand the role that nitrogen plays in biological processes, the chemical transformations 
underlying the nitrogen cycle (Figure 1.1) must also be understood. Briefly, the nitrogen cycle 
encapsulates the numerous biogeochemical transformations of nitrogen as it circulates through the 
atmosphere, terrestrial, and marine ecosystems. Among the cycle itself are various processes, such 
as the conversion of N2 to NH3 (nitrogen fixation), the formation of NO3
- from more reduced forms 
of nitrogen (nitrification), and the use of NO3
- and NO2
- as electron sinks in the absence of O2 
(denitrification).10 Given that this cycle is almost entirely reduction-oxidation (redox) based 
reactions carried out by microorganisms containing complex metalloenzymes with comparably 
complicated active sites, tools are needed to help study such systems in greater depth, and without 




Figure 1.1. The nitrogen cycle, as adapted from 10. Genes encoding enzymes amongst the various pathways are 
labelled in red. Oxidation state is given on the y-axis, with aerobic and anaerobic processes separated along the x-axis. 
Metalloproteins account for nearly half of all proteins in nature.13 In addition to many of 
the reactions of the nitrogen cycle, critical life processes such as photosynthesis14 and respiration15 
are also carried out by metalloproteins. Thus, it has become an ultimate test of our knowledge to 
design new metalloproteins that not only reproduce the structures of native proteins, but also their 
functions.16–19 Such studies are a complement to the traditional biophysical and biochemical 
‘bottom-up’ approach to studying metalloenzymes. These studies reveal what features, when 
removed through mutagenesis, lead to a loss of function. On the other hand, protein design requires 
that structural features are necessary and sufficient for function be introduced. 
As mentioned above, many of the chemical transformations of the nitrogen cycle are redox 
processes carried out by metalloenzymes. However, studying such native enzymes can be 
complicated by the fact that many these systems are large and membranous, such as nitric oxide 
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difficult, and contain many different metal binding sites, which complicate spectroscopic 
analysis.20–29 At present, only 2 crystal structures of NOR have been published, one without bound 
ligands,1 and one with ligand analogues bound at the active site.30 Such difficulties highlight the 
need for new ways to study the structure-function relationship of such metalloproteins. 
1.1.2 Denitrification, the importance of nitric oxide (NO), nitrous oxide (N2O) and NOR 
Denitrification is a means by which many bacteria, and some archaea, continue to carry 
out respiration in the absence of O2 using a variety of different metalloenzymes.
31 This so-called 
anaerobic respiration can be performed by these organisms through the use of NO3
- and NO2
- as 
electron acceptors, and the sequential reduction from nitrate (NO3
-)  nitrite (NO2
-)  nitric oxide 
(NO)  nitrous oxide (N2O)  nitrogen (N2).
32 Essential in this process is the 2-electron, 2-proton 
reduction of NO to N2O (2NO + 2H
+ + 2e-  N2O + H2O), which is carried out by NOR. 
NO was identified in the 1980s to play an important role in biology, but was not fully appreciated 
until 1992, when it was proclaimed the “Molecule of the Year”.33,34 Since then, NO has been 
studied extensively, and found to impact a wide array of biological processes, from blood pressure 
regulation,35 neurotransmission,36 and the immune response in mammalian cells,37 to 
transcriptional regulation and biofilm formation in bacteria.38,39 NOR also plays an important role 
in the increased survival of pathogenic bacteria such as Pseudomonas aeruginosa, a major player 
in Cystic Fibrosis, by helping to detoxify host immune system-generated NO from neutrophils.40 
Furthermore, the nitrous oxide generated in the reduction of NO also has a variety of effects. The 
global nitrogen cycle has been disrupted by the use of artificial fertilizers, which leads to an 
increase in N2O production. N2O is known to be both a potent greenhouse gas and ozone depleting 
substance.41Yet despite the biochemical, biomedical, and environmental significance of both NO 
and N2O, there remains a lack of evidence and study on the specific structural features responsible 
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for NOR activity, and a clear mechanistic understanding of the reaction is still contentious, 
especially for the membrane-bound NORs from bacteria.42,43 
1.1.3 Types of NOR (i.e., bacterial and fungal) 
Curiously, there are a number of different kinds of NOR which share a similar function in 
the reduction of NO to N2O. The crystal structure of the fungal type NOR, referred to as P450nor, 
identified a heme-thiolate active site similar to P450 proteins. Furthermore, this class of NOR is 
structurally and mechanistically dissimilar to the bacterial NOR.44,45 On the other hand, bacterial 
NORs share various structural and functional similarities to the closely-related heme-copper 
oxidases (HCOs).2–4 It is important to note that while it has previously been hypothesized that 
NORs were non-electrogenic, and thus did not translocate charge across a membrane,32,46 recent 
evidence suggests that an electrogenic NOR has been discovered.47 The similarities and differences 
between these two enzymes will be discussed in more detail below. 
NORs have been designated into three main classes, primarily through their electron donors 
and the number of subunits they contain. The first crystal structure for a bacterial NOR came from 
the heavily-studied cNOR of Pseudomonas aeruginosa.1 The name ‘cNOR’ refers to the fact that 
this particular NOR contains a cytochrome c subunit as the electron donor for the catalytic reaction 
at the active center.1 Other NORs include qNORs, which lack this cytochrome c subunit, but are 
instead reduced directly by quinol. The qCuANOR from Bacillus azotoformans contains both a 
CuA site and can be reduced by quinol.
48 Finally, there exist a number of flavodiiron proteins which 
can act as both oxygen and nitric oxide reductases, and while they are similar in function and 
ostensibly similar in structure to the bacterial NORs, which will be the primary focus of this thesis, 
they are mentioned here only for completeness.49–51 
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1.2 FeB site in NOR: similarity to CuB site in heme-copper oxidases (HCO) 
1.2.1 Structural similarities and differences 
HCOs and NORs are structurally homologous, belong to the same superfamily of enzymes, 
and contain a heme-nonheme active site, yet carry out different reactions.20,52,53 The bacterial 
cNOR is a complex enzyme consisting of a low reduction potential c-type heme, a heme b, and a 
heme b3/nonheme iron (FeB) active site.
1 Electrons are transported from heme c to heme b, and 
then to the heme b3/FeB active site, where NO is reduced to N2O. The active site of NOR contains 
a high-spin (HS) heme b3 and FeB coordinated by a 3-His, 1-Glu coordination environment. The 
overall structure of cNOR consists of 12 transmembrane helices and shares many common features 
with the closely related HCO proteins, of which NOR is a member of the HCO superfamily.1 
Important to note, however, is the cNOR from P. aeruginosa contains neither the D- nor K-proton 
pathways of most HCOs, which help facilitate proton translocation and were the primary cause for 
the hypothesis that NORs were not electrogenic.1 Overall, HCOs contain similar structural features 
and cofactors, but with a few noteworthy differences. Instead of a heme c electron-transfer 
component as found in cNOR, many HCOs possess a binuclear average valence CuA center which 
serves largely the same purpose.54 HCOs active site also possesses important differences from 
NORs, such as the identity of the nonheme metal ion (Cu in HCOs, and Fe in NORs), as well as 
the presence of different primary and secondary coordination sphere interactions (e.g. the presence 





Figure 1.2. Crystal structures of (A) ba3 oxidase (PDB code 1XME) and (B) cNOR (PDB code 3O0R). Water 
molecules are shown as small red spheres, while nonheme metal ions are shown as purple and large red spheres for 
copper and iron, respectively. 
1.2.2 Functional similarities and cross reactivity 
It is interesting to note that given the similarities and differences in the structure and 
function of HCOs and NORs, they possess cross reactivity, although each enzyme has been more 
reactive towards its own ‘native’ substrate. For example, HCO from P. stutzeri can catalyze O2 
and NO reductions at 140 mol O2 s-1
 mol-1 protein, and 100 mol NO min-1 mol-1 protein,4 
respectively, while NOR from P. denitrificans can catalyze NO and O2 reduction at 84 µmol NO 
min-1 mg-1 protein and 8.4 µmol O2 min
-1 mg-1 protein, respectively.2 Few characterizations of 
these cross reactivities have been performed,56,57 however, depending on the source of the 
HCO/NOR, the enzyme can have a range of cross reactivities from none to very high.3 One of the 
most intriguing questions about these enzymes is why HCOs are efficient in O-O bond cleavage 
using a 4-electron process, whereas NORs are efficient in N-N bond formation using a 2-electron 
process. Understanding how the structural features responsible for fine-tuning these different 
reactivities is an ultimate test of our knowledge of these enzymes.  
1.3 Proposed NOR mechanism (i.e., cis vs. trans) 
Multiple biophysical, biochemical, and computational studies have been carried out to 



















of NO reduction to N2O – called the cis:b3, cis:FeB, and trans mechanisms (Figure 1.2). Briefly, 
the cis:b3 mechanism suggests that a single NO first binds to the heme group, and is then 
electrophilically attacked by a second NO molecule forming the N-N bond.66 In this case, both 
oxygen atoms of the hyponitrite intermediate are coordinated to the nonheme iron.43 The cis:FeB 
mechanism proposes that both NO molecules bind to the FeB site.
66,9 The cis:b3 mechanism has 
been supported through computational studies,43,58,63 while the cis:FeB has gained recent 
experimental support from electrochemical studies of NOR.53,67 On the other hand, the trans 
mechanism proposes that an NO molecule binds to each iron atom – one at the heme and one at 
the nonheme sites – before N-N bond formation, ultimately leading to N2O. Multiple experimental 
results have been interpreted to proceed through this mechanism, with identification of both heme-
NO and FeB-NO spectroscopic signals during the NOR reaction.
26,68–70 Additionally, spectroscopic 
investigations of small synthetic mimics of the NOR active site have also supported the trans 
mechanism.71 These conflicting interpretations and open questions require new approaches in 
studying NORs. 
 
Figure 1.3. Schematic representation of the trans, cis heme b3, and cis FeB mechanisms. In the proposed cis-heme b3 
mechanism, after one NO is bound to the heme b3 site, a free NO electrophilically attacks this heme bound NO. In the 
cis FeB mechanism, two molecules of NO bind to the FeB site, whereas the trans mechanism suggests one NO binds 
to heme b3 and the FeB site simultaneously for the N-N bond formation to occur. 
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1.4 Biosynthetic model of NOR: FeBMb 
To complement the above-mentioned native NOR, active site model, and computational 
investigations of NOR, our group engineered sperm whale myoglobin into a structural and 
functional model of NOR (L29H, F43H V68E Mb, called FeBMb), which was able to bind 
nonheme Fe and reduce NO to N2O.
6 Further designs improved the percentage of N2O formation,
7 
and additional studies helped to shed light on the NOR mechanism and reactivity.8,9,68 This 
biosynthetic modeling approach offers a complement to the study of native enzymes by allowing 
the determination of the specific, necessary, and sufficient features added that generate a particular 
activity, as opposed to what features, when taken away, abolish activity in the case of native 
enzymes. It has been suggested that conclusions drawn from the study of FeBMb, and thus, other 
related systems, are not well substantiated as these biosynthetic models may not follow the same 
mechanism as the native NOR.43 However, for example, FeBMb was designed largely through 
homology modelling prior to the structure of cNOR being solved,1,6 and has not only recapitulated 
striking active site structural similarity,6–8 but also important mechanistic intermediates and 
activities.8,9,68,72 Thus, while it is true that no biosynthetic design can perfectly recreate the original 
enzyme, FeBMb highlights that studying such systems may help inform and guide future studies 
of the native proteins. Furthermore, many of the above-mentioned reports utilized experimental 
approaches that are either extremely technically challenging for native NOR, or that the native 
NOR is completely unamenable to. 
1.5 More complex metallocofactors 
1.5.1 FeMo cluster of nitrogenase 
While the heteronuclear, heme-nonheme active site of NOR is a challenging avenue for 
protein engineering, a true test of current knowledge would include structural and functional 
designs involving more complex metallocofactors.18 Perhaps the most ambitious of these designs 
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would be for the iron-molybdenum, carbide-containing, iron-sulfur cluster (FeMoco) of 
nitrogenase, the enzymes responsible for biological nitrogen fixation.73–75 N2 is the most plentiful 
source of nitrogen on Earth, but given the strong nitrogen-nitrogen triple bond the molecule has 
low reactivity and is not easily accessible as a nitrogen source for many organisms.74 Nitrogen 
fixation to ammonia is carried out by diazotrophic microorganisms,76–78 which use ambient 
conditions and non-precious metals such as iron to carry out the reaction. On the other hand, the 
Haber-Bosch process is the industrial means by which humans produce ammonia from molecular 
hydrogen and nitrogen. This process consumes over 1% of the world’s energy sources to produce 
140 megatons of ammonia per year, but requires temperatures of 500°C and pressures of 20 MPa, 
which ultimately generate 3% of global CO2 emissions.
79 
Understanding and elucidating the reaction mechanism of these complex enzymes is a great 
challenge for bioinorganic chemists. By being able to explain the N2 reduction mechanism in 
nature there is also the possibility to harness the power of nitrogenase for additional applications.74 
The nitrogenase protein itself is of similar size and complexity to NOR and HCO, but compared 
to the 3-His-1-Glu coordinating ligands of the nonheme iron of NOR, paradoxically, the FeMo 
cofactor of nitrogenase only has 2 amino acid ligands, a cysteine and a histidine, as well as 





Figure 1.4. Crystal structures of (A) Overall structural representation of nitrognease (PDB code 3U7Q) and (B) the 
active site FeMoco cluster from one of the protein subunits, with binding residues and additional cofactors labeled. 
1.6 Project Goals 
The goal of my project is to utilize designed structural and functional biosynthetic protein 
models of NOR (FeBMb) to uncover answers to questions related to the mechanism of NOR, and 
information about the chemical basis for selection of specific nonheme metal ions for particular 
reactivities such as O2 and NO reduction. Specifically, I will substitute different metals into both 
the heme and nonheme sites of FeBMb to investigate the reactivity of the proteins based on changes 
in the d-electron configuration. This thesis discusses my progress in achieving the above goals. 
Chapter 2 of this dissertation focuses on the introduction of zinc-protoporphyrin IX 
(ZnPPIX) into FeBMb to spectroscopically characterize the FeB-NO interaction. Chapter 3 
describes the use of the advanced spectroscopic technique nuclear resonance vibrational 
spectroscopy (NRVS) in defining the different iron-nitrosyl interactions in FeBMb. Chapters 4 and 
5 discuss work related to substituting nonheme iron in FeBMb with other ‘non-native’ metals, such 
as cobalt and manganese, and their effects O2 and NO reduction, respectively. Chapter 6 focuses 
on work related to more ambitious protein design goals, such as the incorporation of the 
nitrogenase FeMo cofactor into a smaller protein scaffold. Finally, Chapter 7 summarizes the work 









An important note about nomenclature of FeBMb is as follows. The corresponding 
nonheme metallated derivatives are represented as MII-FeBMb(M
II) where the first (from left to 
right) MII represents a metal ion with the designated oxidation state (II) occupying the nonheme 
FeB center and the second M
II represents MII-protoporphyrin IX in the heme-binding site. When 
the FeB center is empty, it will be represented as E-FeBMb(Fe
II). Furthermore, nitrosyl derivatives 
will be represented AFTER the corresponded metal to which they are bound. For example, FeII-
NO-FeBMb(Zn
II) would represent FeBMb, with ZnPPIX-replaced heme, Fe
II bound at the nonheme 














Chapter 2 NO Interaction with FeII-FeBMb(ZnII) 
2.1 Introduction 
2.1.1 Metal-nitrosyl complexes and their relevance in NOR 
Given the critical role that NO plays in multiple biological processes, understanding the 
nitrosyl complexes of nitric oxide reductase and their role in the NO reduction mechanism is of 
biochemical significance, and has broad implications for the global nitrogen cycle (see section 
1.1.2). As discussed in section 1.3, three mechanisms of NO reduction to form N2O have been 
proposed: the cis-heme b3, cis FeB, and trans mechanisms. Important to differentiating these 
mechanisms is the study of nitrosyl complexes of either the heme or the FeB center.  
Spectroscopic features for the heme nitrosyl complexes in NORs have been probed;24,29,81 
however, spectroscopic investigation of the FeB nitrosyl complex has been elusive because its 
spectroscopic signatures are often masked by those of the heme nitrosyl (Keq for NO binding to 
ferrous hemes is ~1010-1012M1).81 Therefore, this issue of uncovering the identity of the FeB-NO 
interaction in NOR has become one of the most critical barriers to our current understanding of 
the electronic structure and reaction mechanism of NORs. Because NORs are large membrane 
proteins containing multiple cofactors, their active site heme cofactor(s) cannot be selectively 
replaced to probe the effect of NO binding to the FeB site specifically.  
The Enemark-Feltham notation will be used to describe metal-nitrosyl complexes in this 
dissertation.82 Previously, metal nitrosyls had been classified as derivatives of either NO+ or NO-
,83 but research demonstrated that metal nitrosyls are highly covalent, and attempts to correlate the 
structure, physical properties, and reactivity with the formal oxidation state of the nitrosyl complex 
were unsuccessful.82 Thus, a new description of the bonding in metal nitrosyl complexes was 
developed. Essentially, given that NO is a non-innocent ligand (i.e. its oxidation state is unclear 
when it is bonded to a metal), the Enemark-Feltham notation treats the metal-nitrosyl as an 
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individual complex and counts the electrons accordingly, but is not specific about the formal 
oxidation state of either component of the complex. For example, {FeNO}7 refers to an iron-
nitrosyl d7 complex, which would be either FeIII-NO-, FeII-NO (radical), or FeI-NO+.82 
2.1.2 Synthetic model studies of the active site of NOR used to study metal-nitrosyls 
Several studies have elucidated the electronic and spectroscopic properties of heme-
nitrosyl complexes, including synthetic models of the NOR active site.84–90,71,91,92,42 These 
synthetic models are useful in identifying the minimal requirements needed to mimic a protein 
metal active site, such as the ligands, coordination, and geometry. Given the multiple factors that 
need to be balanced when creating native protein active site mimics, both structural and functional 
models of said active sites, especially for complex heteronuclear metalloproteins such as NOR, are 
rare. Indeed, some models of NOR are capable of binding 2 NO molecules, but do not possess 
NOR activity.84 Furthermore, one NOR synthetic model from Collman and co-workers possesses 
NOR function, but does not contain a glutamic acid ligand to the nonheme site.93 
Recently, Berto et al. reported a thorough spectroscopic study of nonheme {FeNO}7 
species in synthetic models of NOR (Figure 2.1).42 Using the ligand BMPA-Pr and TPA, the 
researchers were able to mimic the primary coordination environment of the NOR nonheme iron 
ion. After addition of NO, they investigated the formed {FeNO}7 using x-ray crystallography, 
electron paramagnetic resonance spectroscopy, infrared vibrational spectroscopy, and nuclear 
resonance vibrational spectroscopy, coupled with DFT calculations. They concluded that the 
properties of the {FeNO}7 were highly tunable based on the number of anionic donors bound to 
the iron center, and that the formal characterization of the interaction is best described as FeIII-NO-




Figure 2.1 Structural Comparison of the FeB Site within NOR (left) and the Model Complex 1-Cl (right), from 
Berto et al.42 
 
2.1.3 Biosynthetic approach to metalloprotein modeling: experimental advantages 
To complement these studies, FeBMb was chosen as a suitable biosynthetic mimic, given 
previous reports demonstrating its ability to be both a structural and functional model of NOR.6,7 
Studying biosynthetic models combines some of the benefits of native proteins (e.g. providing a 
stable protein matrix and amino acid ligands to a metal center, in a comparable solvent 
environment to native proteins), with those of small molecule synthetic models (e.g. a small, easy-
to-purify and well-characterized model free of other chromophores which complicate 
spectroscopy). In particular to this chapter of this dissertation, one of the major advantages of using 
the biosynthetic modelling approach and FeBMb to study the NOR reaction is that the heme can 
be readily replaced with different porphyrin groups, using a well-established acid methylethyl 
ketone extraction.94 Specifically, isostructural zinc-protoporphyrin IX (ZnPPIX) can be introduced 
to FeBMb to allow for spectroscopic investigation of the FeB-NO interaction exclusively (Figure 
2.2). Using such a system, it is possible to identify and characterize the FeB-NO interaction in an 








2.2.1 Design and construction of ZnPPIX-replaced FeBMb: FeBMb(Zn
II) 
E-FeBMb(Fe
III) was expressed and purified as described previously, with small changes.6,7 
Proteins were expressed using E. coli BL21(DE3). Typically, individual cell colonies were grown 
on ampicillin L-agar plates overnight using a cell stock of 30% glycerol. Large media growth was 
performed by adding a single colony to a 6 L flask containing 2 L rich media (10 g bacto tryoptone, 
8 g yeast extract, 5 g NaCl, all per liter). The flask was shaken at 200 rpm, 37°C overnight (~16 
h) until saturation. 100 µM IPTG was then added and shaken at 200 rpm, 37°C, for 4 hours. The 
cells were then pelleted by centrifugation (8000 rpm, 10 min, 4°C).  
The cells were then lysed via sonication with pulses of 6 seconds every 18 seconds, for a 
total of 6 minutes of sonication. After cell lysis, the cell debris was centrifuged (10000 rpm, 30 
minutes, 4°C) to pellet the unfolded, inclusion body fraction from the supernatant. The inclusion 






accomplished by resuspending the inclusion body portion from 4 L cell growth in 100 mL 7 M 
guanidine hydrochloride (GnHCl) and shaking for 16 hours at 4°C. A hemin-CN stock solution of 
20 mg hemin, 66 mg cyanide in 40 mL H2O was added to 1300 mL of 4°C H2O. The solution was 
stirred at 4°C for 10 minutes. The protein/GnHCl solution was added dropwise to the hemin-CN 
solution and stirred at 4°C for 1 hour. The solution was then centrifuged (8000 rpm, 10 minutes, 
4°C) to remove precipitate. The supernatant was further refolded through dialysis against 4x12 L 
10 mM Tris pH 8.0 at 4°C for a total of 4 changes with at least 4 hours between changes. The 
dialyzed solution was then centrifuged (8000 rpm, 10 minutes, 4°C). This centrifuged solution was 
then concentrated to ~10 mL. After concentration, buffer exchange was achieved by loading onto 
a size exclusion column equilibrated with 100 mM potassium phosphate pH 7. Fractions were 
measured via UV-Vis using an Agilent HP 8543 spectrophotometer and only fractions containing 
an R/Z ratio (Abs406 nm/ Abs280 nm) > 4 were pooled and then concentrated to ~ 10 mL. A final 
set of dialyses was performed on the protein against 5x800 mL of chelexed 100 mM KPi pH 7 
containing (1) 30 mM EDTA (2) 100 mM NaCl (3-5) 100 mM KPi pH 7 only. The final purified 
protein product was flash frozen using liquid nitrogen and stored at -80°C. 
Heme extraction of E-FeBMb(Fe
III) was done using methylethylketone (MEK) followed by 
dialysis to remove MEK, using Teale’s method.94 Briefly, 100 µM E-FeBMb(Fe
III) was buffer 
exchanged to H2O and 1% 2 M HCl was added to the protein solution. Upon addition, the protein 
solution color changed from green to red. Next, an equal volume of 4°C MEK/H2O was added to 
the protein solution, and then gently mixed by rocking. Separation of the organic (heme) and 
aqueous (protein) layers was carried out at 4°C using a separatory flask. After collecting the heme-
extracted protein fraction, dialysis against 3x12 L H2O was performed at 4°C with at least 4 hours 
in between each change to fresh H2O. 
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The concentration of heme-extracted E-FeBMb was measured based on 280nm = 30 
mM1cm1. A stock solution of 8 mM ZnPPIX was prepared in 66 mM NaOH. Care was taken so 
that the ZnPPIX stock solution and the protein during subsequent reconstitution process was not 
exposed to light. To 10 M of heme-extracted FeBMb1 in 10 mM potassium phosphate pH 7, 
aliquots of ZnPPIX was added in 0.25 equivalents up to ~1.25 equivalents at 4C with 30 minutes 
in between each addition. After the final addition of ZnPPIX, the solution was allowed to stir 
overnight to ensure that equilibrium was reached.  
The ZnPPIX-reconstituted protein was centrifuged (8000 rpm, 30 minutes, 4°C) to remove 
precipitate followed by concentration to ~5 mL. The bright magenta colored protein was then 
passed down a small DEAE column pre-equilibrated in 50 mM Bis-Tris pH 7.3 to remove any 
excess ZnPPIX. This solution was then dialyzed in chelexed 50 mM Bis-Tris pH 7.3 overnight to 
remove any adventitious metal ions. Final yield of the reconstituted protein was ~30%. Stock of 
E-FeBMbZn
II) was stored at 80C wrapped in foil. During subsequent handling of the protein for 
all the experiments, care was taken not to expose FeBMb(Zn
II) to light.  
2.2.2 Spectroscopic characterization of E-FeBMb(Zn
II) 
2.2.2.1 Ultraviolet-visible absorbance (UV-Vis) 
The extinction coefficient of FeBMb(Zn
II) was determined using the hemochromagen 
method,95 with the exception that no dithionite was added. An extinction coefficient of 551nm = 
12.3 mM1cm1 for ZnPPIX-Pyridine complex96 was used to determine the extinction coefficient 
of FeBMb(Zn
II). The ratio of 66 mM NaOH : Pyridine : H2O : Protein was 50: 33 : 13 : 4. A molar 
absorptivity of ε427nm = 136.2 mM
1cm1 was determined using this modified hemochromagen 
method. Care was taken not to expose the protein to light during sample preparations, setting up 
crystal trays, and crystal soaking experiments. 
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2.2.2.2 Electron paramagnetic resonance (EPR) 
EPR spectra were collected at liquid He temperatures on an X-band Varian E-122 
spectrometer at the Illinois EPR Research Center equipped with an Air Products Helitran Cryostat, 
and EIP frequency counter. Calibration of magnetic fields was done using a Varian NMR 
Gaussmeter. Protein, buffers, and DEA NONOate (250nm = 6.5 mM
1cm1) were degassed in a 
Schlenk line using 3 cycles of vacuum/gas cycling, with each cycling being 15 minutes vacuum, 
5 minutes gas purging, and transferred into the anaerobic chamber where the samples were 
prepared in 50 mM Bis-Tris pH 7.3. FeCl2 stock solutions were prepared inside the glove bag by 
dissolving solid FeCl2 in degassed water.  
For these preparations, the FeB site was reconstituted with 1 eq. Fe
II, added in aliquots of 
0.25 eq., followed by NO addition. Enough time was allowed to ensure metal binding, and NO 
evolution (~30 min). Each step was followed by checking the UV-vis spectra on an Agilent 8453 
photodiode array spectrometer located inside the chamber. After NO addition, the protein was 
passed through a PD 10 column pre-equilibrated in Bis-Tris pH 7.3 to remove impurities. Glycerol 
was added to a final concentration of 22%, and the solution was quickly flash frozen in liq. N2 
outside the glove bag. Spectra were fit using SIMPIPM.97  
Efforts to characterize a radical-like species at g ~ 2.01 was undertaken. EPR power 
saturation experiments were performed with a sample that was purified after NO addition using a 
small size exclusion column, at temperatures of 30K, 55K, 77K, and 111K with a varying 
microwave power from 0.03 to 31.6 or 50.2 mW. The peak to peak height of these spectra were 
measured and plotted as intensity/power(mW) vs. microwave power (mW). Analysis of the 




where I = peak-to peak intensity, I0 = intensity at lowest power P0, K = constant, P = microwave 
power inmW, b = measure of homogeneity of the line shape with a value varying between 1 and 
3, P1/2 is the microwave power at which the amplitude of the EPR signal is one-half of its 
unsaturated value. 
2.2.2.3 Mössbauer 
Mössbauer data were collected at Knox College, IL on an SEE Co. (Edina, MN) 
spectrometer, equipped with a constant acceleration transducer that uses a 57Co/Rh source. Initial 
radioactivity was 100 mCi. A Janis Super-varitemp cryostast, capable of recording temperatures 
from 4K to RT was used. Magnetic field strength was varied from 0.01-9T. Both low field and 
high field data were collected for the 4.2K spectra in the presence of 20 eq. NO. For higher 
temperatures 25K, 75K, 150K, data were collected only at low-field (0.01T), and in the presence 
of 1 and 5 eq. NO. Data analysis was performed by custom built software using nonlinear least 
squares simultaneous fitting of multiple spectra to Spin Hamiltonian model (high field spectra) or 
fitting of a spectrum with Lorentzian lines (low-field spectra). For Figure 2.13 all the S = 3/2 
species were simulated using a slow relaxation model, while the S = 2 species in 0.01 T was 
simulated using a fast relaxation model. For the data shown in Figure 2.14, the 0.01 T data was 
simulated using a fast relaxation model, while the high-field data were simulated using a slow 
relaxation model. Samples were prepared using the same procedure as described in the EPR 
section, except freshly prepared 57FeCl2 was used as the metal solution, and no glycerol was added. 
Samples were flash frozen using liquid nitrogen in Mössbauer sample cups with inserts. 
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2.2.3 Computational and structural characterization of FeBMb(Zn
II) 
2.2.3.1 Crystal structure determination of FeII-FeBMb(Zn
II) 
Crystals were set up and grown at 4C on hanging drops containing 0.1 M sodium 
cacodylate pH 6.77, 0.2 M NaOAc*3H2O, 30-32% PEG 10K as well buffer. Drops contained an 
equal volume of 1.6 mM E-FeBMb(Zn
II) in 20 mM TRIS.H2SO4 pH 8 and the well buffer. E-
FeBMb(Zn
II) crystals were frozen in a cryo protectant solution of 10 mM TRIS.H2SO4 pH 8, 50 
mM cacodylate pH 6.8, and 30% PEG 400.  
For FeCl2 soaking, the crystals were transferred into an anaerobic chamber (Coy 
laboratories) in a cold room by 20 short cycles of vacuuming/purging. After transferring the tray 
into the anaerobic chamber, the cover slides were transferred to new wells containing freshly 
prepared degassed well buffers with some added solid dithionite and were left to equilibrate 
overnight to make them oxygen free. Selected crystals were then harvested, soaked in freshly 
degassed well buffer containing 0.1 M MES pH 6.77, 0.2M NaOAC.3H2O, 32% PEG 10K for 10 
minutes, followed by soaking them in the same well buffer containing 10 mM FeCl2 for 2 hrs. The 
crystals were then soaked in a cryo protectant solution of 10 mM TRIS.H2SO4 pH 8, 50 mM MES 
pH 6.77, 30% PEG 400, and 10 mM FeCl2, then flash frozen using liq. N2 inside the glovebag.  
Data was collected at the APS beamline 21-ID-D which supports tunable energy from 6.5-20 keV, 
equipped with MAR 300 CCD detector. The high-resolution data was collected for 190 frames at 
0.5s/frame, and a rotation of 0.5°/frame. Anomalous data were collected below and above Fe K-
edge at 7.0, and 7.2 keV, respectively, for 380 frames at 0.3s/frame with a rotation of 0.5°/frame. 
Data was processed and scaled in HKL2000.99 The structures were solved by molecular 
replacement using MolRep100 in CCP4101 suite of programs by using 3K9Z6 as the search model 
after replacing the heme iron with Zn. The model was then refined in Refmac 5102 and built in and 
completed in Coot103 by using 2F0 - Fc and F0 - Fc electron density maps. Anomalous electron 
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density maps were generated in PHENIX,104 and figures were made in PyMol at a contour level of 
7 sigma. E-FeBMb(Zn
II) and Fe(II)-FeBMb(Zn
II) were refined to 1.5 Å (Rw=20.7%, Rf=25.4%), 
and 1.52 Å (Rw=17.9%, Rf=21.9%) resolutions, respectively. 
2.2.3.2 Density functional theory (DFT) and quantum mechanics/molecular mechanics 
(QM/MM) 
Two sets of independent calculations were performed: the first set was without NO and the 
second set was with NO bound. The system preparation and solvent equilibration were performed 
with DESMOND.105 The initial protein geometry for the first set of calculations was obtained from 
the crystal structure shown in Figure 2.15. Hydrogens were added to the heavy atoms using 
DESMOND. This structure was immersed in an orthorhombic box of TIP3P water molecules, in 
which the distance between the molecule and the boundary was at least 10 Å, and the overall 
charge of the system was neutralized by the addition of three Cl– ions. For the second set of 
calculations, the optimized geometry from the QM/MM calculation of the protein without NO was 
taken as the initial protein structure with NO added at the Fe center. The AMBER-03106 force field 
parameters were used during the solvent equilibration. The parameters for Zn-protoporphyrin IX 
(ZnPPIX) were chosen to be the same as those for heme,107 where the Fe center has been replaced 
by Zn. For NO, the bond length was determined from a separate DFT calculation with the B3LYP 
functional,108 and 6-31G** basis set,109,110 and the ChelpG charges were used to represent the 
partial charges. All the heavy-atom hydrogen bonds were constrained using the SHAKE algorithm 
as implemented in DESMOND. The solvent equilibration procedure was utilized to obtain the 
starting configurations for the subsequent QM/MM calculations as follows: 
1) Energy of the solvent (water molecules and Cl– ions) was minimized with a restraining 
potential of 100 kcal/mol on the solute (protein + ZnPP and NO, when present); 
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2) 100 ps of solvent equilibration was performed under constant NPT condition at 298 K and 
1.01325 atm, maintaining the restraining potential on the solute; 
3) 1 ns of solvent equilibration was performed under constant NVT conditions at 298 K, 
maintaining the restraining potential on the solute. 
The QM/MM calculations were performed with the Q-Site package, which uses Jaguar for the 
QM part of the calculations and IMPACT for the MM portion. The QM part of the system was 
described by DFT with the B3P86 functional,111 and LACVP** (6-31G** for non-metals and 
lanl2dz for the Fe and Zn centers) basis set.109 The QM region included the Glu68, His29, His43, 
His64, and His93 residues along with the Fe-center, ZnPPIX, and NO. The histidine residues were 
H-capped at the C4-C position, while C-C was H-capped for the glutamate residue to provide 
flexibility to the coordination mode of the –COO group. All the substituents of the porphyrin ring 
were H-capped. The MM part of the system was described by the OPLS2005 force field.112 All 
atoms outside a sphere with a 20 Å radius centered at the Fe remained fixed during the QM/MM 
calculations. The QM-MM interface was modeled by the frozen localized molecular orbital 
method that is implemented in Q-Site. The spin multiplicities of the QM region for the calculations 
without and with NO were 5 and 4, respectively, while the molecular charge was +1 in both cases. 
The structures of the QM region without and with NO are shown in Figure 2.17. 
2.3 Results and Discussion 
2.3.1 Design and construction of ZnPPIX-replaced FeBMb: FeBMb(Zn
II) 
Incorporation of ZnPPIX into FeBMb was monitored by UV-vis (Figure 2.3). Figure 2.3 
shows that the spectral features of the reconstituted protein E-FeBMb(Zn
II) (427 nm, 553 nm, 595 
nm) are different from those of the cofactor ZnPPIX alone (386 nm, 554 nm, 588 nm), suggesting 




Figure 2.3 UV-vis spectra of ZnPPIX (red) and E-FeBMb(ZnII) in 100 mM potassium phosphate pH 7 (blue), 
recorded on a Cary 5000 spectrophotometer. The spectral features of the reconstituted protein E-FeBMb(ZnII) (427 
nm, 553 nm, 595 nm) are different from those of the cofactor ZnPPIX (386 nm, 554 nm, 588 nm) alone, confirming 
that the cofactor is incorporated into the protein. 
 
2.3.2 Spectroscopic characterization of FeBMb(Zn
II) 
2.3.2.1 UV-Vis characterization of FeII-FeBMb(Zn
II) 
FeII titration experiments were collected via UV-vis on a Cary 5000 spectrometer. For 
FeCl2 titrations, aliquots of degassed metal stock solution were added using a gas tight syringe to 
a solution containing 1 mL of 7 M E-FeBMb1(Zn
II) in 50 mM Bis-Tris pH 7.3 in an anaerobic 
cuvette (Starna cells). The protein was degassed in a Schlenk line and transferred to an anaerobic 
chamber (Coy laboratories) where the protein solution was prepared and transferred outside in the 
anaerobic cuvette for metal titration. Spectra were corrected for dilution and baseline. Difference 
spectra (Abs vs. ) were obtained after subtracting the metallated spectra from the spectrum 
without FeII. Positive peaks were observed at 437 nm, 567 nm, 603 nm, while negative peaks were 






were obtained after subtracting the negative absorbance at 426 nm from positive absorbance at 437 
nm during each FeII addition and was plotted as a function of FeII concentration (Figure 2.4). This 
plot was analyzed by least squares fit using the following equation113: 
 
Where P = protein concentration in M, and Kd = dissociation constant. From this analysis, a 





Figure 2.4 (A) UV-vis spectra obtained during titration of aliquots of FeCl2 to 7 M E-FeBMb(ZnII) in 50 mM Bis-
Tris pH 7.3. Insets show blow-ups of the Soret and visible regions. Isosbestic points are shown as asterisk. (B) 
Difference spectra (Abs vs. ) were obtained after subtracting the metallated spectra from the spectrum without 
FeII. Difference of difference absorbance (Abs) were obtained after subtracting the negative absorbance at 426 
nm from positive absorbance at 437 nm during each FeII addition and is plotted as a function of Fe(II) concentration 







Interestingly, compared to the Kd of 21.5 ± 0.5 M for E-FeBMb(Fe
II) binding FeII at the 
nonheme site (Figure 2.5), the data suggest that substitution of heme with ZnPPIX into FeBMb 
increases nonheme FeII binding affinity at the FeB site by ~3-fold. 
 
Figure 2.5. (A) UV-vis spectra obtained during titration of aliquots of FeCl2 to 7 M deoxy FeBMb1 in 50 mM Bis-
Tris pH 7.3. E-FeBMb(FeIII) was reduced in the glove bag with dithionite. Titration was performed outside the glove 
bag by adding aliquots of degassed FeCl2 to the deoxy protein in a gas tight cuvette using a gas tight syringe. 
Spectral changes were monitored using a Cary 3E UV-vis spectrometer. Insets show blow-ups of the Soret and 
visible regions. Isosbestic points at 529 nm, and 578 nm are shown as red stars. (B) Difference spectra (Abs vs. ) 
obtained after subtracting the metallated spectra from the spectrum without FeII. Positive peaks are observed at 446 
nm, 596 nm, while negative peaks are observed at 426 nm, 559 nm. Difference of difference absorbance (Abs) are 
obtained after subtracting the negative absorbance at 426 nm from positive absorbance at 446 nm during each Fe II 
addition and is plotted as a function of FeII concentration and shown in the inset. Attempts to analyze the difference 
of difference plot (Abs vs. FeII concentration) using the above equation resulted in poor fits. Thus, this data was 
analyzed by least square fits using the Hill equation: as the shape of the curve implies cooperative FeII binding. x = 
FeII concentration, Kd = dissociation constant, n = number of cooperative sites. From this analysis, a dissociation 
constant of 21.5 M is extracted. Parameters from fit are: Reduced Chi-Sqr = 6.85786E-6, Adj. R-Square = 0.998, 












Freeze-quench EPR studies of the reaction of reduced NOR from Ps. Aeruginosa26 with 
NO-saturated buffer showed a peak at g ~ 4 within 0.5 ms of mixing, corresponding to ~30% 
population of the FeB-nitrosyl {FeNO}
7 complex with S = 3/2 ground state. Similar EPR features 
have been reported for the reaction of NO with various non-heme iron proteins,114–116 as well as 
model complexes.42 Thus, the NO binding properties of FeII-FeBMb(Zn
II) were studied by EPR 
spectroscopy. The sample containing FeII-FeBMb(Zn
II) in the absence of NO had no detectable 
EPR signal (Figure 2.6). This is to be expected for singlet spin systems given the two metals and 
their oxidation states. 
 
Figure 2.6. X-band EPR of a sample containing 600 M FeII-FeBMb(ZnII) in 50 mM Bis-Tris pH 7.3. Experimental 
parameters: T = 6K, microwave frequency = 9.053 GHz, microwave power = 20 dB, mod amp = 4 G. 
 
With addition of up to 5 equivalents of NO, the major peak observed was a radical-like 
signal at g ~ 2.01, with no other significant spectral features. However, in the presence of 10 
equivalents of NO, an EPR feature at g ~ 4.04 appeared, indicating the formation of a new species. 




Figure 2.7. EPR spectra of samples containing 250 L of 300 M FeII-FeBMb(ZnII) in 50 mM Bis-Tris pH 7.3, 0-20 
eq. NO. 18% glycerol was added as glassing agent. Samples were prepared anaerobically in a glove bag, and flash 
frozen in liquid N2 outside the glove bag immediate after taking out of the bag. These samples were not subjected to 
PD10 column after NO addition, and thus contain adventitiously bound iron at g ~ 4.28, and free NO at g ~ 1.97. 
Experimental parameters: T = 30K, microwave frequency = 9.053 GHz, microwave power = 0.5 mW, modulation 
amplitude = 4 G. From EPR simulations, the population of the radical-like peak at ~2.01 was determined to be ~8%. 
 
EPR spectrum were then collected under conditions to maximize the signal of the g ~ 4 
species (T = 5 K, power = 20 dB). The resulting spectrum shows two well-resolved doublets 1x,1y, 
and 2x,2y at g = 4.36, 3.58, and 4.13, 3.73, respectively, with no other features observed at lower 
field (Figure 2.8). The EPR spectrum was simulated as a {FeNO}7 ferrous-nitrosyl complex with 
S = 3/2 ground state, according to Enemark-Feltham nomenclature.82 The sharp outer doublet 1x,1y, 
accounting for 46% of the spin, is more rhombic with an E/D = 0.063 than the major (54%) broad 
inner doublet 2x,2y which has an E/D of 0.040. The corresponding gǁ components are not well 
resolved in the region of g ~ 1.97. The two different components can be ascribed to either different 
orientations of NO bound to the FeB site, or slight changes in the orientation of Fe
II ligands upon 
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NO binding. Multiple Fe-NO symmetries with different rhombicities are commonly observed in 
heme nitrosyls.92  
Table 2.1. Parameters extracted from fitting of the EPR spectrum in Figure 2.8. The ferrous nitrosyl complex is 
present in two rhombic geometries with E/D = 0.063, and 0.040, respectively. D = 7.2 cm1 as obtained from the 
Mössbauer measurements (Table 2.2) was used to simulate the EPR spectrum. 
Peaks gx gy gz % E/D 
1x,1y 1.985 1.985 1.987 46 0.063 
2x,2y 1.987 1.987 1.987 54 0.040 
 
 
Figure 2.8. X-band EPR spectrum of a sample containing 0.7 mM FeII-FeBMb(ZnII) in the presence of 20 
equivalents of NO in 50 mM Bis-Tris buffer pH 7.3, and the simulated spectrum. Excess NO was used to ensure 
saturation of the FeB site. Experimental parameters: T = 5 K, microwave frequency = 9.053 GHz, microwave power 
= 20 dB, modulation amplitude = 4 G. g values and the components are labeled. *A radical type peak (<1%). 
 
To test whether different components of the FeB-NO complex observed were a result of 
hyperfine interaction with 14N nucleus, EPR simulations were performed taking into consideration 





Figure 2.9. Simulation (red) of the data (blue) shown in Figure S10 taking into account the 14N hyperfine 
interaction. Clearly the simulated spectrum cannot reproduce the experimental data as the resolution of the peaks 
around g~4 are blurred and not resolved. 
 
Detailed characterization of the saturation behavior of the radical-like signal at g ~ 2.01 
was carried out. These analyses gave P1/2 values of 1.68  0.10, 8.73  1.01, 12.55  0.48, and 
29.77  2.23 mW at 30K, 55K, 77K, and 111K, respectively (Figure 2.10). These values of P1/2 





Figure 2.10. EPR spectra of a sample containing 500 M FeII-FeBMb(ZnII) and 20 eq. NO in 50 mM Bis-Tris pH 
7.3, recorded at 30K, 55K, 77K, and 111K under varying microwave power from 0.0317 mW (38 dB) to 31.69 (8 
dB) or 50.2 mW (6 dB). Microwave frequency = 9.242 GHz, modulation amplitude = 4G. 
 
Overall, these results suggested that an S = 3/2 FeB-NO complex could be formed in Fe
II-
NO-FeBMb(Zn
II). No EPR features were observed upon addition of NO to E-FeBMb(Zn
II) (Figure 





Figure 2.11. EPR spectra of samples containing 250 L of 6 mM NO in 50 mM Bis-Tris pH 7.3 (magenta), 300 M 
P in 50 mM Bis-Tris pH 7.3 (blue), 300 M FeCl2 + 1.5 mM NO (red), and 300 M FeBMb(ZnII) in 50 mM Bis-Tris 
pH 7.3 + 3 mM NO (black). 18% glycerol was added as glassing agent. Samples were prepared anaerobically in a 
glove bag, and flash frozen in liquid N2 outside the glove bag immediate after taking out of the bag. Experimental 
parameters: T = 30K, microwave frequency = 9.053 GHz, microwave power = 0.5 mW, modulation amplitude = 4 
G. Traces shown in blue and black have no detectable EPR signal, and the signals for “free” NO and HS Ferric-NO 
are magenta and red, respectively.  
 
2.3.2.3 Mössbauer of 57FeII-FeBMb(Zn
II), and 57FeII-NO-FeBMb(Zn
II) 
To understand the electronic and spin state of the FeB-nitrosyl species further, field-
dependent Mössbauer measurements were carried out at 4.2K. In the absence of NO, a sample 
containing 3.5 mM 57FeII-FeBMb(Zn
II) shows a single quadrupole doublet at 0.01 Tesla (T). In the 
presence of a magnetic field (1-9 T) the doublet splits into multiplets (Figure 2.12), resulting from 
magnetic hyperfine interaction with the electron spin. A quadrupole splitting (EQ) = 2.85  0.01 
mm/s, and isomer shift (Fe) = 1.13  0.01 mm/s are obtained from fits indicative of a high spin 





Table 2.2. Full Mössbauer parameters for 57FeII-FeBMb(ZnII), and 57FeII-NO-FeBMb(ZnII) in the presence of 20 eq. 
NO. ~65% of the S = 3/2 {FeNO}7 complex is formed at the FeB site in the presence of NO, with 35% of 57Fe(II) 
remaining unreacted as S=2 HS ferrous. 
Sample Fe 
(mm/s 
EQ (mm/s) %   
(mm/s) 




































            
 
 
Figure 2.12. Field-dependent Mössbauer spectra of a sample containing 200 L of ~3.5 mM 57FeII-FeBMb(ZnII) in 
50 mM Bis-Tris pH 7.3. Experimental conditions: T=4.2K, H = 0.01 - 9 T. The simultaneous fitting of the spectra 
yield the following parameters, Fe = 1.13 mm/s, EQ = 2.84 mm/s, E/D = 0.19,  = 0.35 mm/s, implying that 57FeII 
is bound in the non-heme site of 57FeII-FeBMb(ZnII) as HS ferrous in a rhombic geometry. 0.01T data was fit with 





In the presence of 20 eq. NO, the Mössbauer spectrum of 57FeII-NO-FeBMb(Zn
II) at low 
field (0.01T) shows two doublets and a magnetically split component. The solid blue line in the 
0.01T field spectrum represents 35% of unreacted FeII species. To simplify the high-field spectra, 
this unreacted component was subtracted, and the splitting pattern of the 65% iron-nitrosyl 
component is shown (Figure 2.13). Simultaneous least-squares fits to the three applied field spectra 
gave Mössbauer parameters (EQ) = 1.70 0.01 mm/s, and Fe = 0.69  0.01 mm/s, indicative of 
S = 3/2 {FeNO}7 species (Table 2.2 and Table 2.3). These experimental Mössbauer properties of 
57FeII-NO-FeBMb(Zn
II) are similar to those of S = 3/2 six-coordinate {FeNO}7 complexes in other 
proteins as well as small molecule models.114,118–121 
 
Figure 2.13. Field-dependent Mössbauer spectra of a sample containing 7 mM 57FeII-NO-FeBMb(ZnII) in 50 mM 
Bis-Tris pH 7.3, collected at 4.2K. Black dots: experimental data; red lines: sum of fit; blue lines: ferrous S=2 
starting material; gray lines: S = 3/2 {FeNO}7 component in intermediate relaxation; green lines: magnetically split 
S = 3/2 {FeNO}7 component. Only the splitting pattern of 65% S = 3/2 {FeNO}7 species is shown in high field. The 
S = 3/2 species at all fields was simulated using a slow relaxation model. The S=2 species in low-field was 




Some of the S = 3/2 species is in intermediate relaxation at low field (0.01T), which is most 
likely due to the proximity to the small population of the metal-associated radical species detected 
by EPR. In applied field, this S = 3/2 component is in the slow relaxation limit and is therefore 
indistinguishable to the other S = 3/2 center that is already in the slow relaxation regime. 
Simulations to the high-field spectra show excellent matches to the positions and intensity of all 
the spectral features, thus supporting that there is only a single type of S = 3/2 species. At low-
field and 25K in the presence of 1 and 5 eq. NO compared to 57FeII-FeBMb(Zn
II), the S = 3/2 
{FeNO}7 species is not observable due to intermediate relaxation of this species, leading to 
spectral broadening (Figure 2.14). At high temperatures, 75K and 150K, the {FeNO}7 species is 
in the fast relaxation regime and can be detected and deconvoluted. The IS and QS values of the S 
= 3/2 {FeNO}7 obtained from these data (Table 2.3) are close to the values obtained from the high 
field data measured at 4.2 K containing 20 eq. of NO. At higher temperatures all of the S = 3/2 
species is close to the fast relaxation limit for which the magnetic hyperfine splitting collapses to 
a single doublet (Figure 2.14, green lines), unlike at low temperature where a magnetically split 
component is also observed (Figure 2.13, green lines).  While the exact cause for a fraction of the 
S = 3/2 species to be in intermediate relaxation at low temperature (Figure 2.13, gray lines) is 
uncertain, it seems plausible that the presence of this center is in close proximity to other 
paramagnetic centers e.g. the radical-like species observed in EPR would make these centers to be 







Table 2.3. Mössbauer parameters extracted from fits of the data shown in Figure 2.14. The parameters for the S=2 
FeII starting material is shown in black, while those of the S = 3/2 {FeNO}7 complex are shown in red. aThe sign of 
QS cannot be determined at low field because in the absence of an applied field, a non-Kramers system like a high-
spin ferrous iron center usually have no magnetic splitting in its spectrum.  In a large applied field, one can 
distinguish the sign of the quadrupole splitting through asymmetry of the magnetic splitting between the higher- and 
lower-velocity lines of a quadrupole doublet.  Thus, in the absence of magnetic splitting it is impossible to determine 
the sign of the quadrupole splitting. bDue to intermediate relaxation, leading to very broad spectral widths, the 
parameters for the S = 3/2 {FeNO}7 species could not be obtained from the fits of the 25K data. cFor a paramagnetic 
center with an intermediate spin relaxation rate, the magnetic structure of its Mössbauer spectrum will have nearly 
collapsed, leaving a much-broadened quadrupole doublet.  It is usual for one line of the quadrupole doublet in this 
situation to have a narrower linewidth than the other line. Therefore, in a good fit to the S = 3/2 quadrupole lines, the 
two lines have unequal linewidth 
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Figure 2.14. Mössbauer spectra of a sample containing 200 L of ~6 mM 57FeII-FeBMb(ZnII) and 1.0 eq. NO (A), 
and 5.0 eq. NO (B) in 50 mM Bis-Tris pH 7.3, collected at 25K, 75K, and 150K in low field (0.01T). The 
parameters of the S=2 FeII starting material (blue lines) and the S = 3/2 {FeNO}7 species (green lines) extracted 
from the non-linear least square analyses of these spectra are shown in (Table 2.3). For all the simulations spectra 
were fit with Lorentzian lines. 
2.3.3 Computational and structural characterization of FeBMb(Zn
II) 
2.3.3.1 Crystal structure of FeII-FeBMb(Zn
II) 
FeII binding was investigated via x-ray crystallography. A 1.52 Å resolution X-ray structure 
of the FeCl2-soaked crystal of FeBMb(Zn
II) clearly shows that a metal is present at the FeB site. 
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Anomalous X-ray scattering data of the crystals collected above Fe K-edge at 7.2 keV 
unambiguously assigned this metal to be Fe (Figure 2.15). 
 
Figure 2.15. 1.52 Å X-ray structure of FeII-FeBMb(ZnII). ZnPPIX, proximal His and the distal residues that 
coordinate to the FeB are shown as sticks. Fe atom is shown as teal sphere, the water molecule is shown as red 
sphere. The anomalous map generated in PHENIX from the data collected at the Fe K-edge at 7.2 keV is drawn at 
7 and shown as purple mesh which clearly shows the presence of Fe metal. Rfac= 0.18, Rf = 0.22. Figure was 
generated in PyMol. PDB ID 4MXK. 
 
Structural overlays of FeII-FeBMb(Zn
II) with the active sites of FeII-FeBMb(Fe
II) and cNOR 
demonstrated that these structures were strikingly similar to each other (Figure 2.16). Thus, the 
FeB site of Fe
II-FeBMb(Zn
II) is a structural analog of the non-heme site of cNOR and FeII-
FeBMb(Fe
II). The close structural similarity between FeII-FeBMb(Zn
II) and FeII-FeBMb(Fe
II) also 
suggests that the ~3-fold higher affinity of FeII in the former was likely influenced by changes in 
the electronic environment around the metal binding site caused by replacement of iron 




Figure 2.16. Overlay of FeII-FeBMb(ZnII), cyan, with the active sites of (A) FeII-FeBMb(FeII), green, and (B) cNOR, 
green. FeBMb residues are labeled in (A), and cNOR residues are labeled in (B). 
 
2.3.3.2 DFT and QM/MM characterization of FeII-NO-FeBMb(Zn
II) 
The electronic state of the S = 3/2 {FeNO}7 species in both proteins and model complexes has 
been most frequently described as a result of antiferromagnetic coupling of HS ferric (S=5/2) to 
NO (S=1) [Fe3+-NO]119,122 or as antiferromagnetic coupling of HS ferrous (S=2) to NO radical 
(S=1/2) [Fe2+-NO].114,121,123 To obtain further insight into the electronic structure of the {FeNO}7 
moiety, the Mulliken spin populations (Table 2.4) at the Fe and NO centers of the structures 
obtained from quantum mechanical/molecular mechanical (QM/MM) calculations were 
















Table 2.4. Experimental (bold), and calculated (parentheses) Mössbauer parameters of 57Fe-ZnPPFeBMb1 in the 
absence and presence of NO. Experimental conditions: T=4.2K, field=0.01T, 1T, 5T, 9T. Mössbauer parameters were 


















3/2 3.66 0.90 
 
In these structures, NO occupies the vacant axial coordination site as the sixth ligand to 
FeB. The Mulliken spin population on the FeB center remains virtually the same in the absence and 
presence of NO, at 3.75 and 3.66, respectively, indicating four unpaired electrons, while the spin 
population on NO is found to be 0.90, indicating one unpaired electron. These results 
unambiguously support the assignment of HS ferrous center (S = 2) antiferromagnetically coupled 
to NO radical (S=1/2) [Fe2+-NO]. Furthermore, the Mössbauer parameters at the FeB site were 
computed in the absence and presence of NO for partially optimized active site structures. As can 





Figure 2.17. QM/MM optimized structures of FeII-FeBMb(ZnII) without (A), and with NO (B). Color scheme: C – 
green, Fe –magenta, N – blue, O – red, H – grey. 
 
Figure 2.18. Optimized active site structures of NO-free (A) and NO-bound (B) FeII-FeBMb(ZnII). Color scheme: C 
– green, Fe –magenta, N – blue, O – red, H – grey. 
 
2.4 Summary 
In conclusion, the NO binding properties of the FeB site in a biosynthetic model protein of 
NOR were probed by replacing the high affinity heme with isostructural ZnPPIX in the protein 
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FeBMb. Such feats are not easily achievable in native NORs, as these are complex membrane 
proteins with multiple heme cofactors. Structural overlays with cNOR clearly show that the FeB 
site in FeII-FeBMb(Zn
II) is a structural mimic of the FeB site in the native enzyme. EPR spectral 
studies show that NO binding to the FeB site yields rhombic signals corresponding to a {FeNO}
7 
S = 3/2 ferrous-nitrosyl complex. Mössbauer, and QM/MM studies confirmed the electronic 
properties of the {FeNO}7 complex in FeII-NO-FeBMb(Zn
II) as HS ferrous (S=2) 
antiferromagnetically coupled with NO radical (S=1/2) [Fe2+-NO]. This exciting finding 
indicates that the radical nature of the NO would facilitate the radical coupling of the second heme-
bound NO to promote N-N bond formation, supporting the proposed trans mechanism of NO 
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Chapter 3 Nuclear resonance vibrational spectroscopy (NRVS) of NO 
interaction with MII-FeBMb(MII) 
3.1 Introduction 
3.1.1 Background information on NRVS 
Nuclear resonance vibrational spectroscopy (NRVS) is an advanced spectroscopic technique 
which gives a complete and quantitative vibrational frequency spectrum for 57Fe-enriched nuclei. 
It offers a selectivity similar to resonance raman (rR) spectroscopy, but is not bound by the optical 
selection rules of rR or infrared spectroscopy.124 This is especially important in the study of NORs, 
given that the Fe-NO stretching mode vibrations are IR-silent and decompose upon laser 
irradiation.42 Unfortunately, performing NRVS requires extremely concentrated protein samples 
(10 to 15 mM) that are impractical when working with membranous, native enzymes such as NOR. 
However, studies have already been performed on myoglobin and its mutants,125,126 thus offering 
a unique opportunity to utilize this advanced spectroscopic technique on the biosynthetic model of 
NOR in sperm whale myoglobin, FeBMb. 
NRVS exploits technology developed at third-generation synchrotron light sources to monitor 
vibrational properties of Mössbauer nuclei, including 57Fe.127 Tuning of a monochromatic X-ray 
beam in the vicinity of the nuclear resonance reveals vibrational sidebands displaced from the 
recoilless resonance observed in conventional Mössbauer spectroscopy. A growing number of 
NRVS applications exploit its exclusive and quantitative sensitivity to vibrational motions of the 
probe nucleus.128,129 Specifically, each vibrational mode contributes to the measured signal in 
direct proportion to the mean squared displacement of the probe nucleus along the beam direction, 
and well-established data analysis methods130 directly extract a partial vibrational density of states 
(VDOS) for that measurement. 
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For a randomly oriented ensemble of molecules containing 57Fe, each vibrational normal mode 
contributes to the 57Fe VDOS an area equal to the fraction, eFe
2 , of the mode’s kinetic energy 
associated with motion of the 57Fe nucleus. The information content of the VDOS is quantitative, 
allowing direct comparison with vibrational predictions on an absolute scale.131,132 The VDOS is 
comprehensive, since all vibrations involving 57Fe contribute, without the artificial restrictions 
imposed by selection rules in more familiar vibrational spectroscopies (infrared and Raman). 
Finally, the VDOS is uniquely site-selective, since only motion of the 57Fe will contribute, even in 
a macromolecule containing thousands of other atoms.  
Based on these characteristics, NRVS is a uniquely valuable probe of protein active sites 
containing Fe. Several investigations have reported the vibrational dynamics of 57Fe in heme 
proteins,125,133,134 and iron porphyrins132,135–137 using NRVS. NRVS measurements on oriented 
single crystals of iron porphyrins exploit the sensitivity to motion along the direction of the x-ray 
beam to provide additional insights into the interpretation of the results on heme proteins.138 
Proteins with nonheme Fe sites are equally amenable to NRVS investigations,139,140 which have 
elucidated the structural characterization of reaction intermediates in nonheme Fe enzymes.141 
Vibrational spectra resulting from previous NRVS measurements on proteins containing multiple 
Fe atoms contain superposed contributions from all sites.142  
3.1.2 FeBMb: ability to site-specifically label either iron site in with 
57Fe 
In FeBMb, 
57Fe-labeling of the heme group can be achieved in one of two ways. First, the 57Fe-
enriched heme group can be used during the protein refolding step of protein purification instead 
of heme. Second, 57Fe-labeled heme can be incorporated through partial unfolding of the protein 
at low pH to remove heme, followed by reconstitution of the protein with 57Fe-enriched 
protoporphyrin IX (see section 2.2.1). Furthermore, 57Fe-labeling of the nonheme site is performed 
through addition of 57FeCl during nonheme reconstitution. Thus, specific labeling of either the 
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heme or nonheme Fe sites of FeBMb with 
57Fe allows for independent monitoring of the vibrations 
of Fe at each site, following the same procedure used for previous NRVS investigations on native 
myoglobin.94 57Fe-encriched heme vibrations will dominate the NRVS signal of the nonheme-
reconstituted protein, even after incorporation of natural abundance Fe (or another metal) into the 
nonheme site, since the natural abundance of 57Fe is only 2%. Similarly, incorporation of 57Fe into 
the nonheme site of FeBMb reconstituted with natural abundance heme should allow us to 
specifically monitor the vibrations of the nonheme Fe. 
3.2 Experimental 
3.2.1 Sample prepration of MII-FeBMb(M
II) and their nitrosyl derivatives 
All samples were prepared in chelexed 50 mM Bis-Tris pH 7.3 buffer, followed by pH 
adjustment and filtration to remove chelex beads. Buffers were degassed in a Schlenk line for 5 
hours by several cycles of freeze-pump-thaw prior to transferring them into an anaerobic chamber 
(Coy Laboratories, Inc.) for sample preparations. Dry Sephadex G25 beads (GE Healthcare) were 
suspended in buffer solution and degassed in the Schlenk line for 3 hours before transferring into 
the glove bag. All solid, plastic materials were kept under vacuum in the antechamber overnight 
prior to transferring them into the glove bag. All protein solutions were exchanged from 100 mM 
phosphate buffer pH 7 to 50 mM Bis-Tris pH 7.3 outside the glove bag using small size exclusion 
columns (PD 10, GE Healthcare) pre-equilibrated in the exchangeable buffer. The protein 
solutions were then degassed by 3 cycles of freeze-pump-thaw in a Schlenk line and brought into 
the glove bag. Diethylamine NONOate (DEA-NONOate: 250nm = 6.5 mM
1cm1, Cayman 
Chemicals) solutions prepared in 10 mM NaOH were degassed by three cycles of freeze-pump-
thaw before being transferred into the glove bag and used as the NO source. A stock solution of 




III) was purified using known protocol as reported previously.6,7 A similar protocol 
was employed for 57FeBMb purification except that, in this case, 
57Fe labeled heme (Frontier 
Scientific) was used during the protein refolding step. The identity of each of the purified proteins 
was confirmed by ESI-MS. The r/z of pure protein was > 4 in 100 mM potassium phosphate buffer 
pH 7. E-FeBMb(Zn
II) was prepared and purified as previously described.8 Pure proteins were stored 
at 80 °C until further use. Molar extinction coefficients of 406 = 175 mM
1cm1 for E-
FeBMb(Fe
III), 433 = 143 mM
1cm1 for the E-FeBMb(Fe
II), and 427 = 136.2 mM
1cm1 for E-
FeBMb(Zn
II) were used to determine the concentrations of the corresponding proteins.8 
E-FeBMb(Fe
III) was reduced inside the glove bag with excess dithionite and passed through a 
small hand-packed size exclusion column (Sephadex G25) pre-equilibrated with 50 mM Bis-Tris 
pH 7.3 to remove excess dithionite and eluted with the same buffer. The eluted protein was then 
concentrated to 1 mM and the nonheme site was reconstituted with either 1.0 equivalent of 57FeCl2 
or ZnCl2 (prepared freshly in the inert atmosphere bag) added in aliquots of 0.25 equivalent with 
15 minutes in between each addition. E-FeBMb(Zn
II) was transferred into the glove bag after 
degassing, concentrated to 1 mM, and the FeB site was then reconstituted with 
57FeII without 
reducing the protein, as ZnPPIX is redox inactive. 
Reconstitution of the FeB site with 
57FeII or ZnII, as desired, was ensured by checking the UV-
vis spectrum after metal addition as evidenced by shifting of the Soret peak from 427nm in E-
FeBMb(Zn
II) and 433nm in E-FeBMb(Fe
II) to 429nm in FeII-FeBMb(Zn
II) and 434nm in MII-
FeBMb(Fe
II).6,8 When applicable, oxidation of the heme iron and nonheme iron was achieved after 
nonheme reconstitution by addition of excess ferricyanide, then passage through a small size 
exclusion column. The nonheme-reconstituted proteins were then concentrated to 10 to 15 mM 
before loading 15 L of the samples into the well of HDPE block sample holder inside the glove 
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bag, transferred outside in a sealed plastic bag, and frozen immediately using liquid nitrogen where 
other components (sapphire window, copper block, brass screws) were assembled.  
Nitrosyl derivatives were prepared using the following protocol. For MII-FeBMb(M
II), 1 
equivalent of NO was added to the nonheme FeII- or ZnII-reconstituted proteins present at 1 mM 
concentration. At each step 0.25 equivalent of NO was added to the reconstituted proteins in the 
form of DEA NONOate, allowing enough time for NO release in between each addition (t1/2 = 16 
min at pH 7.3). NO binding to the proteins was confirmed by measuring UV-vis spectra of NO-
bound samples.  
Excess NO (20 equivalents) was added, in the form of DEA NONOate as described above, to 
57FeII-FeBMb(Zn
II) to saturate the FeB site with NO. After NO binding, the samples were further 
purified by another PD10 column equilibrated in 50 mM Bis-Tris pH 7.3 to remove any trace 
impurities including the decay products of DEA NONOate. All the nitrosyl complexes thus 
prepared were then concentrated to 10 to 15 mM and loaded into NRVS cells as described above. 
The protocol of adding NO at 1 mM of the reconstituted proteins followed by concentrating to 
higher concentrations has proven to be a successful strategy in previous studies of FeBMb variants 
as recently reported for similar spectroscopic techniques such as Mössbauer.8 An aliquot of each 
of the above concentrated samples was diluted and their UV-vis spectra were checked inside the 
glove bag to ensure that no changes in NO coordination occurred during the final step of sample 
preparation.  
3.2.2 57FeCl2 synthesis 
57FeCl2 synthesis was performed inside the glove bag. 300 mL of H2O and 1 mL of 9.14% 
methanolic HCl (285.6 L of 32% HCl + 714.4 L methanol) was degassed and transferred into 
the glove bag. 25 mg 57Fe metal (0.44 mmol) (Cambridge Isotope Lab) was placed in a small, dry 
NMR tube and transferred into the glove bag. The degassed water was transferred into a small 
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water bath and heated to 60 C using a hot plate equipped with a stir bar. The NMR tube containing 
57Fe was immersed in the water bath and 350 l of the 9.14% methanolic HCl (0.88 mmol) was 
added into the tube. H2 evolution started immediately. The reaction was allowed to proceed for 3 
to 4 hours until the gas evolution ceased. The solution was carefully transferred into a tared 
Schlenk flask with adaptor. The Schlenk flask was removed from the bag and immersed in dry 
ice/ethanol slush bath, and slowly opened to vacuum in a Schlenk line. The flask was then slowly 
warmed to 100C using a water bath while in vacuum. After the solvent evaporated and the solid 
turned from green to white, the water bath was replaced with an oil bath and heated to 160C, 
allowing the residual methanol to evaporate. The product was cooled to room temperature slowly, 
purged with Ar, sealed and weighed. The yield of 57FeCl2 was 60-65%. 
3.2.3 NRVS sample collection, data analysis, and density functional theory (DFT) 
calculations 
NRVS data were collected at the Advanced Photon Source (APS) on beamline 3ID-D, as 
described in detail elsewhere.143 Briefly, the X-ray energy was scanned in the vicinity of the 57Fe 
nuclear resonance at 14.4125 keV in steps of 0.25 meV. Data were recorded on frozen solutions 
at 10 to 15 mM protein concentration at temperatures of 60 - 80 K. and each measurement was the 
average of 15 - 35 scans, with each scan lasting approximately 45 minutes. Comparison of early 
and late scans confirmed the absence of spectroscopic changes during X-ray exposure. The VDOS 
was extracted from the measured data using the program PHOENIX.86 
Density functional calculations were performed using Gaussian 09 with the B3LYP108,144 and 
M06L145 functionals. The VTZ basis set146 was used for the iron orbitals and 6-31G* for all other 
atoms. The computational model for the nitrosyl complex of the nonheme site of 57FeII-NO-
FeBMb(Zn
II) used the atomic coordinates deposited in the Protein Data Bank under access code 
3K9Z6 for His 29, His 43, His 64, Glu 68 (with alpha carbons replaced by terminal methyl groups), 
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the iron and a ligated water, and added NO as a sixth ligand. Energy optimization of the 
experimentally observed S = 3/2 state yielded nearly octahedral coordination for the iron, with an 
Fe-NO angle varying from 142.8º (B3LYP) to 143.2º (M06L). The atomic displacements of the 
vibrational normal modes were used to calculate the Fe VDOS as described previously.128 
3.3 Results and discussion 




UV-vis spectroscopy was used to monitor NO binding to FeII-FeBMb(
57FeII) during NRVS 
sample preparation. Representative spectra are shown in Figure 3.1. Upon addition of 1 eq. NO to 
FeII-FeBMb(
57FeII), the Soret peak at 433 nm (Figure 3.1, black curve) underwent a blue shift to 
419 nm (Figure 3.1, red curve), corresponding to the formation of a 6cLS {FeNO}7 species, and 
another broad peak at 398 nm corresponding to a 5cLS {FeNO}7 species (Figure 3.1, red curve 
and inset). This assignment is confirmed by NRVS results (vide infra). Addition of 1 equivalent 
NO to ZnII-FeBMb(
57FeII) sample also caused a blue shift of the Soret peak from 434 nm (Figure 
3.1, cyan curve) to 403 nm (Figure 3.1, purple curve) corresponding to the formation of a 5cLS 




Figure 3.1. UV-vis spectra of FeII-FeBMb(57FeII) (black curve), ZnII-FeBMb(57FeII) (cyan curve), and the 
corresponding mononitrosyl derivatives FeII-FeBMb(57FeII-NO) (red curve) and ZnII-FeBMb(57FeII-NO) (purple curve). 
Inset shows deconvolution of the Soret region of FeII-FeBMb(57FeII-NO) demonstrating two components: one peak at 
419 nm corresponding to the 6cLS {FeNO}7 species, and a second broader peak at 398 nm corresponding to the 5cLS 
{FeNO}7 species. The presence of both 6cLS and 5cLS {FeNO}7 species is consistent with the NRVS results (vide 
infra). In the case of the ZnII-FeBMb(57FeII-NO) sample, the presence of the Soret peak at 403 nm is also consistent 
with the presence of 5cLS {FeNO}7 also observed by NRVS (vide infra). 




Either the heme or nonheme Fe sites of FeBMb was labeled with 
57Fe, allowing the 
independent monitoring of vibrations of 57Fe at each site. Heme vibrations will dominate the 
NRVS signal of MII-FeBMb(
57FeII) since the natural abundance of 57Fe is only 2%. Similarly, 
incorporation of 57Fe into the nonheme site of 57FeII-FeBMb(Fe
II) reconstituted with natural 
abundance heme allows the vibrations of the nonheme 57Fe to be specifically monitored. The 
vibrational densities of states (VDOS) determined from NRVS measurements on FeII-
FeBMb(
57FeII) (Figure 3.2) demonstrate that specific labeling of the heme and nonheme Fe sites 
with 57Fe allows us to distinguish vibrations at distinct sites within the same protein. The 
vibrational signal from the heme Fe strongly resembles that reported for native Mb.125 The 
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dominant feature of the VDOS includes contributions from vibrations of the axial Fe−NHis bond 
to His 93 and of the equatorial Fe−Npyr bonds to the four heme pyrrole nitrogens at approximately 
230 cm-1 and 250 cm-1, respectively. The Fe−NHis frequency is well known from resonance Raman 
measurements on heme proteins,143,147,148 where this vibration is strongly enhanced on excitation 
into the Soret band. The NRVS signal is determined by the relative amplitude of Fe motion and 
also includes the Fe−Npyr vibrations, which are not easily observable using other spectroscopies. 
 
Figure 3.2. Site-selective enrichment of FeBMb with 57Fe allows independent monitoring of Fe vibrations at either the 
heme or nonheme site. The upper and lower traces represent the partial vibrational density of states (VDOS) of FeII-
FeBMb(57FeII) and 57FeII-FeBMb(FeII), respectively, derived from such measurements and reflect the distinct 
coordination of Fe at each site. The heme VDOS is nearly identical to that reported for reduced native myoglobin from 
horse heart, where contributions from the Fe-NHis vibration perpendicular to the heme and vibrations of the in-plane 
Fe-Npyr bonds to the heme pyrrole nitrogens were identified. Although individual vibrations are not resolved for the 
less symmetric nonheme site, the stiffness derived from the VDOS (Table 3.1) nevertheless reflects the lower 
coordination of Fe in this environment. Here and in subsequent figures, error bars reflect experimental uncertainties 
determined from counting statistics, while solid traces represent a five-point running average of the experimental 
VDOS. 
The nonheme iron of 57FeII-FeBMb(Fe
II) displays a clearly distinct vibrational signal dominated 
by a broad feature with a peak near 230 cm-1. The crystallographic model includes His 29, His 43, 







signal observed for the nonheme Fe apparently masks the vibrational structure that one might 
expect in light of this diverse ligand field, and the reduced symmetry in comparison with the heme 
site may further increase the vibrational complexity. Multiple unresolved vibrational modes were 
identified which contribute to a similar broad vibrational feature in reduced cytochrome c, based 
on a quantitative comparison with 54Fe/57Fe isotope shifts observed in resonance Raman 
measurements, and this complexity was attributed to the reduced symmetry of Fe coordination in 
the distorted heme.149 Conformational heterogeneity is well-documented for native Mb and may 
also broaden vibrational features. Regardless of the reasons, the unresolved vibrational complexity 
may hinder the identification of well-defined Fe-ligand vibrations.  
The VDOS for the nonheme 57Fe is clearly distinct from that for the heme 57Fe, in spite of a 
relatively low 57Fe concentration and a consequently reduced signal for the nonheme 57Fe sample. 
This dual confirmation of successful site-specific labeling of each site illustrates the opportunity 
to probe the reactivity and interaction with NO of each Fe independently. 
Fortunately, the vibrational information revealed by the NRVS measurement yields a 
quantitative measure of coordination strength even in the absence of detailed vibrational frequency 
assignments. The VDOS D(?̅?) determines the stiffness: 









an effective force constant that directly measures the force required to displace the iron with its 
coordination environment held fixed.150 The stiffness for both sites is much lower than for the low-
spin heme Fe in reduced cytochrome c,149 where the stiffness was more than 300 pN/pm. The 
stiffness is consistent with the presence of a high-spin Fe at both sites in FeII-FeBMb(Fe
II). This 
contrasts with evidence for a low-spin heme reported for the cNOR from Ps. Nautica.151 Thus 
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suggesting that the spin state of the active site heme iron is not a critical feature in imparting NOR 
activity in these enzymes.  
Within experimental uncertainty, the stiffness of the heme Fe in FeII-FeBMb(Fe
II) is the 
same as in native Mb (Table 3.1), confirming the expectation that introduction of the nonheme 
metal site does not significantly affect the coordination strength of the heme Fe. However, the 
stiffness of the nonheme Fe environment is significantly lower than that determined for the heme 
Fe. The slightly lower force restraining the Fe in the nonheme site presumably reflects its reduced 
coordination. 
Table 3.1. Averaged Experimental Force Constants of Ferrous Iron Sites in Proteins 
Sample stiffness (pN/pm) resilience (pN/pm) reference 
FeII-FeBMb(57FeII) 182 ±  9 20.3 
9 
57FeII-FeBMb(FeII) 155 ±  6 20.1 
9 
FeII-FeBMb(57FeII-NO) 321 ±  21 
 
9 
Mb 189 ±  20 21.3 ±  1.3 
152,149 
cytochrome c 322 ±  17 32.6 ±  1.6 
152,149 
 









which provides information distinct from the stiffness. As defined more generally by Zaccai,153 
the resilience: 







measures the rate at which the mean squared displacement ⟨𝒙𝐅𝐞
𝟐 ⟩ of the probe atom (here, 57Fe) 
increases with temperature. NRVS lacks the energy resolution to capture highly anharmonic 
motions that contribute to temperature-dependent measurements of ⟨𝒙𝐅𝐞
𝟐 ⟩ using techniques such as 
inelastic neutron scattering or Mössbauer spectroscopy above a “dynamical transition” near 200 
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K. On the other hand, at temperatures below 200 K, quantitative agreement between 
determinations of ⟨𝐱𝐅𝐞
𝟐 ⟩ from Mössbauer measurements on oxidized cytochrome c at a series of 
temperatures154 and the values expected on the basis of the Fe VDOS determined using NRVS at 
a single temperature was observed.152 The vibrational contribution to the resilience captures this 
temperature variation in a single parameter, with lower values of the resilience characterizing 
environments with large fluctuations of the 57Fe probe atom. 
Low frequency vibrations play the primary role in determining the resilience, as illustrated by 





in Eq. 2 as a “resilience spectrum” in Figure 3.3. The resilience is equal to the inverse of the area 
of this spectrum, and is primarily determined by vibrations below 100 cm-1. Molecular dynamics 
simulations on myoglobin and cytochrome c show similar mean squared displacements for all 
heme atoms including Fe,152 supporting the suggestion125 that translation of the heme in response 
to fluctuations of the embedding protein matrix make the primary contribution to the to the NRVS 
signal below 100 cm-1. 
As a result, resilience can be viewed as a measure of the elastic properties of the protein 
environment. Previously, significant increase of the resilience in cytochrome c in comparison with 
Mb was observed.152 Here, the resiliences of FeII-FeBMb(
57FeII) and native Mb are the same, within 
experimental uncertainty, suggesting that the introduction of the additional nonheme metal site 
does not seriously perturb the elastic properties of the protein. Moreover, small differences in the 
coupling of the protein fluctuations to the heme and nonheme Fe sites, apparent from examination 
of Figure 3.3, average out to yield values for the resilience that agree quantitatively for the two 
distinct sites, within the experimental uncertainty. This further supports the notion that the 
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resilience quantifies global properties of the embedding protein and contrasts with the sensitivity 
of the stiffness to differences in the coordination of the two Fe sites. Resilience can be interpreted 
as an “outer sphere” force constant that probes the elasticity of the overall embedding protein, in 
contrast with the probe of the immediate coordination environment as quantified by the stiffness. 
 
Figure 3.3. The resilience spectrum suppresses contributions from localized Fe-ligand vibrations and highlights low 
frequency oscillations of the protein that drive translational motion of both Fe sites in reduced FeBMb. Quantitative 
agreement between the areas determined for both sites yield values for the resilience that are identical within 
experimental uncertainty. Nevertheless, comparison as a function of frequency reveals subtle differences in the 




NRVS measurements were recorded on FeIII-FeBMb(
57FeIII) and 57FeIII-FeBMb(Fe
III) (Figure 
3.4). A feature near 270 cm-1 dominates the heme 57Fe VDOS, which strongly resembles that 
previously reported for native sperm whale myoglobin.155 Since Fe ligand vibrations are 
undoubtedly the primary contribution to this feature, this indicates that the ligation of the heme Fe 
to His 93 and to a neutral water molecule is the same in FeBMb as in native Mb. In particular, these 







state of NOR, and the high-spin NRVS signal from the heme Fe contrasts with the low-spin heme 
Fe reported for the cNOR from Ps. Nautica.151  
 
Figure 3.4. The Fe VDOS of FeIII-FeBMb(57FeIII), shown in the upper trace, strongly resembles that reported for native 
sperm whale Mb, indicating that coordination of the heme 57Fe is unaffected by the presence of the additional nonheme 
Fe engineered into the distal pocket. In spite of limited signal, the nonheme 57Fe VDOS (lower trace) clearly reports 




The vibrational dynamics of the heme Fe undergo noticeable changes upon exposure to NO. 
The vibrational signal from FeII-FeBMb(
57FeII-NO) covers a wider frequency range than in the 
absence of NO, with significant features resolved beyond 500 cm-1 (Figure 3.5). The 
experimentally determined stiffness for ZnII-FeBMb(
57FeII-NO) exceeds 300 pN/pm (Table 3.1), 
indicating a substantial increase in the coordination forces exerted on the Fe. The enhanced 
coordination strength is consistent with a low-spin Fe. We observed stiffnesses exceeding 300 








Figure 3.5. The heme Fe VDOS reveals that the presence of a second metal in the nonheme site influences NO binding 
to FeBMb. Fe-NO stretching vibrations, clearly resolved above 400 cm-1, probe the axial ligation. For reference, dashed 
lines indicate Fe-NO stretching frequencies reported for native horse heart MbNO (452 cm-1), characteristic of a six-
coordinate complex with NO coordinated trans to a histidine ligand, and for Fe(DPIX)(NO) (528 cm-1), a typical five-
coordinate heme-NO complex. A substantial fraction of hemes exhibit an Fe-NO stretching frequency characteristic 
of five-coordinate heme nitrosyls when either Zn(II) or Fe(II) is present in the nonheme site. This contrasts with 
previous measurements on native MbNO, which revealed a NRVS signal consistent with six-coordinate heme-NO. 
The presence of well-resolved features yields more specific information on individual Fe-
ligand bonds. In particular, previous NRVS measurements have identified an Fe-NO stretching 
mode in the 520-530 cm-1 range in five-coordinate heme-NO complexes,132,138,156,157 which is also 
observed in resonance Raman measurements.86,158,159 Binding of an imidazole ligand trans to NO 
weakens the Fe-NO bond,160,161 and we observe this mode at lower frequencies in the 450-460 cm-
1 range for these six-coordinate heme-NO complexes.136,162–165 One well-characterized six-
coordinate heme-NO complex is native MbNO, where this Fe-NO vibration appears at 452 cm-1 
and contributes to both resonance Raman and NRVS signals.162,163  
Unlike native MbNO, Fe-NO stretching frequencies near 530 cm-1, characteristic of five-








introduction of a divalent metal in the nonheme site (Figure 3.5). This result supports previous 
evidence for formation of a five-coordinate heme-NO complex in FeII-FeBMb(
57FeII) exposed to 
excess NO, which was based on observation of the same Fe-NO vibration at 522 cm-1 using 
resonance Raman spectroscopy as well as the presence of a 1660 cm-1 N-O stretching frequency 
in IR measurements.68 The altered heme ligation in response to the neighboring nonheme metal 
contrasts with the insensitivity of the unligated heme to the nonheme metal noted above (Figure 
3.2 and Figure 3.4), and demonstrates that the nonheme metal specifically influences the structure 
of the heme-ligand complex. 
In the presence of one equivalent of NO, the FeII-FeBMb(
57FeII-NO) VDOS (Figure 3.5) also 
has a feature with a 480 cm-1 frequency that we attribute to six-coordinate heme-NO. Because the 
NRVS signal depends only on the mean squared vibrational amplitude of the Fe and on the relative 
population of contributing species, the FeII-FeBMb(
57FeII-NO) VDOS data suggest comparable 
amounts of five- and six-coordinate heme-NO (Figure 3.5). Interestingly, the Fe-NO frequency is 
significantly increased with respect to that observed for native MbNO,162,163 providing additional 
information on how the nonheme metal influences the electronic structure of the neighboring 
heme-NO complex. The contribution of a vibrational signal attributable to six-coordinate heme-
NO is significantly reduced for ZnII-FeBMb(
57FeII-NO) in the presence of 1 eq. NO (Figure 3.5). 
Another FeNO vibration undergoes a large shift from ca. 380 cm-1 in five-coordinate to ca. 560 
cm-1 in six-coordinate heme-NO complexes.138,162 Experimental characterization of its kinetic 
energy distribution based on isotope shifts indicates that this vibrational mode primarily involved 
motion of the central nitrogen atom of the FeNO unit.90,162,166 On this basis, this N-centered vibration 
can be qualitatively described as an FeNO bending mode to distinguish it from the Fe-NO 
stretching mode that contributes more strongly to the NRVS signal. However, it must be 
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emphasized that neither mode can exhibit pure Fe-NO bending or Fe-NO stretching character for 
the nonlinear FeNO unit. Both modes exhibit rather modest Soret enhancement in Raman 
scattering from six-coordinate heme-NO complexes, but the FeNO bending frequency is more 
reliably detected in heme proteins because of its large sensitivity to 14N/15N substitution and is thus 
more often reported. Although the Fe amplitude and thus the NRVS signal is necessarily smaller 
for the FeNO bending vibration, the MII-FeBMb(
57FeII-NO) VDOS includes minor features near 
380 and 580 cm-1 consistent with contributions from the FeNO bending vibration of five- and six-
coordinate heme-NO complexes, respectively, supporting conclusions based on the stronger Fe-
NO stretching frequency discussed above. 
RR and IR measurements on FeII-FeBMb(Fe
II) reacted with stoichiometric NO also identify 
FeNO bending and N-O stretching frequencies that are 15 - 20 cm-1 higher and 70 - 80 cm-1 lower, 
respectively, than typically observed for six-coordinate heme-NO.72 Together, the unusual values 
for all three vibrations of the FeNO fragment suggest that nonheme FeII strongly perturbs the 
electronic structure of the heme-NO. It is conceivable that FeII electrostatically predisposes the 
heme-bound NO to the electron transfer that will ultimately be required for reactivity. 
3.3.2.4 57FeII-NO-FeBMb(Zn
II) 
As found above, the nonheme Fe influences the coordination of the heme, strengthening the Fe-
NO bond and weakening the Fe-His linkage to the protein. In contrast, the vibrational dynamics 
of the nonheme Fe in 57FeII-FeBMb(Fe
II) exposed to one equivalent of NO do not differ 
significantly from those observed in the absence of NO (Figure 3.6). This indicates that the ligation 
and electronic structure of the nonheme Fe is insensitive to the structural and electronic changes 
that take place upon NO binding to the heme Fe. Moreover, it indicates that the nonheme Fe has a 
much lower affinity for NO than the heme Fe does. 
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Replacement of FePPIX with ZnPPIX eliminates the possibility of NO binding to heme and 
allows investigation of NO binding to nonheme Fe selectively. The VDOS of nonheme 57Fe in the 
resulting 57FeII-FeBMb(Zn
II) (Figure 3.6) in the absence of NO strongly resembles that observed 
for 57FeII-FeBMb(Fe
II) under the same conditions (Figure 3.2), indicating that the structure of the 
nonheme Fe site is insensitive to the substitution of the heme metal. However, noticeable changes 
in the nonheme VDOS of 57FeII-FeBMb(Zn
II) take place in the presence of excess NO (Figure 3.6), 
which we attribute to the binding of NO to the nonheme Fe under these conditions. 
 
Figure 3.6. The VDOS of the nonheme Fe atom reveals perturbations in 57FeII-NO-FeBMb(ZnII) when the nonheme 
site is saturated with excess NO. When FeII/III is present in the heme site, on the other hand, the nonheme Fe VDOS 
exhibits no significant change upon reaction with stoichiometric NO, in contrast with the clear signatures for NO 
binding to the heme Fe seen in Figure 3.2 and Figure 3.4. 
One significant advantage of the NRVS method is the relative ease of quantitative comparison 
with DFT predictions.132,135,167 Overall, such comparisons provide useful guidance for interpreting 
experimental results, but we have found that predicted vibrational frequencies for the FeNO 
fragment exhibit significant dependence on the functional used for DFT calculations.132,136,167 For 







cm-1.132,136,167 DFT investigations of nonheme FeNO complexes also reveal significant variability 
of the electronic structure predicted using different functionals.168,169 It remains to be established 
whether any currently available functional adequately accounts for electron correlation in Fe 
nitrosyl complexes.  
Examination of a wide variety of functionals found that M06L145 gave the best overall account 
of the Fe VDOS for the five-coordinate nitrosyl heme complex Fe(OEP)(NO).167 The VDOS 
predicted using this functional is presented both as the lower trace in Figure 3.7 and, for 
comparison, as a filled area behind the experimental VDOS in the upper trace of Figure 3.7. The 
M06L prediction does exhibit significant correspondence with the experimental signal, supporting 
the conclusion that direct NO ligation accounts for the observed vibrational changes. 
Unfortunately, because of the limited 57Fe concentration, the relatively low signal level from this 
sample precludes an experimental identification of the Fe-NO stretching frequency. 
 
Figure 3.7. Computational models for the NO-ligated nonheme FeB site in 57FeII-FeBMb(ZnII) using differing 
functionals yield quantitative predictions for the Fe VDOS. Comparison with the experimental VDOS for 57FeII-
FeBMb(ZnII) in the presence of excess NO is consistent with a substantial contribution from NO-ligated Fe. The red 
trace indicates the contribution from Fe motion along the Fe-NO bond direction and highlights the variability of the 
predicted Fe-NO stretching frequency, which shifts from 376 cm-1 using B3LYP to 454 cm-1 using M06L. Image 






Results presented here exploit the ability to replace metals at either Fe site, illustrating an 
important opportunity enabled by the biosynthetic approach. Selective substitution of either the 
heme or nonheme sites with 57Fe provides an independent structural probe for either of the two 
metal sites in FeBMb. NRVS measurements quantify the forces exerted on 
57Fe by its coordination 
environment and indicate the presence of high-spin iron at both sites in the absence of substrate. 
Reduced and oxidized FeBMb serve to model the initial and final states of the enzyme, respectively, 
although the vibrational signals provide no evidence for a solvent-derived ligand bridging the 
metals in the oxidized state, as found in cNOR.1 Rather, vibrations of the heme Fe are comparable 
to those reported for native Mb, confirming that the heme is unperturbed by the engineered 
nonheme site. On the other hand, the observation of distinct vibrational dynamics for the nonheme 
Fe confirms successful site-specific labelling with 57Fe.  
 Substitution of a redox-incompetent ZnII ion for FeII allows the preparation of stable 
mononitrosylated intermediates that would precede the formation of the putative (and unstable) 
dinitrosylated intermediates. The presence of ZnII in the nonheme site perturbs the vibrational 
properties of the adjacent heme-NO complex in a manner consistent with electron transfer to the 
NO ligand. This suggests that electrostatic influence of the nonheme FeII in NOR could act to 
promote the enzymatic reaction in either the trans or the cis heme mechanism.43 With ZnII in the 
heme site, alteration of the nonheme Fe vibrations upon exposure to NO confirms that NO can 
bind to the nonheme FeII if the heme site is unavailable, as would be required in the trans 
mechanism.  
Advances in biosynthetic modeling of NORs have been achieved recently, and, given that both 
the resting state1,170 as well as a ligand-bound and reduced forms of cNOR have been crystallized,30 
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our understanding of NOR modeling should only improve moving forward. Importantly, models 
that can perform enzymatic turnover will be critical as we are unaware of any model, biosynthetic 
or otherwise, that is capable of reducing NO with comparable turnover number to the native 
enzymes. In conjunction with this, development of new models that more closely replicate the 
secondary coordination sphere of native NORs must be developed, as these interactions are critical 
for improving activity.7,171,65 With improved structural information into the active site of NOR, 
fine-tuning of factors such as heme-nonheme distance will also be important. The creation of such 
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Chapter 4 MnII- and CoII-FeBMb(FeII) reacted with O2 
4.1 Introduction 
4.1.1 Cross reactivity of HCOs and NORs 
Heme-copper oxidases (HCOs) perform the 4-electron, 4-proton reduction of O2 to H2O 
(O2 + 4e
- + 4H+  2H2O) and couple this reduction to proton pumping to generate an 
electrochemical gradient that is utilized to synthesize adenosine triphosphate (ATP), the biological 
energy currency.172,173 Nitric oxide reductases (NORs) are structurally homologous to HCOs and 
carry out the 2-electron, 2-proton reduction of NO to N2O (2NO + 2e
- + 2H+  N2O + H2O), an 
important step in the biological denitrification process.9  
Despite their different functions, both enzymes belong to the same enzyme superfamily 
and contain a heme-nonheme active site, with a major difference being that HCOs contain 
nonheme CuB, while NOR contains nonheme FeB, each with different primary and secondary 
coordination spheres (Figure 4.1).20,52,53,174,175 Specifically, CuB in HCOs is bound by three 
histidine residues, one of which is covalently cross-linked to a tyrosine residue implicated in proton 
and electron shuttling to the active site.15 On the other hand, FeB in NORs is bound by a 3-His-1-
Glu ligand set, with two additional glutamates near the active site involved in a hydrogen bonding 
network important for activity, which are not also found in HCOs.1 
It is interesting to note that, while cross reactivity between HCOs and NORs has been 
observed, each enzyme is more reactive towards its native substrate.2,4 Despite studies focused on 
understanding these differences in reactivity,56,57 an open question in the field remains: why do 
HCOs use copper while NORs utilize nonheme iron for their respective activities? While the most 
direct way of addressing this question would be to replace the nonheme metals in HCOs and NORs 
with various other metal ions, such an approach has been unsuccessful in the native proteins due 
to these enzymes being membranous and containing multiple subunits and cofactors, as well as 
63 
 
their overall size (70 - 200kDa) and complexity; any attempt to replace the nonheme metal ions 
with other nonnative metal ions has resulted in misfolded protein whose activity cannot be restored 
even after adding the native metal ion back. Thus, having a single protein that can bind a wide 
array of nonheme metal ions would be ideal for answering such a question. 
 
Figure 4.1. Crystal structures of (A) ba3 oxidase (PDB code 1XME) and (B) cNOR (PDB code 3O0R). Water 
molecules are shown as small red spheres, while nonheme metal ions are depicted as large purple and red spheres 
for copper and iron, respectively. 
To overcome the above limitations, sperm whale myoglobin was engineered into a 
structural and functional model of HCO (L29H, F43H, H64 Mb, called CuBMb), which was able 
to bind Cu and reduce O2 to H2O.
5,176,177 Further designs improved both the number of turnovers,178 
as well as the overall rate of O2 reduction, even matching the activity observed in native systems.
179 
However, CuBMb was unable to bind Fe, not surprisingly, as it lacks the conserved Glu in the Fe-
binding site of NORs. Therefore, the Val68Glu mutation was added to CuBMb, and this new 
protein, called FeBMb, binds nonheme Fe and exhibits NOR activity, making it (Figure 4.2) a 




















Figure 4.2. Crystal structures of (A) FeII-, (B) MnII-, and (C) CoII-FeBMb(FeII). Water molecules are shown as red 
spheres, while nonheme metal ions are shown as magenta, green, and cyan spheres for MnII, FeII, and CoII, 
respectively. 
4.1.2 Studies on FeII- and CuI-FeBMb(Fe
II) reacted with O2 
Previous reports demonstrated that E-FeBMb(Fe
II) was able to bind either Fe, Cu, or Zn in 
the nonheme metal binding site with almost identical geometric structures, making FeBMb an 
excellent system to answer the question of why HCO and NOR use their respective nonheme metal 
ion in their activities.6,7,68,72,180 In a recent report, nonheme Fe and Cu were introduced to the 
nonheme site of E-FeBMb(Fe
II), and the influence of each metal ion on O2 reduction activity was 
probed. The results of this study indicated that both nonheme FeII and CuI impart the full 4e-, 4H+ 
O2-reduction activity to water in FeBMb, while redox-inactive nonheme Zn
II and FeBMb without 
nonheme metal are unable to effectively reduce O2 without large generation of ROS.
180 More 
importantly, 30-fold and 11-fold enhancements in oxidase activity of nonheme CuI- and FeII-
FeBMb(Fe
II), respectively, were observed as compared to ZnII-FeBMb(Fe
II). Detailed 
electrochemical, kinetic and vibrational spectroscopic studies, in tandem with theoretical DFT 
calculations, demonstrated that nonheme FeII and CuI not only donated electrons to oxygen but 
also activated it for efficient O-O bond cleavage. Furthermore, the higher redox potential of copper 
and the enhanced weakening of O-O bond from the higher electron density in the d-orbital of 
copper are central to its higher oxidase activity over iron.180 This direct comparison of the effect 









site provided direct evidence for why nature prefers Cu over Fe in oxidase activity and reasons 
behind such a choice. 
Built upon the above success in elucidating the role of nonheme Cu and Fe ions in HCO 
activity, it was further explored whether or not the nonheme metal ion can be replaced with other 
first-row transition metal ions such as MnII and CoII with different d electron configurations and 
whether the presence of these ions imparted O2 reduction activity. Cobalt and manganese have 
been used previously as robust probes to uncover necessary electronic structural properties and 
structure-activity relationships in other proteins,181–184 including superoxide dismutase,185–189 
catechol dioxygenase,190 myoglobin,191,192 P1B-type ATPases,
193 and metallothioneins.194 
Understanding the roles of nonheme metal ions beyond the Cu and Fe in HCO and NOR will 
provide deeper insights into nature’s choice of metal ion and allow finer control of the enzymatic 
activity in the future. Such an endeavor is a primary goal of protein design,195,196 and, while the 
metals within a designed protein are not often viewed as equally ‘mutatable’ as an amino acid, 
changes to these crucial cofactors provide valuable insights into the enzymatic structure-function 
relationship. 
Toward this goal, preparation and characterization of the binding of MnII and CoII in the 
nonheme site of E-FeBMb(Fe
II) was carried out. The results showed that, while both MnII and CoII 
confer O2 reduction to H2O with high selectivity towards H2O, the redox activity of Mn
II and CoII 
is not strictly required, in contrast to those observed for the CuI and FeII-dependent activity. 
Spectroscopic studies coupled with DFT calculations were carried out to explain mechanistic 
differences in these nonheme metal ion-dependent activities. 
4.2 Experimental 
All chemicals and reagents were purchased from Sigma-Aldrich and used without 
additional purification.  
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4.2.1 Spectroscopic metal titrations and preparation of MII-FeBMb(Fe
II) 
Preparation of the nonheme metal-bound forms of FeBMb(Fe
II) inside of the anaerobic 
chamber utilized UV/Vis spectroscopy collected on a Hewlett-Packard 8453 spectrophotometer. 2 
equivalents of nonheme metal from either MnCl2 or CoCl2 was added to 1 mM E-FeBMb(Fe
II) 
with rapid stirring in 4 aliquots with 5 minutes in between each addition, with 20 minutes of 
incubation after the final addition. Nonheme metal binding was confirmed by UV/Vis. 
For nonheme metal titrations, molar equivalents of nonheme metal from either MnCl2 or 
CoCl2 used were: 0.2, 0.4, 0.6, 0.8, 1, 1.5, 2, 2.5, 3, 4, and 5.  Equivalents were added to 10 μM E-
FeBMb(Fe
II) with rapid stirring and 5 minutes incubation between each addition. A UV/Vis 
spectrum was collected after each addition. The proteins were in a buffer solution of 50 mM Bis 
Tris pH 7. 
4.2.2 O2 Clark-type electrode consumption assays 
The rate of water and ROS production was measured and calculated as previously 
reported.178,180,197,198 Metal-bound protein variants were prepared and transferred outside to an 
Oxytherm Clark-Type electrode (Hansatech) using gas-tight syringes (Hamilton Co.). The reaction 
was started via addition of 18 μM protein to a solution containing 1.8 mM TMPD, 18 mM 
ascorbate, and air-saturated 100 mM potassium phosphate pH 6. Experiments were also carried 
out at 40 µM protein using O2-saturated buffer at 800 µM, in the same buffer using the same 
amount of TMPD and ascorbate. The ratio of ROS/water formation was determined by repeating 
the measurements in the same solution with 7 μM catalase and 250 U superoxide dismutase (SOD) 
added to selectively react with H2O2 and O2
-, respectively, generating O2. This leads to an apparent 
decrease in the O2 consumption rate which can be used to compare the rates with and without 
catalase/SOD as well as to calculate the ratio of ROS/water formed. 
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4.2.3 X-ray absorption near edge structure (XANES) 
XANES samples were prepared anaerobically in custom-made 100 μL Lexan cells sealed 
with Kapton tape. All proteins were concentrated to 2 mM before freezing. The 0 s time point 
samples were frozen in the XANES cells anaerobically before exposure to O2. The 10 min time 
point samples were prepared by reacting the metal-added protein solution with O2-saturated buffer 
before freezing. Mn- and Co-edge (6.537 and 7.709 keV, respectively) were collected at the 
Stanford Synchrotron Radiation Lightsource (SSRL) operating at 3 GeV with 500 mA currents on 
beamline 9-3 using a Si monochromator (ϕ = 90°, energy cutoff 12 keV) and a Rh-coated mirror. 
Data were collected in fluorescence mode on a Canberra 100-element Ge array detector with 
maximum count rates below 120 kHz. Soller slits and a 3 μm Z-1 (Mn oxide) filter were placed 
between the samples and the detector array to reduce Compton and elastic scattering. Edge energy 
was calibrated against an Fe reference foil that was scanned simultaneously with every sample. 
Samples were scanned 4-6 times divided between 2-3 spots (2 mm x 3 mm) in the sample holder 
at a temperature of 8-10 K and averaged for analysis. XANES data were collected from 150 eV 
above and below the edge energies of the specific metals being investigated to aid in background 
subtraction and normalization with energy steps of 0.25 eV in the edge region. Data analysis was 
performed using Athena from the Demeter software suite. A flat pre-edge was achieved by 
subtracting a line anchored through points at least 30 eV below the edge, and the spectra was 
normalized by subtracting a second order polynomial fixed to points greater than 60 eV above the 
edge. 
4.2.4 Spectroelectrochemistry 
The heme redox potential (E°) was determined using an optically transparent thin-layer 
cell and measured spectroelectrochemically via UV/Vis on a CARY 3E as described previously. 
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Potential steps of 25 mV the range of -300 to +200 mV vs SHE were used. Global analysis of the 
data was performed using SpecFit.180,198 
4.2.5 Stopped-flow UV-Vis 
Stopped flow measurements were done on an Applied Photophysics SX18.MV 
spectrometer with a 256-element photodiode array detector. Equal volumes of MII-FeBMb(Fe
II) 
and oxygen-saturated buffer solutions were mixed. The apparatus was equipped with a NESLAB 
RTE-111 refrigerated bath chiller circulator that was used to maintain the reaction temperature at 
8°C. Logarithmic data sampling was used on a total of 1000 spectra collected over a 300 s 
timescale. 
4.2.6 Rapid freeze quench (RFQ) resonance Raman (RR) 
Rapid freeze quench (RFQ) was used to prepare the O2-reacted complex of Co
II-
FeBMb(Fe
II) from the single millisecond to tens of second range, and followed a previously 
described protocol.180,199 CoII-FeBMb(Fe
II) was prepared anaerobically as described above 
(Omnilab System, Vacuum Atmospheres Co.), then loaded into RFQ glass syringes. 7 mL of either 
16O2 or 
18O2 gas was added to 2.5 mL of degassed buffer in air-tight serum bottles, incubated for 1 
hour, then loaded into RFQ glass syringes to prepare O2-saturated buffers. The RFQ syringes were 
screwed into the System 1000 Chemical/Freeze Quench Apparatus (Update Instruments) and 
immersed in a water bath at 4°C. Reactor length and displacement rate were adjusted accordingly 
for specific time points. For the millisecond time points, a total volume of 250 μL of the solutions 
were rapidly mixed by the apparatus and frozen inside an NMR tube cooled to -120 °C using liquid 
ethane. Longer time points on the second scale were prepared and frozen manually using a similar 
setup. Resonance Raman was collected before and after ethane removal via 80 °C incubation for 
2 hours. Measurements were collected using a 407 nm excitation from a Kr laser (Innova 302C, 
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Coherent) using a McPherson 2061/207 spectrograph equipped with a liquid nitrogen cooled CCD 
detector (LN-1100 PB, Princeton Instruments). A long pass filter (RazorEdge, Semrock) was used 
to attenuate Rayleigh scattering. Samples were kept at 110 K using liquid nitrogen. Sample 
photosensitivity was determined by short spectral acquisition with low laser power while spinning 
the sample and comparing the porphyrin skeletal modes in the high-frequency region. The 
frequencies were calibrated relative to aspirin and are accurate to ±1 cm-1. 
4.2.7 Crystallization of MII-FeBMb(Fe
II) 
Crystals of E-FeBMb(Fe
III) were grown as previously described,6 with slight changes. 
Crystals were grown aerobically in large (150 – 200 μL) sitting drops of 1.5 mM protein solution 
in 20 mM potassium phosphate pH 7 mixed 1:1 with well buffer (0.2 M sodium acetate trihydrate, 
0.1 M sodium 2-(N-morpholino)ethansulfonate (MES) pH 6.5 and 30% w/v PEG 10,000). This 
mixture was equilibrated via vapor diffusion against 30 mL of the crystallization solution at 4ºC. 
Crystals appeared within 3 days and matured after 1 week. Nonheme metal-bound crystals were 
prepared by anaerobic soaking of 10 eq. of the appropriate metal solution in a mixture of E-
FeBMb(Fe
II) and well buffer. A cryoprotectant of 50% PEG 400 was used immediately prior to 
freezing the crystals using liquid nitrogen. Diffraction of MnII- and CoII-FeBMb(Fe
II) was carried 
out at 100 K using beamline 14-1 at SSRL. Data were processed using the HKL2000 package.99 
These structures were solved via molecular replacement using the PHENIX software suite,200 with 
PDB 3K9Z as a starting model. Multiple rounds of automated model building and refinement using 
PHENIX, as well as manual model modification using Coot, were carried out to generate the final 
structures. PyMol was used to generate the figures shown. The structures were deposited to the 





Table 4.1. Diffraction and refinement data for MnII- and CoII-FeBMb(FeII) 
 MnII-FeBMb(FeII) CoII-FeBMb(FeII) 
Data Collection   
Source SSRL Beamline BL14-1 SSRL Beamline BL14-1 
Date 2016-07-20 2015-06-11 
Detector CCD, Rayonix MX325HE CCD, Rayonix MX325HE 
Wavelength (Å) 1.2 1.2 
   
Data Reduction   
Software HKL2000 HKL2000 
Spacegroup P212121 P212121 
Unit cell (a x b x c; Å) 39.785 x 48.422 x 78.45 39.66 x 47.33 x 76.06 
Resolution range (highest shell) 50 – 1.58 35.16 – 2.00 
Unique reflections 21305 14401 
Completeness (%) 99.2 99.3 
Redundancy 4.7 4.2 
<I/σ(I)> 55.85 19.36 
   
Refinement PHENIX PHENIX 
Resolution range (highest shell) 39.225 – 1.5799 35.164 – 1.995 
Reflections 21252 14401 
Completeness (%) 99.7 76.65 
Rwork 0.2226 0.1941 
Rfree 0.2519 0.2444 
Molecules in ASU 1 1 
RMSD Bonds (Å) 0.006 0.007 
RMSD Angles (°) 0.902 1.554 
4.2.8 DFT calculations 
All residues coordinated to Fe and Mn/Co were included in the calculations and truncated 
at Cα atoms. In CoII-FeBMb(Fe
II), H43 is also included in the model because it is hydrogen bonded 
to a water molecule (W39) coordinated to Co. A non-substituted porphyrin (Por) was used in the 
models. All models were subject to partial geometry optimizations with only protein residue Cα 
atoms frozen at the X-ray structure positions to mimic the protein environment based on previous 
work.201 All calculations were performed using the Gaussian 09 program with the DFT method 
B3LYP108 with the 6-311G(d) basis for all heavy atoms and the 6-31G(d) for hydrogens, similar 
to previously reported related metalloprotein model studies.202–204 The bulk protein environment 
was simulated with the self-consistent reaction filed method using the PCM approach with a 
dielectric constant of 4.0 as previously reported.205 In addition to electronic energy (E), the zero-
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point energy corrected electronic energy (EZPE), and the enthalpy (H) and Gibbs free energy (G) at 
ambient conditions were calculated in each case. The atomic charges using the Natural Population 
Analysis (NPA) and Muliken spin densities were also calculated. Both ferromagnetically and anti-
ferromagnetically coupled Fe and Mn/Co systems were studied and found to have insignificant 
difference in energies; thus, only the anti-ferromagnetically coupled Fe and Mn/Co systems were 
discussed. 
4.3 Results and discussion 
4.3.1 Spectroscopic metal titrations and preparation of MII-FeBMb(Fe
II) 
Nonheme binding of MnII or CoII to E-FeBMb(Fe
II) was monitored using UV/Vis 
spectroscopy. UV/Vis spectroscopy is advantageous in studying E-FeBMb(Fe
II) in that nonheme 
metal binding close to the heme center can result in a shift of the heme spectrum, which provides 
a rapid and clear indication of nonheme metal binding.6–9,206 Therefore, MnII was titrated to a 
solution of E-FeBMb(Fe
II), and a red shift of the Soret band from 433 nm to 434 nm was observed, 
as well as a splitting of the 557 nm peak in the visible region of the spectrum, indicative of MnII 
binding to the nonheme metal site.6–8 Similar spectral changes were observed upon addition of CoII 
to E-FeBMb(Fe
II) (Figure 4.3). By measuring the spectral changes upon addition of sub-
stoichiometric to excess (5 eq.) amounts of nonheme metal, Kd values of 35 µM and 9 µM for Mn
II 
and CoII, respectively, were obtained. Interestingly, the Kd of Fe
II binding to the nonheme site of 
E-FeBMb(Fe
II) was determined to be 22 µM,8 and, when compared the affinities of these three 
metal ions for the designed nonheme site, follows the Irving-Williams series trend of MnII < FeII 




Figure 4.3. Nonheme metal titrations to FeBMb using (A) MnCl2 and (B) CoCl2. Arrows represent the change in 
spectra upon addition of nonheme metal, with starting spectrum (black), transitioning to the final spectrum (red). 
Molar equivalents of nonheme metal used were: 0.2, 0.4, 0.6, 0.8, 1, 1.5, 2, 2.5, 3, 4, and 5. The proteins were in a 
buffer solution of 50 mM Bis Tris pH 7. 
4.3.2 O2 Clark-type electrode consumption assays 
Having determined the affinity of metal binding at the nonheme site in E-FeBMb(Fe
II) using 
UV/Vis, the rate of oxygen reduction was measured quantitatively using an O2 Clark-type 
electrode and a protocol reported previously in native HCO.207–210 A critical factor in determining 
the success of MnII- and CoII-FeBMb(Fe
II) as models of HCO is demonstrating that they are capable 
of the selective 4-electron and 4-proton reduction of oxygen to water without the release of reactive 
oxygen species (ROS), such as peroxide or superoxide.15,211–215 In order to determine the O2 
reduction product, we added superoxide dismutase (SOD) and catalase to a separate reaction, 
which selectively react with superoxide and peroxide, respectively, forming O2 and resulting in a 
decreased rate of O2 consumption corresponding to the amount of ROS produced. 
In all cases, an initial rapid drop in [O2] was observed, attributable to O2 binding to heme 
as well as the addition of oxygen free buffer from the glovebag (Figure 4.4).  O2 reduction using 
18 μM E-FeBMb(Fe
II) results in an initial rate of 0.21 ± 0.03 μM/s, with 73% ROS formation.216 
The presence of MnII and CoII at the nonheme site in E-FeBMb(Fe
II) had two effects. First, both 




























nonheme metals increase the rate of O2 reduction compared to E-FeBMb(Fe
II) to 1.14 and 1.01 
μM/s, respectively. Second, the presence of MnII and CoII in the nonheme site resulted in greatly 
reduced ROS generation, displaying only 7% and 1%, respectively. In comparison O2 reduction 
by FeII-FeBMb(Fe
II) resulted in 4% ROS formation.180 
 
Figure 4.4. (A) O2 consumption traces of E-FeBMb(FeII) (black), MnII-FeBMb(FeII) (red), FeII-FeBMb(FeII) (green), and CoII-















































































Control experiments using wild-type myoglobin in the presence of MnII and CoII showed 
similar rates to E-FeBMb(Fe
II), as well as a large percentage of ROS production, > 75% (Figure 
4.5), indicating that the designed mutations of FeBMb are responsible for binding of Mn
II and CoII 
and for their respective activities.  
 
Figure 4.5. Oxidase activity of 18 μM WTMb in 100 mM potassium phosphate buffer pH 6 with 250 μM O2, 1.8 
mM TMPD, 18 mM ascorbate, and different nonheme metals added. The measured rates of O2 reduction forming 
either water (blue) or ROS (red) are shown. Error bars indicate standard deviation. 
While the rates of O2 reduction by Mn
II- and CoII-FeBMb(Fe
II) are comparable to that of 
FeII-FeBMb(Fe
II) (1.15 μM/s), the percentages of ROS formation (7, 4 and 1%) for MnII, FeII and 
CoII derivatives follow the same trend as that of metal binding affinities (35, 22 and 9 µM), 
suggesting that higher affinity for the metal ion is associated with lower percentage of ROS 
formation. Furthermore, another trend is also followed in the total turnover numbers (TTN), as 
higher affinity has resulted in higher TTN for MnII-, FeII-, and CoII-FeBMb(Fe
II) completing 5.1 ± 


























































Figure 4.6. Comparison of TON and % ROS formation during O2 reduction to the dissociation constant (Kd) for 
each nonheme metal variant of FeBMb(FeII). Each data point is labeled with its corresponding nonheme metal. 
Since the above results were obtained using 18 µM of protein, additional experiments were 
carried out using 40 µM protein, conditions where the nonheme sites would have higher metal 
occupancy. Interestingly, the TTN for MnII-, FeII-, and CoII-FeBMb(Fe
II) increased from 5.1 ± 1.1, 
13.4 ± 0.7 and 82.5 ± 2.5, respectively, at 18 µM protein, to 11.0 ± 1.3, 17.8 ± 1.2, and 92.8 ± 7.4, 
respectively, at 40 µM protein, with % ROS decreasing from 7, 4, and 1%, to 5, 2.5, and 1%, 
respectively, at 40 µM protein (Figure 4.7). This suggests that the higher metal occupancy of the 
nonheme site resulted in less pronounced differences in TTN and % ROS, but maintained the trend 




Figure 4.7. (A) O2 consumption traces of MnII-FeBMb(FeII) (black), FeII-FeBMb(FeII) (red), and CoII-FeBMb(FeII) 
(blue) carried out using 40 µM protein. (B) O2 consumption rates for the three protein variants. (C) Comparison of 
TTN and % ROS formation at 40 µM protein during O2 reduction to the dissociation constant (Kd) for each nonheme 
metal variant of FeBMb(FeII). Each data point is labeled with its corresponding nonheme metal. 
4.3.3 X-ray absorption near edge structure (XANES) 
In order to understand the interesting differences in O2 reduction activity described above, 
mechanistic investigations of the reaction were carried out. The first step in this process was to 
determine if the redox activity of each nonheme metal ion played any role in this reaction. In native 
HCO, the nonheme CuI has been shown to donate an electron during the O2 reduction catalytic 
cycle.15 However, results from synthetic models of the heme-copper center in HCO using small 
organic molecules as ligands suggest that the nonheme metal ion may act as a Lewis acid, and does 
not participate directly in electron donation.217,218 Using the biosynthetic model of FeII- and CuI-
FeBMb(Fe
II), it was previously reported that the propensity of FeII or CuI to donate electrons to 
heme-bound oxygen is responsible for the difference in O2 reduction activity. Because Fe
II and CuI 
are very different, not only in charges but also in geometric properties, the above conclusion from 
biosynthetic modeling studies is tentative. Since MnII and CoII have the same charge as FeII, with 







































































































II) and comparing them with FeII-FeBMb(Fe
II) offers a unique opportunity to 
elucidate the precise role of d electron-based redox in the O2 reduction activity. 
XANES spectroscopy was used to determine the redox state of the nonheme metal ion 
before and after reaction with O2. Both the pre-edge and edge energies in the XANES spectrum of 
MnII-FeBMb(Fe
II) do not shift after reaction with O2 (Figure 4.8). The overall shape and intensities 
of each spectrum are also similar, supporting the presence of MnII both before and after reaction 
with O2.
219 For CoII-FeBMb(Fe
II), prior to reaction with O2, the edge energy is  7718 eV. Upon 
reaction with O2, the edge energy shifts 4 eV to 7722 eV (Figure 4.8). Additional changes included 
a moderate attenuation of the pre-edge feature 7112 eV and increase in the main peak intensity at 
7727 eV. Post edge features at 7740 eV, 7752 eV, and 7768 eV, showed slight changes in intensity 
as well. None of these features had an energy shift after reaction with O2.  
Previous reports of CoIII complexes typically have a main absorption peak at 7730 eV, as 
well as a secondary peak near 7720 eV. CoII complexes, on the other hand, possess a single peak 
at lower energy of  7720 eV.220 Additionally, CoII XANES in the post-edge region display a local 
minimum intensity at  7745 eV, which leads to a broad shoulder near 7760 eV. On the other hand, 
CoIII displays a peak at  7730 eV, which leads to a local minimum intensity at  7755 eV. Finally, 
previous studies of Co complexes report significant attenuation of white line intensity upon 
oxidation from CoII to CoIII.220 While the  4 eV shift in the edge energy of CoII-FeBMb(Fe
II) reacted 
with O2 is notable, the overall shape and position of other features most closely resembles Co
II 
complexes. Such small changes are attributable to changes in geometry or the ligand set of the 
nonheme CoII caused by reaction of O2 with Co
II-FeBMb(Fe
II), and not from oxidation to CoIII. 
This conclusion is supported by the DFT optimized structures of the oxygen-bound form of the 
protein which indicate a more octahedral geometry for CoII, and which our XANES data most 
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closely match with (vide infra).220 Overall, the XANES spectra for CoII-FeBMb(Fe
II) are indicative 
of CoII present at the nonheme site both before and after reaction with O2.
220,221 In contrast, 
previous XANES studies showed both nonheme CuI and FeII were oxidized to CuII and FeIII under 
similar conditions.180 These results are interesting and indicate that, in contrast to FeII- and CuI-
FeBMb(Fe
II), whose nonheme metals rapidly donate electrons to a heme-oxy species during the O2 
reduction reaction, oxidation of MnII or CoII during this same activity was not observed. 
 
Figure 4.8. XANES spectra of the reaction of (A) MnII-FeBMb(FeII) and (B) CoII-FeBMb(FeII) with O2-saturated 100 
mM potassium phosphate pH 6. Black lines for each plot represent the protein before reaction with O2, while red 
lines represent the protein 10 minutes after reaction with O2. Insets show first derivative spectra. 
4.3.4 Spectroelectrochemistry 
Since the redox activity of MnII and CoII was not observed to play a role in the O2 reduction 
reaction in MII-FeBMb(Fe
II), it was hypothesized that these different nonheme metals influenced 
the activity by exerting an effect on the heme reduction potential.177 Spectroelectrochemistry was 
used to measure the heme FeIII/FeII reduction potential, E°ʹheme, in the presence of different 
nonheme metal ions. The E°ʹheme in E-FeBMb(Fe
II) was determined to be -158 ± 4 mV, and 
increased to 23 ± 4 mV and 4 ± 1 mV upon binding of MnII and CoII, respectively (Figure 4.9). 
Similar trends in the E°ʹheme were observed upon binding of Fe
II, CuI, and ZnII, with values of -46 

















































































± 4 mV, -64 ± 4 mV, and -45 ± 2 mV, respectively.6,180 Given the similar shift in E°ʹheme across all 
nonheme metal ions added, even though some displayed very different O2 reduction activity, we 
concluded that the influence of the nonheme metal ions on the E°ʹheme does not play a significant 
role in the different O2 reduction activities. 
 
Figure 4.9. (A) Nernst fit of the spectroelectrochemical plot for MnII- and CoII-FeBMb(FeII). The center dotted line 
indicates the point at which the fraction of reduced and oxidized protein is equal, and corresponds to the heme redox 
potential. (B) Spectroelectrochemical measurements of the FeBMb heme reduction potential with MnII (top) and CoII 
bottom bound at the nonheme site. 
4.3.5 Stopped-flow UV-Vis 
We next probed the interaction of O2 with Mn
II- and CoII-FeBMb(Fe
II) using stopped flow 
UV/Vis spectroscopy. MnII-FeBMb(Fe
II) very rapidly forms a transient spectrum with visible peaks 
at 547 and 577 nm characteristic of heme-oxy complexes,197,222–224 which then converts to MnII-
FeBMb(Fe
III). CoII-FeBMb(Fe
II) formed a spectrum with peaks in the visible region at 544 and 583 
nm (Figure 4.10), also characteristic of oxygen-bound heme,197,222–224 that transitions to a spectrum 
resembling CoII-FeBMb(Fe




















































of MnII- and CoII-FeBMb(Fe
II-O2) to Mn
II- and CoII-FeBMb(Fe
III) proceed with isosbestic points at 
approximately 520 nm for both variants, and 599 nm for the CoII variant only, indicating no 
observation of additional intermediate formation. This is likely due to the lack of electron donation 
from the nonheme metals, after oxygen binds to heme, supporting the conclusions drawn from the 
XANES data, above. Compared to MnII-FeBMb(Fe
II), however, CoII-FeBMb(Fe
II) formed the 
heme-oxy species more slowly (kobs = 41.2 s
-1 and 2.64 s-1, respectively) and was slower to decay 
to MII-FeBMb(Fe
III), (kobs = 0.971 and 0.119 s
-1, respectively). Higher-order iron-oxo species, such 
as FeIV=O, which is implicated in the HCO mechanism,225 and other similar species, were not 
observed in these cases.226,227  
Interestingly, a clear formation of heme-oxy was not observed in FeII- or CuI-FeBMb(Fe
II) 
because the nonheme FeII or CuI donates an electron to heme-bound oxygen.180 This electron 
transfer thus leads to more highly reactive heme-oxygen species, such as peroxy, which could not 
be detected.180 On the other hand, when redox inactive ZnII is bound at the nonheme site a stabilized 
heme-oxy complex is observed, due to lack of electron donation from the nonheme metal.180 The 
similarities between the spectra of MnII-, CoII-, and ZnII-FeBMb(Fe
II) upon reaction with O2-
saturated buffer suggest that these nonheme metals do not donate electrons during this reaction. 
Ultimately, the formation of the more stabilized reaction intermediate in CoII-FeBMb(Fe
II) could 
help to explain why this derivative has the smallest %ROS production and highest turnover 
81 
 
observed in comparison with MnII- and FeII-FeBMb(Fe
II), given that release of ROS will lead to 
self-degradation of the enzyme.228,229 
 
Figure 4.10. Stopped-flow UV/Vis measurements of (A) MnII-FeBMb(FeII) and (B) CoII-FeBMb(FeII) upon reaction with O2-
saturated 100 mM potassium phosphate pH 6 buffer between 1 ms and 300 s. The coloring order of each trace (from earliest to 
latest) is black (1 ms)  green (for MnII-FeBMb(FeII), 20 ms)  blue (600 ms)  red (300 s). 
Intrigued by these results, the same reaction was investigated in the presence of excess 
(100/1000 eq.) TMPD/ascorbate, acting as electron donor and sacrificial reductant, respectively, 
simulating multi-turnover conditions. For MnII-FeBMb(Fe
II), the spectrum rapidly converted from 
the starting MnII-FeBMb(Fe
II) to a heme-oxy like spectrum with peaks at 547 and 577 nm, and then 
continued to react forming MnII-FeBMb(Fe
III), similar to the case without TMPD/ascorbate 
present. Similarly, CoII-FeBMb(Fe
II) first formed peaks at 544 and 583 nm (Figure 4.11), consistent 
with heme-oxy formation and, again, similar to the single-turnover conditions. Under multi-
turnover conditions, however, CoII-FeBMb(Fe
II-O2) then transitioned to a mixture of the ferric 
product and oxy-heme intermediate, with peaks at 498, 544, 583, and 619 nm. This is the apparent 
steady state of CoII-FeBMb(Fe
II) while it is performing oxygen reduction, as, upon consumption of 
O2, the spectrum returns to Co
II-FeBMb(Fe
II), with visible peaks at 551 and 573 nm, as well as a 
small shoulder near 514 nm indicative of nonheme CoII still bound to FeBMb,
6–8,68,72 which is 






















the differences in total turnover between MnII- and CoII-FeBMb(Fe
II) towards O2 reduction, and to 
showcase the importance of nonheme metal ion identity in maintaining O2 reduction activity by 
forming stable, and suitable, intermediates during the reaction.  
 
Figure 4.11. Stopped-flow UV/Vis spectra of the reaction of  50 μM (A) MnII- and (B) CoII-FeBMb(FeII) mixed with 
O2-saturated 100 mM potassium phosphate pH 6 in the presence of 5 mM/50 mM TMPD/ascorbate. The insets show 
a time trace at 544 nm. 
4.3.6 Rapid freeze quench (RFQ) resonance Raman (RR) 
Having identified a heme-oxy species in CoII-FeBMb(Fe
II), the impact that this nonheme 
metal had on the heme-oxy O-O bond length, and its effect on oxygen activation, was investigated 
using resonance Raman (RR) spectroscopy. Rapid freeze quench (RFQ) samples were prepared 
with 16O2 and 
18O2-saturated buffer. The high-frequency RR spectra show optimum enrichment for 
a heme-oxy complex (v4 at 1377 cm
-1) relative to the starting ferrous and ending ferric products 
(v4 at 1353 and 1371 cm
-1, respectively) (Figure 4.12).  
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Figure 4.12. Resonance Raman spectra of rapid freeze quench samples of CoII-FeBMb(FeII) prepared upon reaction 
with 16O2- (black) or 18O2-saturated (red) buffer. 
Low frequency RR spectra were used to characterize the v(Feheme-O2) modes (Figure 4.13). 
For CoII-FeBMb(Fe
II-O2), v(Feheme-O2) was detected at 599 cm
-1, which is similar to that observed 
in ZnII-FeBMb(Fe
II-O2) and is indicative of a strengthening of the Fe-O bond but a weakening of 
the O-O bond. These data are consistent with our previous determination that the nonheme metal 
ion is capable of activating heme-bound oxygen. Taken together with the XANES data of CoII-
FeBMb(Fe
II) reaction with O2, evidence suggests that nonheme Co
II does not donate electrons 
during the reduction of O2, but is still capable of activating the O-O bond for efficient reduction to 
H2O. Therefore, in the case of O2 reduction using binuclear heterometallic heme-nonheme 
systems, we do not observe electron donation from certain nonheme metals for efficient 4-electron 
reduction of oxygen to water. It appears that this reduction activity can still be accomplished 
through O-O bond activation by the nonheme metal, perhaps acting as a Lewis acid and not a redox 
partner, as described previously for synthetic systems.217,218 The Lewis acidity of other divalent 
metal ions, such as MgII, CaII, SrII, and BaII, was previously quantified from the gZZ values of the 
Wavenumber (cm-1)
1200 1300 1400 1500 1600 1700
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EPR spectra of [M]-O2·
− complexes, and, in the cases where oxidation state was the same, metal 
Lewis acidity would increase with decreasing ionic radii.230 The ionic radii trend for the nonheme 
metals investigated here is MnII (0.83 Å)  > FeII (0.78 Å) > CoII (0.75 Å).231 CoII, being the metal 
with the smallest radii, would thus be the strongest Lewis acid among the three. While we state 
that the O2 reduction rate is similar for the different nonheme metal variants at 18µM, the %ROS 
formation follows the trend MnII > FeII > CoII. Thus, it appears that the stronger the Lewis acidity, 
the more heme-bound oxygen is activated, allowing for easier cleavage of the O-O bond to produce 
more water in the case of these three metal ions. 
 
Figure 4.13. Low-frequency RR spectra of CoII-FeBMb(FeII-O2) prepared as in Figure 4.12, and collected at 407 nm 
excitation. 
4.3.7 Crystallization of MII-FeBMb(Fe
II) 
To understand structural features responsible for the differences in binding affinities and 
reactivity among the three metal ions, we employed x-ray crystallography to determine the binding 
site of MnII and CoII in FeBMb(Fe
II). Diffraction data of MnII- and CoII-FeBMb(Fe
II) at 1.5 Å and 
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1.9 Å, respectively, were collected above and below the K-edge for the respective metal, 
confirming that each crystal structure contained the specific nonheme metal ion in the designed 
nonheme site in the distal heme pocket of FeBMb(Fe
II) (Figure 4.2). As a point of reference, FeII 
is the metal cofactor in the original design of nonheme site, and was shown by crystallography to 
contain FeB coordinated by imidazole nitrogens of H29, H43, and H64, OE1 of E68 and a water 
molecule. The bond distances between FeB and OE1 and OE2 of E68 are 2.19 Å and 3.28 Å, 
respectively, indicating that the E68 coordinated to Fe monodentantly. When MnII is bound at the 
nonheme site, its overall coordination sphere and geometry is similar to that of FeII (Table 4.2), 
but some of the bond lengths have been extended, likely leading to the weaker Kd determined for 
MnII binding compared to FeII. When CoII is bound in the nonheme site, the nitrogens of both H29 
and H64 coordinate to CoII directly, as in FeII- and MnII-FeBMb(Fe
II), but H43 does not. Instead, 
it is replaced by a water molecule that is coordinated to the CoII at a distance of 2.34 Å while 
hydrogen-bonding to one of the nitrogens of H43 at a distance of 2.38 Å. In addition, the distances 
between the CoII and OE1 and OE2 of E68 are 2.36 Å and 2.12 Å, respectively, suggesting that 
E68 coordinates to CoII bidentantly. Finally, there is another water molecule at a similar position 
as the water in FeII- and MnII-FeBMb(Fe
II), making CoII coordination sphere a near-octahedral 
geometry. Petrik et. al. recently identified the role that an extended hydrogen bonding network 
plays in promoting O2 reduction activity in a similar model protein to those used in this study.
232 
Specifically, introduction of an extended hydrogen-bonding network allowed for efficient proton 
delivery necessary for the designed O2 reduction activity through formation of more appropriate 
intermediates compared to the wild type protein. Similarly, the presence of an additional water 
molecule in the CoII-FeBMb(Fe
II) structure compared to the MnII and FeII forms could promote a 
similar effect through enhanced proton shuttling leading to O-O bond cleavage. 
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Table 4.2. Bond lengths of nonheme metal ligands from crystal structures 
FeBMb  
variants 
M-NH29 (Å) M-NH43 (Å) M-NH64 (Å) M-O1E68 (Å) M-O2E68 (Å) M-H2O (Å) 
FeII 2.18 2.12 2.2 2.19 3.28 2.11 
MnII 2.24 2.37 2.28 2.13 3.17 2.33 
CoII 2.05 4.04  2.18 2.36 2.12 2.12 & 2.34 
M-NH29, -NH43, -NH64, O1E68, O2E68, and M-H2O are the bond lengths of nonheme metal and their respective 
coordinating amino acid residue atoms, as well as water molecules. The CoII variant is coordinated by 2 waters, and, 
as such, both bond lengths are given. NH43 of the CoII structure is coordinated to the second H2O molecule with bond 
length 2.38 Å. 
These structural differences and bonding interactions are a likely cause for the observed 
stronger binding of CoII compared to both MnII and FeII, which, in turn, leads to the higher total 
turnovers of CoII-FeBMb(Fe
II). Additionally, with respect to heme ligation and coordination, there 
are important differences. The bond length between O1 of E68 and heme iron is 3.44, 3.22, and 
2.46 Å for FeII-, MnII-, and CoII-FeBMb(Fe
II), respectively. Thus, O1 of E68 in CoII-FeBMb(Fe
II) 
coordinates heme iron, as opposed to the other cases. Such a crowded environment with CoII 
present is likely a key factor for the rate at which the heme-oxy spectrum is formed in these 
variants, with MnII-FeBMb(Fe
II) forming heme-oxy much more rapidly (vide supra) given the less 
crowded heme site. 
4.3.8 DFT calculations 
To help understand the oxy intermediates, and the role nonheme metal is playing in terms 
of oxygen activation and redox activity, density functional theory calculations were employed. All 
residues coordinated to MnII and CoII were included in the calculations, truncated at Cα atoms, and 





Figure 4.14. Optimized oxy-bound structures for (A) MnII- and (B) CoII-FeBMb(FeII) proteins. Color scheme: C –  cyan, N – 
blue, O – red, H – grey, Fe – black, Mn – light purple, Co – navy blue. 
As shown in Figure 4.14, O2 can stably bind with both the heme iron and nonheme metal. 
Interestingly, regarding the oxy-bound forms for these two protein systems, even with initial setups 
of oxidized MnIII and CoIII states, computational results show that the most favorable oxidation 
states for both Mn and Co remain +2, and thus strongly support the above experimental results 
indicating that these metals are not oxidized. Although these two metals do not provide electrons 
as in the case of FeII and CuI studied previously,180 they do help activate O2 as evidenced by 
elongated O-O bond lengths by  0.03 Å compared to the empty non-heme site (Table 4.3). This is 
also in good agreement with resonance Raman experimental results. It is interesting to note that, 
in this oxy-bound form, although the Fe-O bond lengths for MnII and CoII-FeBMb(Fe
II-O2) are 
similar (1.883 and 1.894 Å, respectively), the Co-O distance is significantly shorter than the Mn-




have stronger interaction with the negatively charged O2 moiety in the case of Co
II than MnII which 
helps stabilize the oxy-form. Indeed, the calculated Gibbs free binding energy of O2 to this active 
site is -15.71 kcal/mol for CoII-FeBMb(Fe
II-O2), which is much stronger than that for Mn, -1.43 
kcal/mol. This is in excellent agreement with above observed slower decay rate of this oxy species 
in the case of CoII vs MnII. In addition, computational geometry optimization results of the O2-free 
active sites also reproduced the x-ray structural features, supporting a key difference between MnII 
and CoII in such structures: for Mn, there is a vacant coordination site above the heme plane 
available for incoming O2, while for Co, that site is occupied by E68. Therefore, the O2 binding to 
heme Fe in CoII-FeBMb(Fe
II) needs to displace E68 coordination first, which takes more energy 
and slows down the process, consistent with experimentally observed slower formation rate of the 
oxy species than for MnII-FeBMb(Fe
II).  
The DFT calculations also help to provide additional insights into the observed changes in 
the XANES spectra (vide supra) upon reaction with O2. Heme-bound O2 in Mn
II- and CoII-
FeBMb(Fe
II) interacts more weakly with nonheme MnII than CoII (RM-O of 2.400 and 2.126 Å, 
respectively) (Table 4.3), which would help explain the larger changes observed in the XANES 
spectra of CoII-FeBMb(Fe
II) compared to MnII-FeBMb(Fe
II) when both are reacted with O2. 
Additionally, O2 replaces one of the Co
II Glu68 O ligands, forming a more octahedral geometry 
than the starting structure, which would lead to a XANES spectrum closely matching octahedral 
CoII. Additional discussions regarding centrosymmetry of the CoII center can be found in the 
supporting information. In the case of MnII-FeBMb(Fe
II), addition of O2 to the DFT optimized 
structure leads most notably to translation of the MnII and associated ligands more directly over 
the heme. The overall geometry of MnII, however, is largely maintained (Figure 4.15). These 
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Figure 4.15. Structural overlay of energy optimized active site structures of (A) MnII- and (B) CoII-FeBMb(FeII) 
before and after addition of O2. In (A) MnII-FeBMb(FeII) is represented as green and cyan sticks before and after 
addition of O2, respectively. MnII is shown as a green or cyan sphere before and after addition of O2, respectively. 
Water molecules are shown as blue and magenta spheres, before and after addition of O2, respectively. Heme-bound 
O2 is displayed as orange spheres. Main chain and other atoms are not shown for clarity. The same color scheme is 
used for (B). 
Table 4.3. Bond length of O2-added variants from calculations 
FeBMb  
variants 
RFe-O (Å) RM-O (Å) RO-O (Å) 
E 1.869 / 1.277 
MnII 1.883 2.400 1.301 
CoII 1.894 2.126 1.303 
FeII 1.843 1.997 1.334 
For initial setup of electronic configuration, MnII-FeBMb(Fe
II), MnII is in high-spin state (S 
= 5/2) based on the high-spin feature of several metal systems with this nonheme site,1 and FeII is 
in high-spin (S = 2) based on five-coordinate deoxymyoglobin spin state. The x-ray and the 
optimized structures for the active site are shown in Figure 4.16. In the x-ray structure of MnII-
FeBMb(Fe












His29, His43, His64, and W1. However, in contrast with CoII-FeBMb(Fe
II), Glu68 does not 
coordinate with FeII here. These structural features are also maintained in the optimized structure 
(Figure 4.16), which again supports the x-ray structural finding. 
 
Figure 4.16. Optimized active site structure of MnII-FeBMb(FeII) 
For CoII-FeBMb(Fe
II), the initial setup of electronic configuration has CoII in high-spin (S 
= 3/2) based on the high-spin feature of several metal systems with this non-heme site,1 and FeII 
in low-spin (S = 0) based on its six-coordination. The x-ray and the optimized structures for the 
active site are shown in Figure 4.17. In the x-ray structure of CoII-FeBMb(Fe
II), Co has a trigonal 
bipyramidal five-coordinate structure: one with Glu68, two with His29 and His64, and the other 
two with W39 and W40. W39 forms a hydrogen bond with His43. Glu68 also coordinates with Fe, 
which is clearly different from the case for Mn, where Glu68 does not coordinate with Fe. These 
structural features are maintained in the optimized structure (Figure 4.17), which further supports 








Figure 4.17. Optimized active site structure of CoII-FeBMb(FeII). 
When O2 is bonded to both Fe
III and MnII/III, four different initial electronic configurations 
were examined, with low-spin FeIII ferromagnetically and antiferromagnetically coupled to high-
spin MnII or MnIII respectively, and FeIII always anti-ferromagnetically coupled to the O2 
moiety.180,222,233 However, after geometry optimization, three distinctive structures were obtained 
as shown in Figure 4.18. For the two initial MnII structures, only MnII-FeBMb(Fe
III-O2
-)-AF is 
stable with Mn spin density of 4.812 e (S=5/2), while the MnII-FeBMb(Fe
III-O2
-)-F setup results in 
the oxidized MnIII-FeBMb(Fe
III-O2
-)-F with Mn spin density of 4.057 e (S=2). The two MnIII 
structures resulted in the same initial configurations with Mn spin density of  4.0 e (S=2). However, 
the MnII-FeBMb(Fe
III-O2
-)-AF state is of lower Gibbs free energy than the two MnIII states by 4.52 
(ferromagnetically coupled metals) and 4.72 kcal/mol (anti-ferromagnetically coupled metals). So, 
in the case of Mn, it is not oxidized upon O2 binding, which is consistent with experimental results. 
In this case, the O-O bond is elongated by 0.024 Å compared to the empty non-heme metal 








bound state was found to be thermodynamically stable compared to the resting state with a Gibbs 
free energy change of -1.43 kcal/mol. 
 
Figure 4.18. Optimized structures of (A) MnII-FeBMb(FeIII-O2-)-AF, (B) MnIII-FeBMb(FeIII-O2-)-AF, and (C) MnIII-
FeBMb(FeIII-O2-)-AF 
When O2 is bonded to both Fe and Co, four different initial electronic configurations were 
examined, with low-spin FeIII ferromagnetically and antiferromagnetically coupled to high-spin 
CoII or CoIII, respectively, and Fe always anti-ferromagnetic coupled to the O2 moiety.
180,222,233 
However, after geometry optimization, all calculations converged to have only CoII based on spin 
densities of  2.8 e indicating S = 3/2, and thus only two distinctive structures as shown in Figure 
C3. This is consistent with experimental results indicating that Co is not oxidized. In addition, 
compared with the current method B3LYP which has 18% Hartree-Fock exchange, we examined 
the results of using two additional functionals, BHandHLYP and BPW91 with 50% and 0% 




form, in the final results after geometry optimization the Co spin densities of 2.872 e and 2.786 e 
clearly indicate that the metal is still CoII (S = 3/2), and thus support the conclusion of non-oxidized 
CoII by the B3LYP method. The structural results show that, when O2 is added to the system, the 
coordination bond between Fe and Glu68 is broken, and O2 is coordinated to both Co and Fe. So 
Co now has an octahedral six-coordination. The O atom in O2 coordinated to Fe is named as Ob 
and the other one is named as Ot. The Gibbs free energy difference of CoII-FeBMb-O2
--F (F for 
ferromagnetic coupling) and CoII-FeBMb-O2
--AF (AF for antiferromagnetic coupling) is < 1 
kcal/mol. Hence, we will focus on CoII-FeBMb-O2
--AF in the following studies. In this case, the 
O-O bond is elongated by 0.026 Å compared to the empty non-heme metal system,1 indicating that 
CoII indeed helps activate O2 moiety as found experimentally. This O2 bound state was found to 
be thermodynamically stable compared to the resting state with a Gibbs free energy change of -
15.71 kcal/mol. 
 




For the Co system, the schematic electronic configuration of metal 3d orbital/O2 π 
interactions is shown below. In addition, as shown in the frontier MO picture below (αHOMO-3, 
isosurface contour value = ±0.02 au), there is clear bonding interaction between Fe dπ and O2 π* 
due to electron transfer from FeII to O2 to form the anti-ferromagnetically coupled Fe
III and O2
-. In 
contrast, there is no such interaction between Co and O2 as shown in the same picture (Figure 
4.20). 
       
Figure 4.20. Electronic configuration and orbital plots of metal 3d orbital/O2 π interactions. 
After O2 binding, the more centrosymmetric Co
II site can be seen by two changes. First, 
the coordination number changes from five to six. Second, as shown in the following table (Table 
4.4), the significantly changed angles (those in red) all become closer to 90 or 180 degrees as 
follows: the NE68-Co-OW3 angle is 15
o closer to 180o, and NH29-Co-OW3, NH64-Co-OW3, NE68-Co-
OW40 angles have ca. 4-11
o closer to 90o. All other angle changes are smaller than 2 degrees. Such 





Table 4.4. Ligand-Co-Ligand angles in optimized Co-FeBMb and Co-FeBMb-O2 models 
 NH29-Co-NH64 NH29-Co-NE68 NH29-Co-OW3 NH29-Co-OW40 
CoII-FeBMb 99.8 97.3 104.3 89.9 
CoII-FeBMb-O2--AF 99.4 95.6 93.1 89.8 
 NH64-Co-NE68 NH64-Co-OW3 NH64-Co-OW40  
CoII-FeBMb 96.0 95.7 170.4  
CoII-FeBMb-O2--AF 95.4 91.3 168.1  
 NE68-Co-OW3 NE68-Co-OW40 OW3-Co-OW40  
CoII-FeBMb 153.3 82.4 82.1  
CoII-FeBMb-O2--AF 168.0 91.2 80.6  
4.4 Summary 
The roles of Mn and Co in conferring and fine-tuning O2 reduction activity in a biosynthetic 
model of HCO/NOR in myoglobin were investigated. MnII or CoII binding at the nonheme iron 
site was observed with UV/Vis spectroscopy and confirmed by x-ray crystallography. Activity 
assays of O2 reduction with and without catalase and SOD identified the majority of product 
formation as H2O rather than ROS. Interestingly, the TTN and ROS production of each nonheme 
variant follows the same trend as Kd, suggesting that nonheme binding affinity plays a role in the 
activity of each variant, especially given that E-FeBMb(Fe
II) displays poor O2 reduction activity 
and product selectivity. Spectroscopic results from XANES and RR suggest that electron transfer 
from the nonheme metal ion is not strictly required for selective 4-proton, 4-electron reduction of 
O2 to H2O. Rapid stopped-flow UV/Vis and RR spectroscopies, coupled with DFT calculations, 
identified important mechanistic information regarding the roles of nonheme MnII and CoII in O2 
binding and activation. Overall, these results clarify future efforts towards understanding specific 
structural, redox, and electronic features required for efficient O2 reduction and may assist in future 
designs of catalysts for oxygen reduction for fuel cells.C 
                                                 
C This chapter has been adapted from an article accepted, as of the writing of this thesis, and published online in the 
journal Journal of the American Chemical Society, and used in accordance with the publisher’s copyright privileges 
for publication in a dissertation thesis. Full citation: Reed, J. H., Shi, Y., Zhu, Q., Chakraborty, S., Mirts, E. N., Petrik, 
I. D., Bhagi-Damodaran, A., Ross, M., Moënne-Loccoz, P., Zhang, Y., and Lu, Y. (2017) Manganese and Cobalt in 
the Nonheme Metal-binding Site of a Biosynthetic Model of Heme-Copper Oxidase Superfamily Confer Oxidase 




Chapter 5 MnII- and CoII-FeBMb(FeII) reacted with NO 
5.1 Introduction 
5.1.1 Biological importance of NO 
Since being proclaimed the “Molecule of the Year” in 1992,33 nitric oxide (NO) has been 
extensively studied and identified as a key player in a number of biological processes, including 
neurotransmission,36 the mammalian immune response,37 and blood pressure regulation.35 In 
addition, NO is a key intermediate in the denitrification pathway, whereby, in the absence of 
molecular oxygen (O2), certain bacteria reduce nitrates (NO3
-) and nitrites (NO2
-) to NO, then 
nitrous oxide (N2O), and finally nitrogen gas (N2).
31 Important in carrying out these 
transformations are a number of metalloenzymes, one of which, nitric oxide reductases (NORs), 
performs the 2-electron, 2-proton, bond-forming reaction of NO reduction to N2O (2NO + 2e
− + 
2H+  N2O + H2O).
32,69,234 
5.1.2 Nitric oxide reductase and the importance of nonheme metal ion in NOR activity 
NORs are transmembrane enzymes within the same superfamily as heme-copper oxidases 
(HCOs).235 The NOR active site contains a bimetallic heteronuclear active site consisting of a 
heme-nonheme FeB center. The FeB site is bound by three His and one Glu ligands, while the heme 
has proximal His-coordination.1 HCOs, on the other hand, contain a CuB center coordinated by 
three His, without the Glu ligand present (Figure 5.1).236 Some HCOs, like cytochrome cbb3 
oxidase, possess NOR activity,237,238,4 although this activity is decreased compared to native 
NOR.1,4 A holistic understanding of the particular structural features responsible for NO reduction 





Figure 5.1. Crystal structures of (A) ba3 oxidase (PDB code 1XME) and (B) cNOR (PDB code 3O0R). Water 
molecules are shown as small red spheres, while nonheme metal ions are shown as purple and large red spheres for 
copper and iron, respectively. 
Multiple biophysical, biochemical, and computational studies have been carried out to better 
understand NORs.43,58–65,22 Such investigations have led to three hypothesized mechanisms of NO 
reduction to N2O – called the cis:b3, cis:FeB, and trans mechanisms (Figure 5.2). Briefly, the cis:b3  
mechanism suggests that a single NO first binds to the heme group, and is then electrophilically 
attacked by a second NO molecule forming the N-N bond.66 In this case, both oxygen atoms of the 
hyponitrite intermediate are coordinated to the nonheme iron.43 The cis:FeB mechanism proposes 
that both NO molecules bind to the FeB site.
66,9 The cis:b3 mechanism has been supported through 
computational studies,43,58,63 while the cis:FeB has gained recent experimental support from 
electrochemical studies of NOR.53,67 On the other hand, the trans mechanism proposes that a single 
NO molecule binds to each iron atom – one at the heme and one at the nonheme sites – before N-
N bond formation, ultimately leading to N2O. Multiple experimental results have been interpreted 
to support this mechanism, with identification of both heme-NO and FeB-NO spectroscopic signals 
during the NOR reaction.26,68–70 Additionally, spectroscopic investigations of small synthetic 
mimics of the NOR active site have also supported the trans mechanism.71 These conflicting 




















Figure 5.2. Schematic representation of the trans, cis heme b3, and cis FeB mechanisms. In the proposed cis-heme b3 
mechanism, after one NO is bound to the heme b3 site, a free NO electrophilically attacks this heme bound NO. In 
the cis FeB mechanism, two molecules of NO bind to the FeB site, whereas the trans mechanism suggests one NO 
binds to heme b3 and the FeB site simultaneously for the N-N bond formation to occur. 
To complement the above-mentioned native NOR, small molecule active site model, and 
computational investigations, a structural and functional biosynthetic model of NOR was 
engineered in sperm whale myoglobin (L29H, F43H V68E Mb, called FeBMb), which was able to 
bind nonheme Fe and reduce NO to N2O.
6 Further designs improved the percentage of N2O 
formation,7 and additional studies helped to shed light on the NOR mechanism and reactivity.8,9,68 
This biosynthetic modeling approach offers a complement to the study of native enzymes by 
allowing the determination of the specific, necessary, and sufficient features added that generate a 
particular activity, as opposed to what features, when taken away, abolish activity in the case of 
native enzymes.  
It has been suggested that conclusions drawn from the study of FeBMb, and, thus, other 
related systems, are not well substantiated as these biosynthetic models may not follow the same 
mechanism as the native NOR.43 However, for example, FeBMb was designed largely through 
homology modelling prior to the structure of cNOR being solved,1,6 and has not only recapitulated 
striking active site structural similarity,6–8 but also important mechanistic intermediates and 
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activities.8,9,68,72 Thus, while it is true that no biosynthetic design can perfectly recreate the original 
enzyme, FeBMb highlights that studying such systems may help inform and guide future studies 
of the native proteins. Furthermore, many of the above-mentioned reports utilized experimental 
approaches that are either extremely technically challenging for native NOR, or that the native 
NOR is completely unamenable to. For instance, one interesting finding for FeBMb was its ability 
to bind multiple metal ions (Fe, Cu, or Zn) depending on the exogenous metal source used.239 Such 
nonheme “metal mutagenesis” has not been successfully reported in native HCOs nor NORs, and 
attempts to replace CuB with different nonheme metals in closely-related HCOs disrupts the overall 
protein structure leading to loss of activity.239  
The role that nonheme metal ion plays was previously investigated in the NOR activity of 
I107E FeBMb (referred to as FeBMb2). Using either Fe
II- or CuI-FeBMb2(Fe
II), N2O formation was 
observed over time via GC-MS analysis. However, N2O formation was not observed under similar 
conditions using ZnII-FeBMb2(Fe
II), indicating that redox active nonheme metal ions such as FeII 
or CuI are necessary for efficient NO reduction.7 Interestingly, this is a similar conclusion to a 
study on different nonheme metal variants of FeBMb which compared O2 reduction rates of Fe
II-, 
CuI-, and ZnII-FeBMb(Fe
II), which possessed O2 reduction activity only when the redox-active 
nonheme metals FeII and CuI were bound at the nonheme site.239 However, recently published data 
suggests that efficient O2 reduction is in fact possible with Co
II-FeBMb(Fe
II), despite oxidation of 
CoII to CoIII not being observed during the reaction.240  
To expand upon these studies, a similar approach was utilized by replacing nonheme FeII 
with CoII in FeBMb, and the NO reduction reaction was investigated. Of particular interest was the 
role nonheme CoII was playing in the reaction, both in terms of its redox activity, as well as how it 
is coordinating NO. Such distinctions would be invaluable in more precisely investigating and 
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distinguishing the feasibility of the above-mentioned mechanisms. Cobalt has been used 
previously to probe to uncover necessary electronic structural properties and structure-activity 
relationships within proteins.181–184 By replacing one metal ion with another, metal ion geometry, 
reduction potential, ligand binding affinity and mode, and d-electron configuration are altered. 
This has been used to study several proteins including superoxide dismutase,185–189 catechol 
dioxygenase,190 myoglobin,191,192 metallothioneins,194 and methionine aminopeptidases,241 to 
name a few, but never in NORs. In much the same way that traditional site-directed mutagenesis 
is useful in assessing the importance of individual amino acids in enzymatic activity, metal 
substitution would be helpful in evaluating the importance of the above-mentioned properties. 
Herein, investigations and spectroscopic characterization of the reaction of NO with CoII-
FeBMb(Fe
II) are described. 
5.2 Experimental 
5.2.1 Purification of NO gas 
An NO gas line was first purged with helium for 2 hours to remove O2. Next, the line was 
switch to NO gas (Matheson Trigas, 99%) which was purified of higher-order NxOy contaminants 
such as N2O3 and NO2 by bubbling through a 300 mL solution of 1 M NaOH, then a 300 mL 
volume of ultrapure water.242 NO gas was collected from the headspace of a round-bottom flask 
containing 50 mM Bis-Tris pH 7, which had been bubbled with the purified NO gas for 2 hours to 
form a saturated NO solution (2 mM). 
5.2.2 NO Clark-type electrode measurements 
NO consumption was measured using an ISO-NO Clark-type electrode (World Precision 
Instruments) in the anaerobic chamber at 25°C. Data were recorded on an Apollo 4000 (World 
Precision Instruments). The assay solution was 1 mL of 50 mM Bis-Tris pH 7 contained 25 µM 
CoII-FeBMb(FeII), 2.5 mM N,N,N′,N′-tetramethyl-p-phenylenediamine (TMPD), and 25 mM 
ascorbate. Aliquots of 1-(hydroxy-NNO-azoxy)-L-proline (PROLI NONOate) were added to the 
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solution until the desired [NO] was reached and a steady background rate was achieved. NO 
consumption was initiated via addition of CoII-FeBMb(Fe
II). 
5.2.3 Gas chromatography-mass spectrometry (GC-MS) studies of NOR activity for CoII-
FeBMb(Fe
II) 
GC-MS was carried out on a HP-Molesieve column (Aglient), equipped on a Hewlett 
Packard 5890 gas chromatography system coupled to an online mass spectrometer (Micromass 70-
VSE). NO reduction was investigated both in the absence and presence of TMPD plus ascorbate. 
Given the long incubation times (20 hours) required for the headspace of the reaction vessels to 
equilibrate upon addition of NO, residual O2 from leakage was scavenged by a combination of 
glucose, glucose oxidase, and catalase, as described previously.3 Reaction samples ranging from 
1 mL – 1.5 mL of 50 mM Bis-Tris pH 7 contained 0.6 mM protein, 10 mM glucose, 100 µg/mL 
glucose oxidase, 50 µg/mL catalase, and, where applicable, 60 mM TMPD, 600 mM ascorbate, 
were kept in gas-tight flasks fitted with septum. 2 mL of purified NO gas (1 atm) was injected into 
the headspace of the reaction vessels using gas-tight syringes and stirred at room temperature. 250 
µL of head space gas from the reaction vessels was analyzed via GC-MS. 
5.2.4 Fourier-transform infrared (FTIR) measurements of solution [N2O] 
Given the difficulties in detecting N2O using GC-MS due to long incubation times 
stemming from the high solubility of both NO and N2O, 2 mM and 25 mM, respectively, FTIR 
provides an alternative that has the added benefit of allowing solution-based detection of product. 
N2O formation was monitored using FTIR with the ν(N-N) mode of N2O at 2231 cm
-1.68,237,243 
CoII-FeBMb(Fe
II) was mixed with diethylammonium (Z)-1-(N,N-diethylamino)diazen-1-ium-1,2-
diolate (diethylamine NONOate, Cayman Chemical) and the FTIR spectra recorded. Diethylamine 
NONOate solutions were prepared in 10 mM NaOH and the concentrations confirmed by aliquot 
addition to deoxymyoglobin. 30 µL aliquots of 1 mM protein solutions were added to a CaF2 
window (International Crystal Laboratories, Carfield, NJ), to which diethylamine NONOate was 
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added to produce 2 equivalents of NO per iron. After mixing, a second CaF2 window was placed 
on top of the sample to form an optical cell with a 100 µm Teflon spacer to control path length 
(International Crystal Laboratories, Garfield, NJ). FTIR spectra were collected at room 
temperature on a Bruker Tensor 27 equipped with a liquid-N2-cooled MCT detector, purged with 
compressed air, dried, and depleted of CO2 (purge gas generator, Puregas LLC). Sets of 100-scan 
accumulations were acquired in 2 minute intervals until the 2231 cm-1 band stopped growing. 
Blank spectra were collected under identical conditions. N2O saturated solutions were used to 
create intensity standards for the 2231 cm-1 band. 
5.2.5 FTIR photolysis 
Low-temperature (15 K) FTIR photolysis experiments were performed as described 
previously.68 Sandwich films were made by adding 15 µL of a 1 mM MII-FeBMb(Fe
II) into an 
FTIR cell fitted with a 15 µm Teflon spacer. UV-vis was used to confirm the formation of the NO 
adduct, and then the FTIR cell was mounted to a sample rod and flash frozen in N2(l) then inserted 
into the sample compartment of a closed-cycle cryogenic system (Omniplex, Advanced Research 
Systems). The cryostat was fit into the FTIR sample compartment, and the sample was kept in the 
dark while being cooled to 15 K. Temperature monitoring and control was done using a Cryo-Con 
32 or a Lake Shore Model 331 unit. FTIR spectra were collected in 1000-scan accumlations at 4-
cm-1 resolution. Photolysis of the nitrosyl complexes was performed by continuous illumination of 
the sample directly in the FTIR sample chamber for 3 minutes using a 300 W arc lamp which was 
heat and NIR emission filtered. After the photolysis process was finished, it was confirmed to be 
fully reversible by reproducing the photo-induced difference spectra after raising the sample 
temperature to 80 K. 
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5.2.6 UV-Vis characterization of MnII- and CoII-FeBMb(Fe
II) reacted with NO 
Characterization of the nonheme metal-bound forms of FeBMb(Fe
II) inside of the anaerobic 
chamber utilized UV/Vis spectroscopy collected on a Hewlett-Packard 8453 spectrophotometer. 
NO titration experiments were performed by formation of MII-FeBMb(Fe
II), and then 
substoichiometric to excess addition of a PROLI NONOate solution dissolved in 10 mM NaOH 
(ε252 = 8.4 mM
-1 cm-1, Cayman Chemical) with 5 minute incubation in between equal NO addition 
to allow for complete NO evolution and binding. Kinetic UV-Vis spectra were collected on the 
same spectrophotometer equipped with a kinetics module. 
5.2.7 EPR characterization of CoII-FeBMb(Fe
II) reacted with NO 
EPR was collected at He(l) temperatures (4.2 K) and N2(l) temperatures (77 K) on an X-
band Varian E-122 spectrometer in the Illinois EPR Research Center equipped with an Air 
Products Helitran Cryostat and EIP frequency counter. A Varian NMR Gaussmeter was used to 
calibrate the magnetic fields. Samples were prepared via anaerobic formation of MII-FeBMb(Fe
II) 
in 50 mM Bis-Tris pH 7, after which NO was added via diethylamine NONOate and allowed to 
bind. UV-Vis spectra were collected inside the anaerobic chamber after each step to follow 
reaction progress. Glycerol was used as a glassing agent to a final concentration of 22%. Solutions 
were flash-frozen using N2(l). 
5.3 Results and discussion 
5.3.1 CoII-FeBMb(Fe
II) with NO via NO electrode and GC-MS 
Clark-type electrodes have been effectively used to measure NO consumption rates for 
NORs.1,2,244 Whe NO consumption rate of CoII-FeBMb(Fe
II) was determined through addition of 
the protein to NO solutions containing TMPD and ascorbate, acting as electron donor and 
sacrificial reductant, respectively. NO was added via aliquots of the NO donor PROLI NONOate 
to a 1 mL solution of 50 mM Bis-Tris pH 7 inside of an anaerobic chamber to prevent O2 
contamination. Upon addition of the NO donor, a rapid increase in the [NO] was observed. Once 
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a background rate of [NO] decrease was achieved, TMPD and ascorbate were added to a final 
concentration of 2.5 mM and 25 mM, respectively. After another background rate was reached, 25 
μM CoII-FeBMb(Fe
II) was added to the solution. A rapid drop in the solution [NO] was observed, 
which was reproducibly 2 equivalents of NO. After this initial drop, the rate of [NO] decrease 
returned to the baseline rate prior to CoII-FeBMb(Fe
II) addition (Figure 5.3). Thus, a significant 
increase in the rate of NO reduction was not observed under these conditions, and the initial rapid 
drop in [NO] was likely attributable to NO binding to the heme group of CoII-FeBMb(Fe
II). Multi 
turnover NOR activity was also not observed in FeII-FeBMb(Fe
II), yet N2O formation was observed 
using GC-MS, indicating a functional model. Thus, N2O formation via Co
II-FeBMb(Fe
II) was 
monitored using both GC-MS and FTIR. 
 
Figure 5.3. NO consumption trace of CoII-FeBMb(FeII). Reactions were carried out inside of an anaerobic chamber in 
a 1 mL reaction vessel containing 50 mM Bis-Tris pH 7.3 under rapid stirring. Addition of NO donor PROLI NONOate 
is indicated, as well as addition of TMPD and ascorbate to final concentrations of 2.5 mM and 25 mM, respectively. 
CoII-FeBMb(FeII) was added to a final concentration of 25 μM, and is also noted. 
Previous studies indicated that FeII-FeBMb(Fe
II)6 as well as FeII- and CuI-FeBMb2(Fe
II)7 
were capable of reduction of NO to N2O under single turnover conditions after long incubations 




















(20 hours) and headspace gas collection using GC-MS measurements. These experiments were 
performed on CoII-FeBMb(Fe
II) under the same conditions to observe N2O formation. In each case, 
the first three peaks of the GC-MS measurements correspond to argon (MW 40), dinitrogen gas 
(MW 28), and NO gas (MW 30), respectively (Figure 5.4 and Figure 5.5). At longer retention 
times, another peak appeared with a molecular weight of 44 Da. Both CO2 and N2O have this mass, 
and similar retention times,245 complicating differentiation of these two gases via GC-MS. We 
compared of the fragmentation pattern of these peaks in an attempt to more clearly identify which 
gas was present.  
 
Figure 5.4. Time dependent GC-MS measurements for reaction of CoII-FeBMb(FeII) with 1 atm NO at timepoints (A) 
0 s, (B) 1 h, (C) 4 h, and (D) 20 h. The * highlights the small, later peak which has a principle mass component of 44 












Figure 5.5. Mass fragmentation patterns for GC-MS peaks in Figure 5.4. From left to right (A) is the first peak, (B) 
is the second peak, (C) is the third peak, NO, which is not present in the 0 minute timepoint as NO had not been 
added yet, and (D) the fourth peak, labelled as *. 
 
N2O has a principle fragmentation pattern of peaks at 44 (N2O), 30 (NO), 28 (N2), and 16 
(O) Da in descending order of intensity.246 On the other hand, CO2 has a fragmentation pattern of 
peaks at 44 (CO2), 28 (CO), and 16 (O) Da, in descending order of intensity.
246 For CoII-
FeBMb(Fe
II) under single turnover conditions, this small peak had a primary mass component of 
44 Da, with secondary peaks of 28 (N2), 18 (H2O), 30 (NO), and 32 (O2) Da in descending order 
of intensity (Figure 5.5). Thus, the fragmentation pattern of CoII-FeBMb(Fe
II) contained 
components from both N2O and CO2, complicating differentiation of these two gases. The use of 
TMPD and ascorbate was previously reported to simulate turnover conditions in CuBMb (FeBMb 
without the V68E mutation), which produced greater amounts of N2O that removed uncertainty in 
its identification.245 
While multi-turnover NO reduction by CoII-FeBMb(Fe
II) was not observed under the 
conditions of the NO electrode experiments (Figure 5.3), it was hypothesized that high [NO] as 








used in the GC-MS conditions would help facilitate greater production of N2O. Thus, similar GC-
MS measurements were carried out, except purified NO was added to a solution containing CoII-
FeBMb(Fe
II) and TMPD and ascorbate. Under such conditions, the appearance of a larger peak at 
longer retention time was observed (Figure 5.6). The fragmentation pattern of this peak had a main 
mass component of 44 Da, with secondary peaks of 30 Da, 28 Da, and 18 Da, in descending order 
of intensity (Figure 5.6). This fragmentation pattern is more consistent with N2O formation, and 
may indicate that CoII-FeBMb(Fe
II) is capable of NO reduction under high [NO] in the presence of 
TMPD and ascorbate. While encouraging, the long incubation times required to allow NO and 
N2O partitions to equilibrate between the aqueous phase and the headspace are not ideal, and a 
more direct measurement of N2O produced in solution was obtained using solution-based FTIR. 
 
Figure 5.6. Time dependent GC-MS measurements and corresponding fragmentation pattern for reaction of CoII-
FeBMb(FeII) with 1 atm of NO at timepoints (A) 0 s, (B) 1 h, (C) 4 h, and (D) 20 h. (E) Fragmentation pattern of longer 
retention time peak. 
5.3.2 CoII-FeBMb(Fe
II) with NO via FTIR 
The appearance of a peak at 2231 cm-1 corresponding to the N-N stretch of N2O in solution 
was monitored by FTIR spectroscopy. 50 µM of CoII-FeBMb(Fe
II) was added to a solution 









containing 10 mM ascorbate, 0.1 mM TMPD, and 1.3 mM diethylamine NONOate was used as 
the NO donor. The 2231 cm-1 peak was observed with increasing intensity over time in this case, 
where TMPD and ascorbate were in excess of the protein (Figure 5.7). In a control experiment 
under similar conditions using E-FeBMb(Fe
II) N2O formation was not observed. This interesting 
finding indicates that while significant NOR activity of CoII-FeBMb(Fe
II) was not observed in the 
sub-millimolar [NO] employed in the NO electrode experiments (vide supra), N2O formation is 
detectable near saturating [NO]. A likely implication of these results is that occupancy of a low-
affinity NO binding site is required for N2O production. Additional spectroscopic measurements 
were taken to determine whether the N2O production involved direct coordination of NO to Co
II. 
 
Figure 5.7. Room temperature FTIR detection of the formation of N2O upon decomposition of DEA-NONOate and 










5.3.3 CoII- and MnII-FeBMb(Fe
II) NO reactivity: Characterization of intermediates via UV-Vis 
Having determined that CoII-FeBMb(Fe
II) possesses NOR activity, but only under high 
[NO], the effects the nonheme metal was having upon exposure of NO to CoII-FeBMb(Fe
II) were 
investigated. First, UV-Vis spectra of the reaction of 2 mM NO with 10 µM CoII-FeBMb(Fe
II) were 
collected. The NO donor PROLI NONOate was used for these measurements, as its short half life 
(t1/2 = 1.4 s) allows for rapid spectroscopic collection without interference from slow NO release. 
The appearance of visible peaks at 545 and 577 nm, and a Soret band at 419 nm roughly 1 s after 
NO addition suggests fast binding of NO to the heme to form a 6-coordinate low-spin (6cLS) 
heme-nitrosyl. The spectrum formed at 1 s is not entirely stable, however, as a decrease in the 
Soret absorption was observed over the next 60 s, with minimal perturbation of the visible peaks. 
Next, a blue shift in the Soret to 412 nm was observed along with a decrease in the visible peak 
intensity until 600 s. At this point, no additional changes in the UV-Vis spectrum over 60 minutes 
were observed (Figure 5.8).  












Wavelength (nm)  
Figure 5.8. UV-Vis spectra of the reaction of 2 mM NO (from PROLI NONOate) with 10 µM CoII-FeBMb(FeII) in 50 
mM Bis-Tris buffer pH 7. Lines represent 0 s (black), 1 s (red), 60 s (green), and 3600 s (blue) timepoints.  
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This end product displays similar spectroscopic features as a 5cLS heme-nitrosyl species 
observed previously in FeII-FeBMb(Fe
II).68 The same experiment was performed in the presence 
of 10 mM ascorbate and 0.1 mM TMPD, simulating multi turnover conditions. A spectrum with 
visible peaks at 547 and 577 nm and Soret at 420 nm was rapidly formed after 1 s. There was then 
a slight attenuation in the Soret intensity, and a blue shift to 418 nm, with no changes observed in 
the spectrum over the course of 60 minutes (Figure 5.9).  
 
Figure 5.9. UV-Vis spectra of the reaction of 2 mM NO (from PROLI NONOate) with 10 µM CoII-FeBMb(FeII) in 
the presence of 10 mM ascorbate and 0.1 mM TMPD. Lines represent 0 s (black), 1 s (red), 60 s (green), and 3600s 
(blue) timepoints. 
The overall features of CoII-FeBMb(Fe
II) reacted with 2 mM NO in the presence of 
ascorbate and TMPD are most similar to the 60 s timepoint of CoII-FeBMb(Fe
II) reacted with NO 
in the absence of ascorbate and TMPD (Figure 5.10). This indicates that the presence of ascorbate 
and TMPD seems to stabilize the 6cLS heme-nitrosyl and to prevent a second NO molecule to 
attack the proximal side of the heme to form the ‘dead-end’ 5cLS species.68,247 This allosteric effect 














by ascorbate/TMPD would explain the observed NOR activity only in the presence of ascorbate 
and TMPD. 
 
Figure 5.10. UV-Vis spectra comparing CoII-FeBMb(FeII) reacted with 2 mM NO (from DEA NONOate) in the 
absence of ascorbate and TMPD after 60 s (red) and 3600 s (blue), and in the presence of ascorbate and TMPD after 
3600 s (black). Inset shows the Soret region of each spectrum magnified. 
Titration from sub-stoichiometric to excess (200 equivalents) amounts of NO added to 10 
μM CoII-FeBMb(Fe
II) were performed to observe the stability of these the different species. Similar 
spectra as the above-mentioned kinetics study were observed for CoII-FeBMb(Fe
II-NO) at 1 
equivalent NO with a Soret peak of 420 nm, and visible bands of 547 and 577 nm (Figure 5.11). 
Upon titration of NO from 1 to 2 equivalents, a blue shift of the Soret peak from 420 to 418 nm 
was observed, along with slight increases in the intensity of the visible bands (Figure 5.11). Further 
additions of NO up to 2 mM lead to an increased blue shift of the Soret band to 412 nm, with 
minimal  changes in the visible peaks (Figure 5.11). These data are consistent with what was 
observed in the kinetics data, and indicate that a 5cLS ‘dead-end’ product is formed upon reaction 
of excess NO with CoII-FeBMb(Fe
II) when TMPD and ascorbate are not present. 










































Figure 5.11. UV-Vis spectra of the titration of NO (from PROLI NONOate) with 10 µM Co II-FeBMb(FeII), lines 
represent 0 eq. NO (black), 1 eq. NO (red), 2 eq. NO (green), and 200 eq. NO (blue). NO additions of 0.1, 0.2, 0.3, 
0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1.0, 1.2, 1.4, 1.6, 1.8, 2.0, 3.0, 4.0, 5.0, 25.0, 50.0, 100.0, and 200.0 equivalents to Co II-
FeBMb(FeII) were incubated for 5 minutes in between each addition to allow complete NO release and binding. 
Similar UV-Vis experiments were carried out on MnII-FeBMb(Fe
II). 10 µM MnII-
FeBMb(Fe
II) was reacted with 2 mM NO (Figure 5.12). The immediate formation of visible bands 
at 545 and 582 nm, as well as a Soret peak at 419 nm are similar to the case of CoII-FeBMb(Fe
II) 
and suggest the formation of a 6cLS heme nitrosyl species. In contrast to CoII-FeBMb(Fe
II), 
however, additional changes in the peak positions are not observed, and instead the 6cLS heme 
nitrosyl species is not observed to decay over the course of 1 hour.  











Figure 5.12. UV-Vis spectra of the reaction of 2 mM NO (from PROLI NONOate) with 10 µM MnII-FeBMb(FeII) in 
50 mM Bis-Tris buffer pH 7. Lines represent 0 s (black), 1 s (red), 60 s (green), and 3600 s (blue) timepoints. 
 UV-Vis measurements were carried out on 10 µM MnII-FeBMb(Fe
II) reacted with NO in 
the presence of TMPD and ascorbate (Figure 5.13). Visible bands at 546 and 581 nm, as well as a 
Soret peak maximum at 419 nm are observed 1 second after mixing of NO. An increase in the 
Soret absorbance is observed over the course of approximately 10 minutes, which then attenuates 
slightly over the next 50 minutes, without shift in the wavelength. The visible peaks continually 
increase in intensity over the course of 60 minutes, and also do not shift in wavelength. These 
features suggest formation and maintenance of a 6cLS heme-nitrosyl species when MnII is present 
at the nonheme site. In the case of MnII-FeBMb(Fe
II), the presence of TMPD and ascorbate does 
not significantly influence the coordination environment of the heme formed upon reaction with 
NO, indicating that the electronic interaction of nonheme MnII with heme-bound NO is different 
than nonheme CoII interacting with heme-bound NO. Future investigations of the potential activity 

















II) towards NO reduction might prove fruitful, though, like CoII-FeBMb(Fe
II) 
would likely be the most appropriate and accurate method for which to test this activity.  
 
Figure 5.13. UV-Vis spectra of the reaction of 2 mM NO (from PROLI NONOate) with 10 µM MnII-FeBMb(FeII) in 
the presence of 10 mM ascorbate and 0.1 mM TMPD. Lines represent 0 s (black), 1 s (red), 60 s (green), and 3600s 
(blue) timepoints. 
 Titrations of NO to MnII-FeBMb(Fe
II) were performed as described for CoII-FeBMb(Fe
II) 
(Figure 5.14). At 1 eq. NO, visible peaks of 546 and 579 nm were observed, as well as a Soret 
peak at 418 nm, similar to the kinetics traces and indicative of 6cLS heme-NO. Further additions 
of NO lead to moderate changes, with a slight attenuation of the Soret peak intensity, as well as a 
blue shift to 417 nm. The visible bands increased in intensity slightly during the titration. 
Interestingly, a shoulder at 405 nm was also observed upon increasing addition of NO, possibly 
indicating 5cLS heme formation after large excess of NO addition and extended incubations. 














Figure 5.14. UV-Vis spectra of the titration of NO (from PROLI NONOate) with 10 µM MnII-FeBMb(FeII), lines 
represent 0 eq. NO (black), 1 eq. NO (red), 2 eq. NO (green), and 200 eq. NO (blue). NO additions of 0.1, 0.2, 0.3, 
0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1.0, 1.2, 1.4, 1.6, 1.8, 2.0, 3.0, 4.0, 5.0, 25.0, 50.0, 100.0, and 200.0 equivalents to MnII-
FeBMb(FeII) were incubated for 5 minutes in between each addition to allow complete NO release and binding. 
5.3.4 CoII-FeBMb(Fe
II) NO activity: Characterization of intermediates via EPR 
The NO binding properties of CoII-FeBMb(Fe
II) were next studied by EPR spectroscopy. 
The sample containing CoII-FeBMb(Fe
II) without NO displayed a distorted axial pattern with broad 
peaks in the g ~ 6 region, indicative of high-spin (HS) CoII (Figure 5.15).248 As increasing amounts 
of NO were added, two effects were observed. The HS CoII signal at g ~ 6 becomes split into 
multiple features, possibly due to the interaction of CoII with the heme(FeII-NO). Interestingly, 
formation of {CoNO}8 would lead to a decrease of the HS CoII signal due to the formation of an 
EPR-silent d8 species. Given that such an attenuation was not observed, this indicated that the CoII 
was of very low NO affinity, thus leading to its NOR activity only at very high [NO]. The signal 
at g ~ 2.01 was similar to what was previously observe upon addition of excess NO to FeII-
FeBMb(Zn
II), and the saturation behavior of this radical-like signal indicates that it is not likely a 
free radical.8 EPR spectra were also collected with parameters to maximize the signal from heme 











coordination changes.7 The EPR spectrum of CoII-FeBMb(Fe
II) prior to NO addition is featureless 
(Figure 5.15). As NO is added, a clear three-line hyperfine structure appears, suggesting the 
formation of a 5cLS FeII-NO species caused by breakage of the proximal His bond of the heme, 
supporting the UV-Vis results.249 
 
Figure 5.15. X-band EPR spectra of 250 μM CoII-FeBMb(FeII) in 50 mM Bis-Tris buffer pH 7 and increasing 
equivalents of NO (from top to bottom, 0, 1, 2, 5, 10, and 20). Experimental parameters for (A) T = 5 K, microwave 
frequency = 9.255 GHz, microwave power = 20 dB, modulation amplitude = 16 G. Experimental parameters for (B) 
T = 30 K, microwave frequency = 9.255 GHz, microwave power = 16 dB (except for the bottom spectrum, which is 
30 dB), modulation amplitude = 4 G. 
 In order to better understand the role that TMPD and ascorbate were playing in conferring 
NOR activity, and what effect they were having on the heme-NO coordination, samples of CoII-
FeBMb(Fe
II) in the presence of saturating [NO], with or without TMPD and ascorbate were 
prepared and analyzed via EPR (Figure 5.16). In the absence of TMPD and ascorbate, a distinct 
three-line hyperfine structure is observed, indicative of a 5-coordinate ferrous heme-nitrosyl 
species formed a result of breakage of the proximal His-Feheme bond.
250 On the other hand, in the 
spectrum collected in the presence of TMPD and ascorbate a different hyperfine splitting pattern 
is observed, likely due to hyperfine interactions from both bound NO and the proximal histidine, 
resulting in the formation of  a 6-coordinate ferrous heme-nitrosyl species.7,250 Thus, while the 
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binding of nonheme CoII causes cleavage of the proximal His-Feheme bond and formation of a 5c 
heme nitrosyl when TMPD and ascorbate are absence, in the presence of these reagents 5c heme 
formation is prevented, instead remaining as 6c. These results are in agreement with what was 
observed in UV-Vis and again suggest a potential allosteric role played by TMPD and ascorbate 
in preventing proximal His-Feheme bond breakage, and thus avoiding the ‘dead-end’ 5cLS species. 
 
Figure 5.16. X-band EPR spectra of 50 μM CoII-FeBMb(FeII) in 50 mM Bis-Tris buffer pH 7 with 2 mM NO and in 
the absence (A) or presence (B) of 0.1 mM TMPD and 10 mM ascorbate. Experimental parameters were T = 77 K, 
microwave frequency = 9.288 GHz, microwave power = 20 dB, modulation amplitude = 10 G. 
5.3.5 CoII-FeBMb(Fe
II) NO activity: Characterization of intermediates via low temperature 
UV-Vis photolysis and FTIR  
Low-temperature FTIR was utilized to characterize CoII-FeBMb(Fe
II-NO) and compare it 
to FeII-FeBMb(Fe
II-NO). The dark minus illuminated FTIR difference spectra of CoII-FeBMb(Fe
II-
NO) collected at 10 K identify a positive band at 1549 cm-1 that downshifts to 1526 cm-1 with 15NO 
that is assigned to v(NO) of 6cLS heme(FeII-NO) (Figure 5.17).72 This result is nearly identical to 
that observed with FeII-FeBMb(Fe
II-NO), which displayed positive bands at 1549 cm-1 and 1527 
cm-1 indicating that both nonheme FeII and CoII have similar effects on the electronic and 
vibrational structure of heme-bound NO. Furthermore, the similarity of the v(NO) vibration 
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indicates that the strength of the N-O bond is not significantly perturbed between these two metals, 
and that the heme-bound NO is comparably activated for reduction in each case. 
 
Figure 5.17. Low temperature FTIR photolysis difference spectra (dark minus illuminated, blue) of 14NO (black) and 
15NO (red) bound FeII-FeBMb(FeII) and CoII-FeBMb(FeII). 
5.4 Summary 
In summary, a nitric oxide reductase model was descrbied with nonheme FeII substituted 
with a CoII ion. Using FTIR spectroscopy, NOR activity was observed under high concentrations 
of NO, likely indicating a low NO affinity nonheme metal site, which is also supported from EPR 
measurements where {CoNO}8 formation was not observed. UV-vis and EPR data indicate the 












reaction of NO without TMPD and ascorbate present. This 5cLS heme-nitrosyl has been 
implicated as a ‘dead-end’ product in FeBMb systems performing NOR, due to its inability to react 
with the nonheme-nitrosyl complex on the other side of the heme plane.247 Spectroscopic 
comparisons between the FeBMb mutants I107E/F indicate that the in increased hydrophilicity 
imparted to the distal pocket by the I107E mutation may play a key role in the increased N2O 
production observed with this mutant, perhaps by coupling proton transfer to FeIII-nitroxyl species, 
N-N bond formation, and N-O bond cleavage. Interestingly, the CoII coordination sphere in CoII-
FeBMb(Fe
II) involved only two of the three distal histidines and includes two water molecules 
(Figure 5.18). Specifically, H43 acts as a hydrogen bond partner to one of the solvent molecule 
and may facilitate proton transfer as E107 in FeBMb2. NO binding at the nonheme Co
II site were 
not observed in FTIR and EPR measurements. This interesting finding suggests that the NOR 
activity observed at high [NO] proceeded through the cis-heme b3 mechanism instead of the trans, 
which, from computational studies, is postulated to be the most energetically favorable NOR 
reaction mechanism in cNOR.43,58,63  
 
Figure 5.18. Crystal structures of (A) FeII-FeBMb(FeII) and (B) CoII-FeBMb(FeII). Water molecules are shown as red 








Chapter 6 Utilizing Rosetta to engineer more complex metal binding sites 
6.1 Introduction 
6.1.1 What is Rosetta and what is it used for? 
The Rosetta software suite is a collection of different functionalities that was derived from a 
method of ab initio structure prediction based on the assumption that the distribution of 
conformations sampled by a local segment of a polypeptide chain is reasonably approximated by 
the distribution of structures adopted by that sequence, and closely related sequences in known 
protein structures.251,252 Since the initial publication of Rosetta’s computational framework,251 its 
use has grown to an international, multi-institutional collaboration including government 
laboratories, academic research centers, and partner corporations.253 Rosetta has been used in the 
areas of de novo protein design,254–256 enzyme design,257–260 protein docking,261–263 ligand 
docking,264,265 and many others.266–268 This thesis will not discuss all the computational details or 
scoring functions within the Rosetta suite, as they are out of scope, but will provide an overview 
and background information for some of the most applicable components used in the following 
experiments. 
6.1.2 Rosetta Match 
The Rosetta Match and Rosetta Design functionalities of the Rosetta software suite rely on 
constructing a theoretical enzyme – or “theozyme” – which attempts to optimize enzyme active 
site geometry for transition state stabilization.269 Rosetta Match, also known as “The Matcher”, 
attempts to find a scaffold and sequence positions on that scaffold that satisfy a set of geometric 
constraints for a ligand. Rosetta Match involves the use of 4 distinct parts: the ligand, ligand 
interactions (i.e. geometric constraints), a scaffold protein, and the positions to match on the 
scaffold protein (Figure 6.1). Furthermore, Rosetta Match requires a scaffold library of different 
proteins that are needed to actually compare the geometric constraints against in an attempt to find 
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a match. Depending on the amount of time or computational power available, the computational 
library can include everything from a single protein scaffold, to the entire Protein Databank 
(PDB).260,270  
 
Figure 6.1. An overview of the components used by Rosetta Match, (A) a ligand, (B) the ligand interactions (i.e. 
geometric constraints), (C) the scaffold protein, and (D) the scaffold protein positions to match. 
 The Matcher will compare the geometric constraints provided against the different scaffold 
proteins and positions to match those geometric constraints. If all constraints provided are met, 
then this is considered a “Match” for the Matcher, and can be further processed through additional 
Rosetta tools, most often Rosetta Design, to be described later.260,269 
 An important part of utilizing Rosetta Match involves creating geometric constraints, 
which are divided into 6 degrees of freedom composed of: one (1) distance measurement, two (2) 
angle measurements, and three (3) dihedral measurements. To clarify which measurements are 
which, protein-sided measurements are defined as “upstream”, while ligand-sided measurements 
are defined as “downstream” (Figure 6.2). 




Figure 6.2. Schematic representation of the different degrees of freedom required by Rosetta Match. (A) 1 distance 
measurement between 2 heavy (i.e. non-hydrogen) atoms, (B) 2 angle measurements of 3 heavy atoms, with angle A 
representing the ligand-sided (downstream) angle, and angle B representing the protein-sided (upstream) angle, and 
(C) 3 dihedral/torsion measurements of 4 heavy atoms. Red circles are used in the angle and dihedral cases to more 
explicitly show which atoms are involved in this particular example.  
 After constraints are measured, they must be input into a specific constraint file format 
(Figure 6.3). The constraint file requires different blocks of text that refer to different pieces of 
information required for the Matcher to function. In Figure 6.3, the first “TEMPLATE” line 
provides information about the PDB atom names which will be used in the measurement of the 
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geometric constraints, and includes, from left to right, the atoms used for distance, angle, and 
dihedral measurements (i.e. N1 = distance, C2 = angle, C3 = dihedral). The second “TEMPLATE” 
line gives information about the PDB code for the ligand the Matcher is using. The third 
“TEMPLATE” line identifies the Rosetta atom type used by the Matcher, which in this case 
“OOC”. The Rosetta documentation provides additional information about Rosetta atom types and 
their identifiers. The fourth “TEMPLATE” line provides the 1 letter amino acid code that the 
Matcher will use in an attempt to find suitable protein amino acids to fit the given geometric 
constraints. This constitutes the first atom block.260 
 The next set of information is a part of the geometry block, and is broken into multiple 
pieces. The first column of data after “CONSTRAINTS” refers to the different measurements 
made (see Figure 6.2). The next column gives the value for that particular measurement. The 
distanceAB value is given in Å, while angles and dihedrals are given in degrees. The next column 
is the sampling range for the value. It can best be viewed as a ± from the given value. For example, 
in the “distanceAB” row, the sampling range tells Rosetta Match to look for distances of 2.8 ± 0.1 
Å, in this particular case. The third column is the weight of the measurement, and is ignored by 
Rosetta Match, but will be useful when running Rosetta Design (6.1.3 Rosetta Design). The next 
column is the periodicity for the value, and is best described through an example. For the 
“angle_A”, the given value is 120°, and the periodicity is 120°. This means that Rosetta Match 
will attempt to find matches at 120° (the value) + 120° (the periodicity) until 360° has been 
covered. Thus, Rosetta Match will sample potential geometric constraints at 120°, 240°, and 360° 
angles in the protein scaffold being run. Furthermore, given the sampling range of 5°, each of 
these angles will also have a ± value of 5° being sampled. Finally, the last column is the sampling 
level, and gives an N value to the equation 2N + 1, which tells how many total measurements 
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within the sampling range to measure. For example, with a sampling range of 10, and sampling 
level of 2, angle_A in Figure 6.3 will have 1 group of sampling centered around 120° that includes 
130°, 125°, 120°, 115°, and 110°, as well as 2 other groups of sampling centered around 240° and 
360°. If all other values were maintained, but the sampling level was changed to 1, then the 
sampling around 120° in angle_A of Figure 6.3 would only include 130°, 120°, and 110°.260 
 
Figure 6.3. Example constraint file format with different constraints and the atom and geometry blocks labeled. 
6.1.3 Rosetta Design 
Typically, after Rosetta Match is finished, a large number of PDB files will be generated, 
depending on the constraints given and the residue locations specified for Matching. The Matcher 
excels at grafting the theozyme geometrically onto a scaffold structure. The next step utilizses 
Rosetta Design to restrain the theozyme residues to the desired theozyme geometry during 
sequence optimization and gradient-based minimization.260 Not doing this design step can lead to 
clashes with the ligand, the scaffold backbone, or other resides (Figure 6.4).  
CST::BEGIN
TEMPLATE::   ATOM_MAP: 1 atom_name:  N1 C2 C3
TEMPLATE::   ATOM_MAP: 1 residue3: 3MA
TEMPLATE::   ATOM_MAP: 2 atom_type: OOC,
TEMPLATE::   ATOM_MAP: 2 residue1:  ED
CONSTRAINT:: distanceAB:   2.8   0.10  100   0    0
CONSTRAINT:: angle_A:    120     5.0    25  120   2
CONSTRAINT:: angle_B:    120     5.0    25  120   2
CONSTRAINT:: torsion_A:    0     5.0    10  180   1
CONSTRAINT:: torsion_AB:   0     5.0    10  180   1
















Figure 6.4. A sample Rosetta Match output PDB file, showing the ligand (PDB code ICS, FeMo cofactor) and nearby 
residues as sticks. 
The next step in the workflow is to employ Rosetta Design to introduce optimal residues 
identities for other scaffold positions in order to remove clashes, optimize geometries of the 
catalytic side chains, and stabilize the entire scaffold.260 Rosetta Design uses the same constraints 
file as Rosetta Match, except the “weight” column is taken into consideration. The values for that 
column range from 0 to 100, and define what importance Rosetta Design gives to a specific 
constraint. For instance, in Figure 6.3, distanceAB is given a weight of 100, while torsionA is 
given a weight of 10. That means that when Rosetta Design generates its libraries and scores the 
different designs, distanceAB will have a 10-fold higher impact on scoring than torsionA.260 
Upon running Rosetta Design, a scorefile will be generated that provides Rosetta’s different 
calculated scores for a wide variety of parameters of the protein (Figure 6.5). Utilizing a 
combination of score filtering, manual inspection, and other considerations such as expression 
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system, the designs can be ranked and the most likely candidates for the intended function then 
expressed and purified. 
 
Figure 6.5. Portion of a scorefile generated by Rosetta Design. Each column represents a different scored parameter, 
e.g. all_cst is a measure of how closely the design is to the constraints given in the constraint file with a maximum 
value of 1, tot_burunsat_pm is a count of how many buried unsatisfied polar resides were detected.260  
6.2 Experimental 
6.2.1 Rosetta Match 
As mentioned above, the number of input PDB scaffolds is largely a function of computational 
power and time. In order to effectively determine what starting structures would be best when 
running Rosetta Match a cavity search for the nitrogenase cofactor binding site was performed 
using the MarkUS function annotation server.271,272 A part of the MarkUS server is Volumetric 
analysis of Surface Properties (VASP), which performs a volumetric comparison of structural 
neighbor binding sites, effectively searching for similar volume cavities.273 PyMol was utilized to 
generate a PDB file containing only the atoms within a 20 Å radius around the FeMo cofactor from 
the nitrogenase structure with PDB ID 3U7Q. After loading the PDB into PyMol the following 
command was used to select those atoms: 




Figure 6.6. PDB file generated from 20 Å radius around FeMo cofactor from PDB 3U7Q.  
Next, the selection was extracted to a new object using the Action menu and the new PDB saved 
and uploaded to the MarkUS server (Figure 6.6).274 The FeMo cluster was contained in what VASP 
labeled “Cavity 1”, and the server gave the different PDB accession codes that contain 
comparably-sized cavities to this. Furthermore, VASP calculates cavity size, which was used in 
sorting the results. All of the PDBs listed as cavity matches in the VASP window were downloaded 
from the PDB. 
In order to identify suitable scaffolds, the VASP cavity size and molecular weight of each 
identified PDB was compared and graphed against the native nitrognease (Figure 6.7). A cutoff 
value of 50,000 Da was used as the point at which designs would be run through the Rosetta 




Figure 6.7. Comparison of the molecular weight and VASP cavity sizes of all PDB files identified by VASP as 
volumetrically similar to the FeMo cofactor binding cavity of nitrogenase 
The downloaded PDB files were “cleaned” to be correctly parsed by Rosetta.275 This 
generated PDB files that were then run on the Matcher. A parameters files for the FeMo cofactor 
of nitrogenase was made using PyMol and a Rosetta functionality through Putty. First, the PDB 
file 3U7Q was loaded into PyMol and the FeMo cofactor (resn ICS) was selected, then saved as 
the filename .sdf. In this particular case, the molybdenum atom (MO) was changed to FE because 
Rosetta does not recognize molybdenum when running the Matcher. The sdf file was then 
convered to a params file on Putty with the following command: 
/mnt/people/lulab/rosetta/rosetta3.4/rosetta_source/src/python/apps/public/molfile_to_params.py 
[filename].sdf 


























The next file required was the positions file (.pos extension). This was simply a file 
containing the numbers corresponding to the pose position of the amino acids that were to be used 
when running Rosetta Match. In this case, the entirety of every scaffold structure was used, so the 
file was simply the numbers 1- 500, individual numbered with spaces in between each (e.g. 1 2 3 
4 5 … 498 499 500). The constraints file was generated by measuring the different parameters of 
the corresponding chosen atoms, in this case, FE1, S3, C1 and FE8, S6, C1 (Figure 6.8). Finally, 
the flags (options) file was also made to utilize the appropriate commands required for the Matcher. 
A shell script was written to simplify running the multiple PDB files on the lipid cluster (Figure 
6.9). The shell script was initiated using the “qsub” command through Putty.  
 
Figure 6.8. Constraint file generated for the FeMo cofactor of nitrogenase from PDB code 3U7Q. 
CST::BEGIN 
  TEMPLATE::   ATOM_MAP: 1 atom_name: FE1 S3 C1 
  TEMPLATE::   ATOM_MAP: 1 residue3: ICS 
 
  TEMPLATE::   ATOM_MAP: 2 atom_type: S 
  TEMPLATE::   ATOM_MAP: 2 residue3: CYS 
 
  CONSTRAINT:: distanceAB:    2.27   0.05 100.00  1        1 
  CONSTRAINT::    angle_A:  117.60   0.00  25.00  180.00   2 
  CONSTRAINT::    angle_B:  105.90   0.00  25.00  180.00   2 
  CONSTRAINT::  torsion_A:  171.30   5.00   0.00  180.00   2  
  CONSTRAINT::  torsion_B:  142.70   5.00   0.00  180.00   2 




  TEMPLATE::   ATOM_MAP: 1 atom_name: FE8 S6 C1 
  TEMPLATE::   ATOM_MAP: 1 residue3: ICS 
 
  TEMPLATE::   ATOM_MAP: 2 atom_type: Nhis 
  TEMPLATE::   ATOM_MAP: 2 residue3: HIS 
 
  CONSTRAINT:: distanceAB:    2.33   0.05 100.00  1        1 
  CONSTRAINT::    angle_A:  110.76  10.00  25.00  180.00   1 
  CONSTRAINT::    angle_B:  128.10  10.00  25.00  180.00   1 
  CONSTRAINT::  torsion_A:  176.85  10.00   0.00  180.00   1  
  CONSTRAINT::  torsion_B:   11.00  10.00   0.00  180.00   1 






Figure 6.9. Shell script used to run Matcher on lipid cluster. 
6.2.2 Rosetta Design 
After completion of Rosetta Match, a large number of “Matches” were identified. The next 
step of the Rosetta workflow involved utilization of Rosetta Design.260 Both the parameters and 
constraints (Figure 6.8) files used were the same as in running Rosetta Match. The flags file (Figure 
6.10), was written to utilize Rosetta enzyme design functionalities. After Rosetta Design was 
finished running, a large number (> 20,000) of designs were generated, with each containing scores 
within the score file (Figure 6.5). The designs were filtered using the DesignSelect script and a 
“requirements” file (Figure 6.11).276 The same Rosetta Design files and parameters were run 
against this native nitrogenase to calculate the scores that the native protein has, in order to 
compare these scores against the designed proteins and use in the requirements file for cutoff 
values.260 At this point, the designs were manually inspected, and suitable candidates narrowed 
down based on expression system, size, active site geometry, and number of mutations. 
#!/bin/bash 
#$ -S /bin/bash 
#$ -N "FeMoCo" 
#$ -cwd 
#$ -pe orte 2 











for pdb in *.pdb; do 
 







Figure 6.10. Flags/options file used when running Rosetta Design on lipid cluster 
 
Figure 6.11. Requirements.txt file used to identify the appropriate cutoffs and parameters for the Rosetta Design PDB 
files to be manually considered 
6.3 Results and discussion 
6.3.1 Finding a scaffold to bind FeMo cluster 
Rosetta Match and Rosetta Design generated a large number of potential candidate scaffold 
proteins. Table 6.1 provides an overview of the scores and filters used to identify target scaffolds 
that might house the FeMo cofactor. After filtering, there were approximately 50 structures 



























req all_cst value < 0.5 
req SR_1_all_cst value < 0.4 
req SR_2_all_cst value < 0.4 
req SR_3_all_cst value < 0.4 
req SR_3_interf_E_1_2 value < -1.0 
req nlr_totrms value < 0.5 
req nlr_SR1_rms value < 0.5 
req nlr_SR2_rms value < 1.0 
req SR_3_dsasa_1_2 value > 0.7 
req total_score value < -50.0 
req tot_burunsat_pm value < 195.0 
req tot_NLconts_pm value > 25.0 
req tot_pstat_pm value > 0.6 
output sortmin total_score 
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solubility, and expressiblity in E. coli were considered and compared with the scores calcuated for 
the native nitrogenase.260 Based upon all of these considerations, the scaffold 3NWO, a proline 
iminopeptidase from M. smegmatis was selected as a suitable scaffold for the FeMo cofactor. A 
comparison of the mutant protein generated by Rosetta Match/Rosetta Design, and the native 
protein is shown in Figure 6.12. This protein will be referred to as FeMo 3NWO. 
 
Figure 6.12. (A) Active site of the mutant form of PDB code 3NWO housing the FeMo cofactor. Mutated residues 
are shown in blue and as sticks, while nonmutated residues and secondary structure are white and shown as lines. (B) 
Comparison of the mutant and native forms of 3NWO. Coloring is the same as in (A), expect the native form of the 














Table 6.1. Design results 
Feature Feature Name Av. Value 





value observed in 
16067 designs 
Av. Value 

















            
Total restraints 
score /REU 
all_cst 1.69 +/- 
4.73 
0.00/128.17 0.24 +/- 0.09 < 0.5 11099 
Restraint score 
catres1 /REU 
SR_1_all_cst 0.32 +/- 
1.15 
0.00/53.23 0.01 +/- 0.01 < 0.4 13850 
Restraint score 
catres2 /REU 
SR_2_all_cst 0.53 +/- 
1.75 
0.00/28.26 0.11 +/- 0.05 < 0.4 13619 
Restraint score 
catres3 /REU 
SR_3_all_cst 0.84 +/- 
2.37 




SR_3_interf_E_1_2 1.58 +/- 
55.41 
-7.01/2612.53 -1.48 +/- 0.30 < -1.0 6273 
Active site 
repack rmsd 
w/o ligand /A 
nlr_totrms 0.69 +/- 
0.37 
0.00/2.50 0.51 +/- 0.05 < 0.5  5672 
Catres 1 
repack rmsd 
w/o ligand /A 
nlr_SR1_rms 1.20 +/- 
0.85 
0.00/2.38 0.39 +/- 0.82 < 0.5 6676 
Catres 2 
repack rmsd 
w/o ligand /A 
nlr_SR2_rms 1.54 +/- 
1.38 
0.00/4.83 0.77 +/- 0.00 < 1.0 6608 
Catres 3 
repack rmsd 
w/o ligand /A 
  N/A N/A N/A     
Ligand 
"Buriedness" 
SR_3_dsasa_1_2 0.58 +/- 
0.13 






            
Total score 
/REU 
total_score 61.87 +/- 
399.73 
-438.39/6509.37 -1641.71 +/- 
13.79 
< -50.0 8017 
# buried non 
H-bonded 
polar atoms 
tot_burunsat_pm 95.85 +/- 
28.69 
32.00/188.00 470.20 +/- 
11.15 
< 195.0 9435 
# non-local 
contacts 
tot_NLconts_pm 49.50 +/- 
14.53  
16.00/95.00 265.60 +/- 
6.54 
> 25.0 15463 
packstat tot_pstat_pm 0.64 +/- 
0.06 




6.3.2 Attempts at purification of FeMo cluster binding scaffold (FeMo 3NWO) 
FeMo 3NWO contained 16 mutations in the designed FeMo cluster pocket generated and 
many troubleshooting attempts were performed to optimize growth, refolding, and protein stability 
conditions. This thesis will not cover these efforts exhaustively. The calculated molecular weight 
of the protein was 35335 Da. 
Ideally, high-throughput methods protein cloning, expression, and purification would be 
carried out.277 Additionally, use of more robust computational approaches, such as MD 
simulations, might help reduce the amount of time spent troubleshooting protein purification of 
highly-mutated scaffolds, such as those identified in the Rosetta pipeline.278  
6.3.2.1 Growth conditions 
Initially, 5 mL starter cultures using kanamicin (100 μL/mL) and lysogeny broth (LB) were 
grown at 37°C from individual colonies off of an LB+kanamicin plate for 8 hours. These starter 
cultures were then innoculated into 8 L cultures of rich media (4x2 L flasks) and grown overnight 
(16 hours) at 37°C till saturation. At this point, 1 mM Isopropyl β-D-1-thiogalactopyranoside 
(IPTG) was added to the culture to induce protein expression. The culture was shaken at 200 rpm 
and 37°C for 4 hours, at which point the cells were harvested by centrifugation.  
Cell lysis of 4 L of culture was performed using sonication in 100 mL lysis buffer (25 mM 
HEPES, 500 mM NaCl, 10 mM imidazole, pH 7). Cell lysate was collected prior to centrifugation 
(12000 rpm, 30 minutes, 4°C). Supernatant and inclusion body fractions were collected after this 
centrifugation step. The protein of interest (POI) was observed in both the supernatant and 
inclusion body fractions, as evidenced by a band ~35 kDa in SDS PAGE.  
8 mL of the supernatant fraction was mixed with 2 mL of 50% Ni-NTA slurry equilibrated in 
lysis buffer at 4°C for 60 minutes. The lysate-Ni-NTA mixture was added to a small PD10 column 
with the bottom outlet capped. Once the beads had settled, the bottom outlet cap was removed and 
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flowthrough collected. The beads were then washed with 6x1 mL wash buffer (lysis buffer, but at 
20 mM imidazole), and each 1 mL fraction collected. The beads were then washed again with 6x1 
mL elution buffer (lysis buffer, but at 125 mM imidazole). A final elution was performed using 
2.5 mL of 25 mM HEPES, 500 mM NaCl, and 500 mM imidazole, and this entire 2.5 mL fraction 
was collected. Unfortunately, the POI did not appear to bind the Ni-NTA beads despite the 
presence of a 6His tag from the pET-28b (+) vector. Instead, the POI is merely diluted as observed 
in the SDS PAGE gel, and not separated from the other, non-target proteins. Fractions 2a-d were 
collected and run on a size exclusion column using 25 mM HEPES, 500 mM NaCl pH 7 (Figure 
6.13).   
 
Figure 6.13. Size exclusion column chromatograph of fractions collected after Ni-NTA column purification. The 
wavelengths measured were 410 nm (blue), 280 nm (red), and 260 nm (pink).  
SDS PAGE analysis identified the POI present in fractions 10, 11, and 12, although further 
purification steps were unsuccessful. In order to better separate the POI during the Ni-NTA 
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purification step, a commercial, pre-packed column (GE HiTrap IMAC HP) was used instead of a 
slurry added to a PD10 column. A gradient method was run on the AKTA system to aid in protein 
elution, using 25 mM HEPES, 500 mM NaCl at pH, and this same buffer with 1 M imidazole. The 
protein was prepared as described above, and the supernatant was top-loaded into a 5 mL IMAC 
HP column using a P-1 pump and eluted using a gradient method. Wavelengths of 260, 280, and 
410 nm were monitored during the protocol. The elution profile showed a very sharp peak early 
on at fraction ~19, and no other major peaks (Figure 6.14).  
 
Figure 6.14. Elution profile of FeMo 3NWO run on gradient method using a GE HiTrap IMAC HP. Wavelengths 
measured were 260 nm (red lines), 280 nm (blue lines), and 410 nm (pink lines).  
These fractions were collected and analyzed by SDS PAGE (Figure 6.15). The SDS PAGE 
gel showed a large number of contaminating proteins present in the wash fraction of the gradient, 
meaning that most of the unwanted proteins were removed from the cell lysate during Ni-NTA 
purification. In addition, the elution fraction contains only 1 observable band at the approximate 
137 
 
molecule weight (~35 kDa) of the POI. Thus, it is likely that the commercial Ni-NTA column 
successfully bound the POI and was able to separate it from the crude cell lysate. 
 
Figure 6.15. SDS PAGE gel of the wash (~5-15) and elution (~19-21) fractions from Figure 6.14. Left side numbers 
represent molecular weight in kDa. 
In order to more precisely measure the molecular weight of the POI, a portion of the elution 
fraction was buffer-exchanged to water using the 0.5 mL centricons and analyzed via electro-spray 
ionization mass spectrometry (ESI MS). The resulting mass was determined to be 35396 Da 
(Figure 6.16). This is approximately +61 Da from the expected molecular weight of 35335 Da, 
possibly due to the presence of acetate esters, although these should be ionized away and not 
present. In any case, over the next 3 - 6 hours, the elution fraction was kept at 4°C, but the protein 
precipitated in this timeframe. Thus, while it appeared possible to purify FeMo 3NWO, it was 
inherently unstable in the conditions under which it was purified. Thus, conditions were 
investigated to reduce this overall instability. 
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As a note, attempts to improve overall yield of FeMo 3NWO, and especially to improve 
expression of the soluble fraction of the protein, were largely unsuccessful. Changes in the cellular 
growth temperature (16 °C, 20 °C, 25 °C, 30°C, and 37°C) showed no differences in inclusion 
body vs soluble fraction ratio. Changes in the concentration of IPTG (100 µM – 1 mM) added 
upon protein expression induction also did not lead to improved soluble fraction yield.279 
Additionally, autoinduction media, which can aid in increasing the amount of soluble protein 
generated during cell growth,280 was unsuccessful in improving the amount of soluble protein the 
case of FeMo 3NWO, although it did improve overall protein yield in the insoluble, inclusion body 
fraction. 
 
Figure 6.16. ESI MS of the ‘elution’ fraction from Figure 6.14. Expected molecular weight is 35335 Da. 
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6.3.2.2 Refolding conditions 
FeMo 3NWO was grown using 4 L of autoinduction media at 37°C for 48 hours. The cells 
were harvested and the inclusion body portion was unfolded using 100 mL of 6 M GnHCl 
overnight. The unfolded protein was added drop-wise to 1400 mL 10 mM TRIS pH 8 at 4°C with 
rapid stirring. This was stirred at 4°C for 1 hour. After this 1 hour, the solution was centrifuged 
(8000 rpm, 30 minutes, 4°C) to removed precipitant. The supernatant was collected and 
concentrated to ~10 mL, at which point it was loaded onto a size exclusion column and run using 
10 mM TRIS pH 8 (Figure 6.17). The chromatogram from this column had a primary protein peak 
at fractions 20 – 28, with minimal other additional elution.  
 
Figure 6.17. Size exclusion chromatograph from the supernatant fraction of refolded inclusion body of 4 L of 
autoinduction media for FeMo 3NWO. The wavelengths monitored were 410 nm (blue lines), 280 nm (red lines), and 
260 nm (pink lines). 
An SDS PAGE gel was run to alayze fractions 20 – 28 (Figure 6.18). The lanes containing 
fractions 20 and 21 contain only a few small bands at ~15 kDa. Fractions 22 – 27 all contain a 
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large number of bands. Fraction 22 has the most distinct bands at ~15 kDa, and lighter bands at 
higher molecular weights. Most importantly, there appear to be 2 bands at 35 and 37 kDa. These 
two bands are also present in fractions 23 – 27. It is likely that the band at ~35 kDa is FeMo 
3NWO, but it is unclear what the other contaminating proteins may be. However, given that all 
the bands appear in every fraction, separation of the proteins based on size was quite poor.  
 
Figure 6.18. SDS PAGE analysis of protein purification protocol from a size exclusion column of refolded FeMo 
3NWO (Figure 6.17). The lane labels, from left to right, are fractions 20 – 24, BIORAD Precision Plus Protein Ladder 
(L), and fractions 25 -28. 
Given the most distinct appearance of the band at ~35 kDa in fractions 24 – 27, these were 
pooled and analyzed by ESI-MS (Figure 6.19). The primary protein peak observed was at 35204 
Da. Other peaks were 36625 and 44525 Da, although the overall concentration of the main peak 
was not significantly higher than the background signal. This peak is close to the expected 
molecular weight of 35335 Da for FeMo 3NWO. In fact, removal of the start codon methionine 
gives a calculated molecular weight of 35203.47 Da. Thus, it is possible that the observed band 
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after protein refolding and size exclusion chromatography is FeMo 3NWO without the start codon 
methionine.  
 
Figure 6.19. ESI MS of pooled fractions 24 – 27 from Figure 6.17. 
Again, unfortunately, after approximately 3 - 6 hours, the solution pooled after size 
exclusion chromatograph showed a large amount of precipitation. The same molecular weight 
observed in Figure 6.19 was not observed when repeat measurements using ESI MS were 
performed on the same sample (Figure 6.20). It still appeared that the protein was unstable under 
the conditions of refolding that were used, and attempts to refold the protein at different pH values 





Figure 6.20. ESI MS of pooled fractions 24 – 27 from Figure 6.17 collected approximately 6 hours after Figure 6.19 
was collected.  
6.3.3 Use of CcP as FeMo cluster binding scaffold 
Given the difficulties in stabilizing the original design (3NWO), a new scaffold protein was 
utilized in an attempt to overcome some of the challenges presented above. First, a minimal 
number of mutations required to geometrically house the FeMo cluster were desired. Second, the 
protein to be used would ideally have a stable apo form. Third, the protein would be one which the 
Lu lab already utilizes to reduce the amount of troubleshooting required. Cytochrome c peroxidase 
(CcP) fits these criteria, and was selected as the new scaffold protein for the FeMo cluster. 
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6.3.3.1 Rosetta Design to identify mutations suitable for the FeMo cluster in CcP 
The Rosetta Match and Rosetta Design functionalities were utilized on the CcP structure 
2CYP. A large number (~2000) of mutant proteins were identified after Rosetta Design was run. 
ScoreFiltering was employed using the cutoff values in Figure 6.21. This reduced the number of 
suitable designs down to ~15.  
 
Figure 6.21. Cutoff requirements used in filtering the CcP designs identified by Rosetta Design. 
Next, the designs were manually inspected to take into account factors such as proximal 
and distal heme residues important for binding as well as sterics. In addition, in some of the designs 
Rosetta Design would incorporate unnecessary, unproductive mutations for binding of the FeMo 
cofactor, such as moving a salt bridge through a 3-mutation change of a loop region to move a 
glutamate residue down the loop, which were ignored and removed during manual inspection. 
Ultimately, the mutant protein R48A W51H H52A H175A S185C CcP (“FeMo CcP”) was 
identified for a few reasons. The W51H and S185C mutations were identified by Rosetta Match 
as the FeMo ligands, and are not sterically problematic. H52A, and H175A were introduced 
because these histidines could influence FeMo cofactor binding, and were thus removed. R48A 
was introduced to remove steric hinderance in the cluster bound form (Figure 6.22). 
req all_cst value < 0.5 
req SR_1_all_cst value < 0.05 
req SR_2_all_cst value < 0.05 
SR_3_all_cst value < 0.4 
req SR_3_interf_E_1_2 value < 0 
req nlr_totrms value < 0.5 
nlr_SR1_rms value < 0.5 
nlr_SR2_rms value < 1.0 
req SR_3_dsasa_1_2 value > 0.7 
req total_score value < 0 
tot_burunsat_pm value < 195.0 
tot_NLconts_pm value > 25.0 
tot_pstat_pm value > 0.6 




Figure 6.22. Mutations (blue) compared against wild type (red) CcP in the designed FeMo binding pocket. 
A Gibson Assembly was used to incorporate the mutations. Given the large distance 
between mutations R48A and S185C, a 2-block Gibson Assembly was utilized. The components 
used in the Gibson Assembly are outlined in Figure 6.23. A 2% agarose DNA gel was used to 
make sure that the correct products were generated during PCR and the assembly itself (Figure 




Figure 6.23. Components of the Gibson Assembly used to generate FeMo CcP. Overlaps between inserts are 













Vector forward primer:  ggggagccgctaacaacgtct 
Vector reverse primer:  catcttccctcagcttgagtgc 
Insert1 forward primer: gcactcaagctgagggaagatg 
Insert1 reverse primer: ctccatggaatcttgggaccc 
Insert2 forward primer: agttcctggagcccattcaca 




Figure 6.24. 2% agarose DNA gel used during Gibson Assembly of FeMo CcP. The different wells, from left to right, 
are (1) the DNA ladder, 2-log 0.1 – 10kb, Insert 1, Insert 2, Vector, and the finalized Gibson Assembly 
Purification of FeMo CcP followed a previous reported protocol.281,282 5 mL starter cultures 
were grown for 8 hours and inoculated into 2 L rich media cultures for overnight growth. 100 µM 
IPTG was then added to induce protein expression for 4 hours, after which time the cells were 
harvested or frozen at -20°C. The cells were lysed in 200 mM KPi pH 7.5 30 mM EDTA, with a 
small amount of PMSF dissolved in ethanol added. The cell debris were removed via 
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centrifugation (8000 rpm, 30 minutes, 4°C), and then the supernatant fraction was batch-bound to 
DEAE beads overnight by adding Millipore water till the conductance was < 3 milliSiemens. Next, 
the DEAE column was run using the “CcPDEAE1” program, which utilizes buffer A (50 mM KPi 
pH 7 1 mM EDTA), and buffer B (buffer A + 500 mM KCl) (Figure 6.25). 
 
Figure 6.25. DEAE column chromatograph of the supernatant from a 4 L growth of FeMo CcP. Wavelengths 
monitored were 260 nm (pink), 280 nm (blue), and 410 nm (red). 
Fractions 14 – 76 from Figure 6.25 contained the FeMo CcP, and thus these were pooled 
and concentrated then further purified by size exclusion chromatography running 100 mM KPi pH 
7. The purified protein was then concentrated and analyzed via UV/Vis spectroscopy (Figure 6.26), 
ESI mass spectrometry (Figure 6.27), and PAGE (Figure 6.28).  
UV/Vis demonstrated that only a small fraction <5% of heme contamination was present 
(Figure 6.26). ESI mass spectrometry of the protein identified the correct molecular weight (Figure 
6.27). Curiously, the protein did not appear to migrate in the PAGE gel exactly to the correct 
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molecular weight, which may be due to the low pI ~ 5. Since SDS was not used for the gel in 
Figure 6.28, the charge would not be uniform and thus the protein might migrate at a different rate. 
However, use of WT CcP (lanes 5 – 7) confirmed that the large band in lanes 1 – 4 (FeMo CcP) 
was indeed the correct molecular weight. Overall, it was much more straightforward to purify the 
FeMo CcP protein compared to FeMo 3NWO, given the increased stability of FeMO CcP and 
known purification scheme.  



















Figure 6.26. UV/Vis spectrum collected in 100 mM KPi pH 7 of the concentrated fractions from FeMo CcP after size 




Figure 6.27. ESI MS of the concentrated fractions of FeMo CcP after size exclusion chromatography. The expected 




Figure 6.28. PAGE analysis of FeMo CcP and WT CcP. Lanes 1 – 4 are of FeMo CcP at undiluted, 2-fold, 5-fold, 
and 10-fold dilutions. Lanes 5 – 7 are of WT CcP at undiluted, 2-fold, and 10-fold dilutions.  
A collaboration was established with Marcus Ribbe from the University of California 
Irvine, an expert of the biosynthesis, extraction, handling, and reinsertion of the FeMo cofactor.283 
Purified protein samples were shipped to assess spectrophotometric and chromatographic evidence 
for cluster incorporation, as well as possible activities. Preliminary results detects similar EPR 
signals from FeMo CcP upon addition of an Fe-S analog of the FeMo cluster, both before and after 
addition of dithionite.  
6.3.4 Improvements to approach 
The approach described in this thesis chapter suffers from a low-throughput methodology 
that relies quite heavily on manual inspection, as well as chemical and biological intuition. As 






expended in purifying this mutant, future endeavors should seek to reduce this time spent prior to 
attempts at protein expression. 
Computationally, when a large number of mutations are identified by Rosetta Design, such 
as the 16 found in the case of FeMo 3NWO, each can be reverted individually back to the native 
residue, and then repacked and minimized in Rosetta. In a step-by-step manner, then, non-
productive mutations that negatively impact the scoring parameters from Table 6.1 can be removed 
as excessive and unnecessary. Experimentally, more high-throughput analysis of protein stability 
could be employed in order to maximize the number of suitable scaffolds, such as uitilization of 
fluorescent tags which bind to misfolded or unfolded proteins.284,285 Unfortunately, given the 
instability of the FeMo cofactor and its analoges, high throughput analysis of ligand binding is 
unsuitable in this case, but might be suitable for the apo forms of the proteins. 
6.4 Summary 
In conclusion, the Rosetta software suite, most notably Rosetta Match and Rosetta Design, 
were utilized to identify scaffolds which could possess suitable amino acid positions for mutation 
to geometrically house the FeMo cofactor of nitrogenase. Utilizing the full Rosetta pipeline, a 
proline iminopeptidase (PDB ID 3NWO) was identified as appropriate for investigation by having 
suitable geometry and Rosetta scores. Unfortunately, extensive optimization of purification 
protocols and growth conditions were unsuccessful in obtaining sufficient quantities of protein for 
analysis. To overcome this limitation, a protein which met the criteria of being stable in the apo 
form, expressible in E. coli, and previously studied in the Lu lab was chosen. Cytochrome c 
peroxidase met these criteria, and mutations to house the FeMo cofactor in the CcP scaffold were 
identified using Rosetta. The plasmid DNA for these mutations was cloned via Gibson Assembly, 
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and the protein then purified and identified using PAGE and ESI mass spectrometric analysis. 





















Chapter 7 Conclusions and Future Directions 
7.1 Overall summary 
This thesis describes work done towards understanding O2 and NO reduction in a 
biosynthetic model of NOR in sperm whale myoglobin (FeBMb), as well as utilization of the 
Rosetta software suite to engineer more complex heteronuclear metallic binding sites. Chapter 2 
focused on describing computational and spectroscopic studies of the FeB-NO interaction, which 
was isolated using a ZnPPIX-replaced variant of FeBMb which did not bind NO at the heme site. 
Chapter 3 described results using NRVS to collect complete vibrational modes and properties of 
both the heme-NO and nonheme-NO interactions with a variety of different heme and nonheme 
metal ions, as well as, how these influence the properties of NO, and what these influences have 
on the NOR reaction mechanism and future designs moving forward. Replacement of ‘native’ 
nonheme iron in FeBMb with ‘non-native’ cobalt and manganese, and the effect that these 
substitutions had on O2 reduction was covered in Chapter 4. The same investigation was carried 
out, but with regards to NO reduction in Chapter 5. The Rosetta software suite was utilized in 
Chapter 6 in an attempt to expand the scope of biosynthetically designed enzymes. Rosetta Match 
and Rosetta Design were used in identifying new scaffolds, or mutations in CcP, that would 
potentially house the nitrogenase FeMo cofactor.  
7.2 Future directions 
7.2.1 Detection and characterization of F33Y tyrosyl radical in F33Y CuBMb 
This thesis has focused mainly on characterizing the effect that replacing and changing the 
identity of the heme and nonheme metal has on different reactivities of FeBMb. Of note is that the 
impact that specific residues have on these activities has not been fully investigated nor thoroughly 
characterized. For instance, introduction of the F33Y mutation into CuBMb (FeBMb without the 
V68E mutation) imparts greater activity, higher turnovers, and decreases the amount of ROS 
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produced when performing O2 reduction.
5,178 Studies into the effects that this mutation has on the 
heme-O2 character and hydrogen bonding network around the heme pocket have not fully 
elucidated all influences of this mutation,232 especially considering that in native HCOs the 
catalytic tyrosine is expected to play a role in both proton and electron shuttling during catalysis.15  
An interesting direction to take the research would be to obtain a deeper understanding of the 
roles of tyrosine (Tyr) in proton-coupled electron transfer (PCET) processes in heme-copper 
oxidases (HCOs), by measuring reduction potentials (E°´) of Tyr next to the heme-copper active 
site, their dependence on pH (i.e., Pourbaix diagram) and then determining their effects on HCO 
activity. While Tyr has been shown to have fundamental implications in numerous enzymes, from 
O2 reduction in HCOs, to water oxidation in Photosystem II,
286–288 a holistic understanding of the 
roles of Tyr has been hampered in native enzymes due to enzyme size, difficulties in purifying to 
homogeneity and the presence of other cofactors that interfere with the focus on Tyr. One challenge 
is in understanding the role of the E°´ of Tyr and its pH dependence in the functionality of HCOs.  
Such studies have not been performed in native enzymes.287 To overcome these limitations, 
structural and functional models of HCOs (e.g. F33Y CuBMb) previously prepared in the Lu group 
could be used to explore the role of the Tyr in the O2 reduction mechanism of HCOs. A deeper 
understanding of the kinetic and thermodynamic effects of Tyr redox pH dependence is 
fundamental to discerning its role in the above-mentioned processes and will lead to a new 
generation of robust, low-overpotential biocatalysts for the oxygen-reduction reaction (ORR). 
Efforts to change the pKa of the F33Y tyrosine through the introduction of unnatural amino acids 
in CuBMb variants have provided valuable insights into the specific role that these physical 
parameters play in the reaction.289 However, these studies did not measure these effects inside the 
protein, but were rather collected in solution. Thus, creating a model system to study the influence 
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of reduction potential and pKa for the catalytic tyrosine residue towards O2 reduction is a major 
barrier to fully characterizing this reaction. 
7.2.1.1 Generation of Pourbaix diagram 
A Pourbaix diagram compares the voltammetric half-wave potential to the solution pH for 
whatever system is being studied. Such investigations of tyrosine-radical proteins are very 
few,287,290 and these systems are de novo designed proteins without catalytic activity. Thus, these 
results lay the foundation for future studies on more complex systems from which deeper, more 
meaningful, and possibly fruitful information can be gathered. In order to hone-in on the 
catalytically-active Tyr residue, the mutant protein K102Q Y103F Y146F Y151F F33YCuBMb – 
hereby referred to as ‘No Y’ F33Y CuBMb – was purified to remove the additional tyrosine 





Figure 7.1. Crystal structure of F33Y CuBMb (PDB code 5HAV) showing the additional tyrosine residues (Y103, 
Y146, Y 151) which were mutated to phenylalanine. 
7.2.1.2 Use of differential pulse voltammetry (DPV) 
Preliminary data suggests that ‘No Y’ F33Y CuBMb exhibits similar behavior to the small 
model protein utilized in the literature. With application of thin liquid layers of protein on the 
surface of a glassy carbon electrode surface, the potential of the tyrosyl radical redox pair shifts in 
a pH-dependent manner from higher potentials at low pH (approx. +0.9 V vs. AgCl for pH 4) to 
significantly lower potentials as high pH (approx. +0.65 V vs. AgCl for pH 10).  Analysis of 
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denatured protein shows that these potentials are lower than observed in a completely unfolded 
state (approx. +0.97 for pH 4 and approx. +0.71 for pH 10), so it appears that the protein is not 
completely denaturing upon application to the electrode surface.  However, because the traces had 
very weak current response upon use of a new sample (frozen after purification), but a previous 
sample showed the appearance of more ideal traces with better current response after a time, some 
protein degradation or other conformational changes may be involved on a larger timescale. Buffer 
exchange of the protein into a solution of the appropriate pH prior to measurement of reduction 
potential may prevent any problems associated with transfer of protons to the protein on the surface 
of the electrode and may be applied in the future to optimize current response. 
7.2.2 Additional FeBMb mutants (e.g. F33Y and/or G65Y) 
As previously mentioned, F33Y CuBMb shows significantly improved O2 reduction activity 
compared to CuBMb without the mutation.
178 While this type of effect is promising, the question 
of whether or not these effects are cumulative and translational remains to be further investigated. 
That is to say, does the F33Y mutation impart similar effects in a similar, but different biosynthetic 
system? One means of targeting this goal would be to create mutants in FeBMb that mirror those 
already characterized for CuBMb. These mutants include, but are not limited to, F33Y and G65Y, 
or L32E.  
7.2.2.1 Effects on NO reduction 
Previous results in the FeBMb scaffold demonstrated that introduction of the I107E mutation 
improved product (i.e. N2O) formation significantly.
7 This was attributed largely to introduction 
of an extended hydrogen bonding network that seeks to mimic the native glutamate residues found 
in NOR.65 However, there exists an additional glutamate important for activity that has yet to be 
biosynthetically mimicked in the FeBMb proteins.
1 One promising mutation, based on the crystal 
structure of FeII-I107EFeBMb(Fe
II) is that of L32E, which is adjacent to the distal pocket, would 
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not significantly increase the size of the residue (Figure 7.2). Additionally, since both F33Y and 
G65Y have also been implicated in altering the hydrogen bonding network in and around the distal 
heme pocket, such an effect may also have a beneficial impact on NO reduction as it did for O2 
reduction.178,232 Most notably, these mutations may be coupled with additional design principles, 
such as nonheme and heme metal replacement as described in this thesis, or heme type replacement 
to tune reduction potential as described previously, in order to facilitate rapid, multi turnover NO 
reduction.198 Such an endeavor has been an elusive component of the FeBMb model since it was 
first designed,6 but such advances in the scope of design principles and avenues should allow for 
this hurdle to be overcome. 
 
Figure 7.2. Positioning of important binding/catalytic residues needed for the L32E I107E FeBMb mutant. PDB 
structure was generated from FeII-I107EFeBMb(FeII) crystal structure (PDB ID 3M39). 
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7.2.2.2 Effects on O2 reduction 
While F33Y and G65Y were shown to have beneficial effects in CuBMb towards O2 reduction, 
it has not been observed whether or not this same effect will occur in a system such as FeBMb. 
Given the differences between the two proteins, including different primary coordination spheres 
and, most strikingly, differences of the nonheme metal identity, it would be of great interest to 
characterize the effect that these tyrosine mutations have on O2 reduction activity. Additional 
structural and spectroscopic studies would be warranted to explain any differences that might arise.  
7.2.3 Additional nonheme metals in FeBMb (e.g. V or Ni) 
This thesis has described studies involving manganese and cobalt binding to the nonheme 
site in FeBMb. It has been shown that such substitutions play an important role in tuning the activity 
and other properties of the protein. This would be an even greater tool should the array of nonheme 
metals capable of binding the nonheme site were increased. Thus, the ability of other first row 
transition metals such as vanadium, chromium, or nickel to bind to the nonheme site of FeBMb 
should be investigated and their nonheme site binding conditions optimized. This will allow for 
increased catalytic scope and provide further fine-tuning of reactivity, a keystone of protein design 
and engineering in general.  
7.2.4 Increasing reactivity scope of FeBMb 
While the majority of this thesis has focused on O2 and NO reduction, myoglobin itself has 
been used for a wide variety of catalytic purposes.292,293 It is possible that given the introduction 
of an additional nonheme metal, this catalytic scope can  be further increased. This may include 
organic or other small molecule substrates, which would be useful for catalytic and synthetic 
purposes in the production of valuable products,292 or an expansion to other similar substrates to 
O2 and NO, such as CO, CN, acetylene, or even N2 if the design is robust enough. 
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7.2.4.1 Heme replacement in Mb already demonstrated 
Interestingly, noble-metal replacement of the heme group in myoglobin has been 
performed by the Hartwig group.294 Utilizing low Fe expression conditions, along with affinity 
purification and a wide variety of different PPIX groups (e.g. Co, Cu, Mn, Ir, Ag) they were able 
to successfully purify myoglobin containing these different PPIX substituents in an efficient, 
higher throughput manner than the harsh, acid-MEK conditions described in this chapter. They 
identified Ie(Me)-PPIX as being particularly effective in both C-H insertion and cyclopropanation 
reactions, while also comparing the reactivities across multiple mutations of the H93 position.294 
Similar strategies have been employed in some P450 systems, with comparable results.295    
7.2.4.2 Nonheme replacement possible in FeBMb, allowing for large number of metal 
combinations 
Given that FeBMb can bind not only different heme groups, but is also capable of binding 
multiple different nonheme metals as well, there is a distinct possibility that such a combination 
broadens the substrate scope and activity of the protein. While it would be a monumental 
undertaking to individually investigate every combination of heme/nonheme metal, the 
development of the above-mentioned higher throughout method of heme replacement, coupled 
with the development of a means for more readily incorporating a nonheme metal of choice during 
protein purification of FeBMb would allow for more rapid, efficient, and scalable studies. 
7.2.5 FeMo-CcP investigations 
Preliminary results from the Ribbe lab suggest that the L-cluster, an Fe-S analog of the 
FeMo-cofactor, is capable of binding to FeMo-CcP, and that this bound L-cluster is also redox-
active. Future endeavors towards crystallizing both the apo and holo form of the protein are 
imperative, as well as activity assays towards the various substrates of native nitrogenase. These 
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studies will help inform additional mutations that can be made to CcP for improving activity, 
cofactor and substrate binding, and stability. 
7.3 Conclusions 
7.3.1 Support for trans NOR mechanism in FeBMb 
The NO binding properties of the FeB site in a biosynthetic model protein of NOR were 
probed by replacing the high affinity heme with isostructural ZnPPIX in the protein FeBMb. Such 
feats are not easily achievable in native NORs, as these are complex membrane proteins with 
multiple heme cofactors. Structural overlays with cNOR clearly show that the FeB site in Fe
II-
FeBMb(Zn
II) is a structural mimic of the FeB site in the native enzyme. EPR spectral studies show 
that NO binding to the FeB site yields rhombic signals corresponding to a {FeNO}
7 S = 3/2 ferrous-
nitrosyl complex. Mössbauer, and QM/MM studies confirmed the electronic properties of the 
{FeNO}7 complex in FeII-NO-FeBMb(Zn
II) as HS ferrous (S=2) antiferromagnetically coupled 
with NO radical (S=1/2) [Fe2+-NO]. This exciting finding indicates that the radical nature of the 
NO would facilitate the radical coupling of the second heme-bound NO to promote N-N bond 
formation, supporting the proposed trans mechanism of NO reduction by NORs. 
7.3.2 Site-specific labelling of nonheme and heme irons possible 
Selective substitution of either the heme or nonheme sites with 57Fe in FeBMb provides an 
independent structural probe for either of the two metal sites. NRVS measurements quantify the 
forces exerted on 57Fe by its coordination environment and indicate the presence of high-spin iron 
at both sites in the absence of substrate. E-FeBMb(Fe
II/III) serve to model the initial and final states 
of the enzyme, respectively, although the vibrational signals provide no evidence for a solvent-
derived ligand bridging the metals in the oxidized state, found in cNOR.1 Rather, vibrations of the 
heme Fe are comparable to those reported for native Mb, confirming that the heme is unperturbed 
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by the engineered nonheme site. On the other hand, the observation of distinct vibrational 
dynamics for the nonheme Fe confirms successful site-specific labelling with 57Fe.  
Substitution of a redox-incompetent ZnII ion for FeII in either the nonheme or heme sites allows 
for the preparation of stable mononitrosylated intermediates that would precede the formation of 
the putative (and unstable) dinitrosylated intermediates. The presence of ZnII in the nonheme site 
perturbs the vibrational properties of the adjacent heme-NO complex, in a manner consistent with 
electron transfer to the NO ligand. This suggests that electrostatic influence of the nonheme FeII 
in NOR could act to promote the enzymatic reaction in either the trans or the cis heme 
mechanism.43 With ZnII in the heme site, alteration of the nonheme Fe vibrations upon exposure 
to NO confirms that NO can bind to the nonheme FeII if the heme site is unavailable, as would be 
required in the trans mechanism. 
7.3.3 O2 reduction not dependent on redox activity of nonheme metal 
The roles of manganese and cobalt in conferring and fine-tuning O2 reduction activity in FeBMb 
were investigated. MnII or CoII binding at the nonheme iron site was observed with UV/Vis 
spectroscopy and confirmed by x-ray crystallography. Enzymatic activity assays of O2 reduction 
with and without catalase and superoxide dismutase identified the majority of product formation 
as H2O rather than ROS such as peroxide. Interestingly, the total turnover number and ROS 
production of each nonheme variant follows the same trend as Kd, suggesting that nonheme 
binding affinity plays an important role in the ability of each variant to perform multiple, complete 
reactions, especially given that E-FeBMb(Fe
II) displays poor O2 reduction activity and product 
selectivity. Spectroscopic results from XANES and rR suggest that electron transfer from the 
nonheme metal ion is not strictly required for selective 4-proton, 4-electron reduction of O2 to 
H2O. Rapid stopped-flow UV/Vis and rR spectroscopies, coupled with DFT calculations, 
identified important mechanistic information regarding the roles of nonheme MnII and CoII on O2 
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binding and activation. Overall, these results clarify future efforts towards understanding specific 
structural, redox, and electronic features required for efficient O2 reduction and may assist in future 
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